Use of OCT and Oculus Pentacam HR as Aids to Semi-Scleral Contact Lens Fitting by Otchere, Heinz
Use of OCT and Oculus Pentacam HR
®
 as 
Aids to Semi-Scleral Contact Lens Fitting 
 
 
 
                                     by 
Heinz Otchere 
 
 
 
       A thesis 
presented to the University of Waterloo 
in fulfillment of the 
thesis requirement for the degree of 
Master of Science 
in 
Vision Science 
 
 
Waterloo, Ontario, Canada, 2013 
 
 
 
© Heinz Otchere 2013 
ii 
 
AUTHOR'S DECLARATION 
I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, 
including any required final revisions, as accepted by my examiners. 
I understand that my thesis may be made electronically available to the public. 
iii 
 
Abstract 
Purpose 
 
To determine whether semi-scleral contact lenses (sSCL) can be appropriately fitted using 
corneal sagittal depth (CSD) measurements with OCT and to determine the impact of fit on 
fitting characteristics, visual acuity (VA) and comfort ratings. The specific aims of each 
chapter are as follows: 
 
Chapter 2: To determine the repeatability and accuracy of the Oculus Pentacam HR
®
 
(Wetzlar, Germany) based on six polycarbonate aspheric surfaces of known radius of curvature 
and shape factors. 
 
Chapter 3: The first purpose was to assess the repeatability of the Visante™ OCT and  Oculus 
Pentacam HR
®
 in measuring the topographic corneal thickness (TCT) in keratoconus (KC) and 
pellucid marginal degeneration (PMD). The second purpose was to compare the 
reproducibility of the two instruments for TCT measurements. 
 
Chapter 4: The first purpose was to assess the repeatability of the Medmont E300™ and 
Oculus Pentacam HR
®
 in measuring the topographic radius of curvature in KC and PMD. The 
second was to compare the reproducibility of the two instruments for topographic radius of 
curvature measurements. 
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Chapter 5:  The main purpose of this study was to measure CSD using Visante™ OCT and 
its effect on the sSCL selection.  The second purpose was to assess the effect of the fitting 
characteristics of sSCL on the cornea, and how VA is impacted by the choice of fit. The third 
purpose was to measure the topographic corneal clearance (TCC) using the ultra-long OCT 
(UL-OCT). The fourth purpose was to assess the effect of time on the TCC over 1 hour of 
sSCL. The last purpose was to assess the comfort ratings of the sSCL. 
 
Methods 
 
Chapter 2: Six polycarbonate aspheric surfaces (Bausch and Lomb, Rochester, NY, USA) of 
specific colour coding (red, white, blue, brown, green and yellow) and of known radius of 
curvature and shape factor were randomly selected and measured using the Oculus Pentacam 
HR
®
. Three repeated measurements of all the six surfaces were taken at approximately two 
minute intervals. These measurements were repeated at least 48hrs apart on three separate 
days. 
 
Chapter 3: Twenty healthy participants who had been diagnosed with KC (n=18) and 
PMD (n=2) were recruited. This study involved two study visits where corneal thickness 
measurements were repeated after at least 48 hours. Measurements from one eye only were 
taken (right eye=12; left eye=8). On the first study visit, two repeated corneal thickness 
measurements were obtained, first with the Visante™ OCT and second with the Oculus 
Pentacam HR
®
. This measurement was repeated at least 48hrs later and the same order of 
measurements was maintained for all the participants. Topographic corneal thickness (TCT) 
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(microns) were recorded in the 90, 180 and oblique (45 and 135) meridians at 1mm 
intervals across 8mm of the central cornea.  
Chapter 4: Twenty healthy participants who had been diagnosed with KC (n=18) and 
PMD (n=2) were recruited. This study involved two study visits where radius of curvature 
measurements was repeated after at least 48 hours. Measurements from one eye only were 
taken. Two repeated radius of curvature measurements were obtained, first with the Medmont 
E300™ and second with the Oculus Pentacam HR®. This measurement was repeated at least 
48 hours and the same order of measurements were obtained for all the participants. 
Topographic radius of curvature (diopter) was recorded in the 90, 180 and oblique (45 
and 135) meridians at 1mm intervals across 8mm of the central cornea.  
 
Chapter 5: Three sSCL (Jupiter 15mm; Essilor) were fit to 20 subjects who had previous 
diagnoses of KC (n=18) or PMD (n=2). The fitting of the sSCL were based on the CSD 
measured with the Visante™ OCT at a 15mm chord on the horizontal meridian. To select the 
sSCL from the diagnostic trial lens set, values of 325 (lens 1), 375 (lens 2) and 425 (lens 3) μm 
were randomly added in sequence to the CSD. Subjects were allowed to wear each of the sSCL 
for 1hour. After this time, the central corneal clearance (CCC) was assessed using an UL-OCT, 
high contrast visual acuity (HCVA) and low contrast visual acuity (LCVA) were measured 
using a LogMAR VA chart and comfort ratings were obtained using a comfort rating scale (0-
100). 
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Results 
 
Chapter 2: To assess repeatability, the measurements were compared to the results obtained 
for the three separate days. There were no significant differences between the radius of 
curvature measurements obtained on the three separate days (p>0.05). Similar findings were 
also obtained for the shape factor (p>0.05) except for colour brown (r=7.81mm, p=0.70) 
(p=0.01). There was more variability relative to the mean in the distribution for the colour 
green (r=7.80mm, p=0.49) with coefficients of variation (COV) of 0.70%. Similar patterns 
were seen in colours blue and white with COV of 0.60% and 0.61% respectively. The highest 
COV for the shape factor was seen in the colour green with 33.19% and the yellow (r=7.3mm, 
p=0.75) surface recorded the lowest COV with 10.43%. There were significant linear 
correlations (r=0.99, p=0.001) between the mean radius of curvature, shape factors and the 
true values for all the three day sessions.  
 
Chapter 3: The mean CCT for Visante™ OCT was 484.97±43.14µm and Oculus Pentacam 
HR
® 
was 478.86±45.31µm. There was no significant difference in the TCT between the two 
visits (p=0.54) and measurements (p=0.63) for Visante™ OCT. There was also no significant 
difference in the combined visits, axes and locations (p=0.86). For Oculus Pentacam HR
®
, no 
significant difference was found in the visits (p=0.18) but difference exists in the 
measurements (p=0.001). There was also significant difference in the combined visits, axes 
and locations (p=0.001). Tukey post-hoc analysis shows the differences (p˂0.05) were found in 
the +1 and +4 locations in the 135 meridian. For reproducibility, significant differences were 
found in the interactions between instruments, axes, measurements and locations (p˂0.05). 
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Chapter 4: The mean central radius of curvature (CRC) for Oculus Pentacam HR
®
 was 
50.38±5.81D and that of Medmont E300™ was 49.41±4.93D. There was a significant 
difference in the visits (p˂0.05) but no difference in the measurements (p=0.98) for the 
Medmont E300™. There was also no significant difference in the combined visits, axes and 
locations (p=0.12). Results from the Oculus Pentacam HR
® 
show no significant differences in 
the visits (p=0.32) and measurements (p=0.66). There was also no significant difference in the 
combined visits, axes and locations (p=0.24). For reproducibility, significant differences were 
found between the instruments, axes and locations (p˂0.05). Other interactions between the 
instruments did not show any difference. 
 
Chapter 5: The mean CSD in the horizontal meridian was 3.78±0.53 (range: 3.33-4.17) mm at 
a 15mm chord. The mean CCC was 190±100, 360±120 and 450±170 µm for each lens 
respectively (p=0.001). The mean CCC loss was 30.00±40.00, 30±60.00 and 40.00±50 µm for 
each lens respectively (p>0.05). The mean HCVA for lenses 1, 2 and 3 were 0.05±0.12, 
0.07±0.11 and 0.11±0.08 respectively, which were significantly different (p=0.02). Tukey post 
hoc analysis demonstrated that this difference was only significant between lenses 1 and 3 
(p=0.01). Similar findings were found for LCVA. The overall comfort rating for all three sSCL 
was 77.7±10.6. The comfort ratings for lenses 1, 2 and 3 were 74.9±9.2, 79.7 ±11.6 and 
78.6±10.8 respectively. These differences were not significantly different (p=0.24). 
 
Conclusions 
 
Chapter 2: Oculus Pentacam HR
® 
was a repeatable and accurate instrument for this experiment 
for the majority of radii of curvature and shape factors. Based on the small number of test 
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surfaces in terms of number and curvature variations, it was unpredictable as to whether either 
the range of radii of curvature or shape factors were over or under-estimated by the instrument, 
as no clear trends were detected.  
 
Chapter 3: The Visante™ OCT gave repeated measurements for the two visits as there were no 
significant differences in respective locations in all meridians. Oculus Pentacam HR
®
 gave 
repeatable measurements for the majority of the locations. The two instruments were not 
reproducible and should not be used interchangeably; therefore, care must be taken interpreting 
the TCT from the two instruments. It is advisable to take at least two measurements and 
average in order to minimize variations between measures. Manufacturers of Oculus Pentacam 
HR
® 
may consider including a calibration test surface so that practitioners would be able to 
calibrate the instrument each time it is being used.  
 
Chapter 4: Each of the instruments per se gave repeatable measurements, as there were no 
significant differences in the two visits, axes and locations. However, although the two 
instruments were found to be produce similar results for the majority of the locations; there 
were significant differences between measurements of the two devices particularly for the 
oblique meridians in the periphery.  
  
Chapter 5: Evaluation of CSD can be used effectively to select which sSCL to fit on the eye. 
The results of this study suggest that lens 2 (adding 375 μm to the CSD) gave the best 
combination of VA and comfort ratings. However, evaluation of the fluorescein pattern must 
be balanced with the VA and comfort ratings for successful fitting of sSCL in a clinical setting. 
ix 
 
There was also a likelihood of topographic corneal loss after 1 hour of sSCL wear; however, 
this may vary depending on many factors such as scleral zone and its relationship with the 
scleral conjunctiva. Eyelid force, design of the contact lens and other unknown factors may 
play a part in the contact lens settling time and amount. 
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Chapter 1 
Introduction and Literature Review 
 
1.1 Keratoconus and Pellucid Marginal Degeneration 
Keratoconus (KC) as it is known today has evolved from several prior names and descriptions, 
including hyperkeratosis, ochlodes, conical formed cornea, cornea conica, cornée conique, 
sugar loaf cornea, prolapses corneae, procidentia corneae, among many others. 
1
 Until 1854, 
the meaning, description and associations of the condition were somewhat obscured. 
1
 John 
Nottingham is credited to have given a treatise on KC 
1, 2
 and current trends have been given by 
Krachmer et al. 
3
 Keratoconus is derived from the Greek word kerato (cornea) and conus 
(cone) and is the most common primary corneal ectasia. It is a bilateral, 
4, 5
 asymmetric, 
6, 7
 
usually progressive corneal thinning 
8
 that results in corneal protrusion, irregular astigmatism 
and decreased vision. 
9, 10
 Specifically, the cornea assumes a conical shape as a result of 
characteristic apical corneal epithelial thinning, 
11
 stromal degeneration and subsequent 
biomechanical alteration. 
12
 Research has shown that the corneal thinning is usually located in 
the infero-temporal region and the central region (as seen in so-called “nipple cones”), 13-15 
though some authors have reported thinning in the superior regions of the cornea. 
16-18
 The 
protrusion of the cornea results in a significant increase in myopia and irregular astigmatism 
(typically with-the-rule astigmatism, WTR), which affects visual acuity (VA). The onset of the 
condition typically occurs around the onset of puberty, 
6, 19
 although other reports show that it 
can occur as early as six years 
20
 and as late as 50 years. 
21
 The condition is known to progress 
until the fourth decade of life and then usually stabilizes. A recent report has shown that 50% 
2 
 
of individuals affected with KC in one eye will have the other unaffected eye develop the 
condition in 16 years. 
22
 Figure 1-1 shows both normal and keratoconic eyes. 
 
A variety of risk factors have been shown to play a significant role in the development of the 
condition. These include constant eye rubbing, 
6
 the presence of systemic conditions such as 
sleep apnea and associated conditions like atopic dermatitis, 
23-28
 floppy eyelid syndrome, 
29-35
 
chronic allergies and eczema, 
24, 36-39
 and genetics. 
39, 40
 KC is also associated with other 
syndromes. For examples, KC is found in 0.5-15% in patients with Down’s syndrome. 3, 41-47 It 
has also been reported in individuals with Leber´s congenital amaurosis, 
48, 49
 Ehlers-Danlos 
syndrome 
50-52
 and osteogenesis imperfecta. 
53, 54
  
        
Fig 1-1a: Normal cornea                          Figure 1-1b: Keratoconic cornea. 
Figure 1- 1 a&b: Comparison of normal and KC corneae.  
 
A condition that is often confused with KC is pellucid marginal degeneration (PMD). PMD is 
an idiopathic, bilateral, non-inflammatory, peripheral corneal ectasia usually affecting the 
inferior quadrant in a crescent fashion. 
55-58
 The word pellucid meaning “clear” was originally 
described by Schlaeppi in 1957 
55, 59
 to denote the clarity of the cornea, irrespective of the 
ectasia that is observed under the slit lamp biomicroscope. Early studies had previously termed 
3 
 
the condition as pellucid corneal marginal degeneration 
55
 or pellucid marginal dystrophy. 
60
 
The onset of PMD is not known, although some authors have reported the onset ranging from 
20-40 years of age. 
59, 61
 There seems to be no sex, racial or ethnic preponderance, however, 
Sridhar et al. 
62
 reported higher prevalence in a male population and superior localization of the 
ectasia in some people. The corneal thinning is usually observed in the inferior portion of the 
cornea usually in the 4 to 8 o’clock position, accompanied by 1-2mm of normal cornea 
between the limbus and the thin area. 
59
 Though mainly inferior thinning is seen, there are 
cases of superior thinning. 
63
 This unusual characteristic of the corneal thinning results in 
marked irregular astigmatism (usually against-the-rule astigmatism, ATR) and subsequent 
reduction in VA. 
62
 Figure 1-2 shows early and advanced PMD. 
        
               Figure 1-2a: Early PMD                                           Figure 1-2b: Advanced PMD.  
 
Figure 1- 2 a&b: Comparison of early and advanced PMD.  
 
 
1.2 Aetiology 
1.2.1 The Role of Genetics  
After many years of research into the probable cause of KC and PMD, many questions 
regarding the exact cause of these conditions still remain unanswered because no distinct factor 
has been identified to cause these ectatic conditions. However, clinical research suggests that 
4 
 
genetic factors (especially in KC) play a role, as a genetic link has been reported among family 
members by numerous authors. 
2, 5, 43, 64-68
 Previous family studies without the benefit of 
corneal topography reported 6-8% of individuals with KC had close family members affected 
by the disease. 
67, 69
 However, when studies use corneal topographers to assist with the 
diagnosis, it has been reported to be as high as 50% among family members. 
70
 Wang et al. 
71
 
in a family study investigated genetic contributions to the development of KC using familial 
aggregation and by testing genetic models with segregation analysis, together with assisted 
Topographic Modeling System (TMS-1). They found the prevalence of KC in first degree 
relatives to be 3.34%.  Again, they found KC to be 15 to 67 times higher in families with KC 
than that in the general population (0.23-0.05%) and show an autosomal dominant mode of 
inheritance with variable expression. 
43, 65, 72
 Twin studies by Tuft et al., 
40
 support the role of 
genetics in the development of KC. Irrespective of the genetic link associated with KC among 
twins, the Dundee University Scottish Keratoconus Study (DUSKS) 
73
 reported variability of 
the role of genetics in twins. This has also been reported by Bourne et al. 
74
 Ioti et al. 
75
 found 
KC or KC suspect patterns in 60.2% of family members of Japanese KC patients using the 
Orbscan (Bausch and Lomb, Rochester, NY, USA). Other researchers have also reported the 
influence of genetics in the development of this condition. 
6, 17
 
 
A strong genetic link for PMD has not been reported, though some authors have described 
some form of association in asymptomatic family members based on corneal topography and 
unilateral cases. 
76, 77
 Controversy still exists whether KC and PMD are distinct disease or 
phenotypic variations of the same disorders 
3, 78
 and that PMD is a peripheral form of KC. This 
hypothesis has been supported by various studies. 
62, 79, 80
 Kayazawa et al. 
80
 found 17 patients 
5 
 
out of 20 with PMD showed characteristics of PMD and central KC on the same cornea. Three 
patients with PMD without KC showed bilateral involvement of the condition. Among the 17 
cases of PMD with KC, eight patients showed bilateral involvement and the others showed 
unilateral involvement. Their conclusion was that PMD with or without KC may be a variant 
of KC or a different manifestation of the same etiologic factor. Similar findings have been 
reported by Varley et al., 
79
 Karabatsas et al. 
61
 and Sridhar et al. 
62
  
 
1.2.2 Biochemical Factors 
Biochemical factors (oxidative stress) may also be responsible for the ectasia in KC. 
5, 6
 
Kenney et al. 
10
 proposed the “oxidative stress” hypothesis as the possible cause of KC. They 
presented one of the most comprehensive works on KC using immunochemistry and molecular 
techniques to explain the cause of the condition. Their study put forward four hypotheses, 
which according to them may explain the biochemical abnormalities found in KC corneae. The 
hypotheses are: (1) there is abnormal processing of the free radicals and superoxides within 
the KC corneas; (2) there is a build-up of destructive aldehydes or peroxynitrites; (3) the cells 
that are damaged irreversibly undergo the process of apoptosis; and (4) the cells that are 
damaged reversibly undergo wound healing or repair. As part of their conclusion, they stated 
that during the wound healing process (similar to corneal epithelial healing following extensive 
eye rubbing) various degradative enzymes and wound healing factors are upregulated, which 
leads to focal areas of corneal thinning and fibrosis.  
 
According to their working hypothesis, factors which are capable of producing the free radicals 
and may contribute to the cascade of abnormal changes in the cornea include ultraviolet light, 
6 
 
atopy, mechanical eye rubbing, and poorly fitted contact lenses. They proposed that susceptible 
corneae exhibit an inability to process reactive oxygen species because they lack necessary 
protective enzymes such as aldehyde dehydrogenase class 3 (ALDH3) and superoxide 
dismutase. The reactive oxygen species result in an accumulation of toxic by-products such as 
malondialdehyde (MDA) and peroxynitrites that can damage corneal proteins and trigger a 
cascade of events that disrupt the cornea’s cellular structure and function. According to them, 
this process can result in corneal thinning, scarring, and apoptosis. Figure 1-3 shows the 
oxidative stress pathway.  
 
The cytotoxic effect of nitric oxide (NO) which serves as mediator in many chemical processes 
in the eye can also be affected by the free radicals. Their effects are mediated by peroxynitrite 
(a potent oxidant) and superoxides. The peroxynitrite reacts with certain proteins to form a 
stable compound nitrotyrosine (NT) which has destructive effect on the tissues of the cornea. 
 
Figure 1- 3:  The free radical hypothesis to explain KC.  
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1.3 Epidemiology 
Variations in the incidence and prevalence of KC have been reported by numerous authors. 
81-
83
 The table below summarizes the incidence and prevalence rates of studies conducted by 
various authors.  
Table 1- 1: Incidence and prevalence rate of KC. 
 
Author Sample 
size 
Incidence 
rate per 
100,000 
Prevalence 
rate per 
100,000 
Source 
Kennedy et al. 
84
 64 2.0 54.5 Hospital 
Pearson et al. 
85
 382 4.5 57 Hospital 
Nielson et l. 
83
 772 1.3 86 Hospital 
Tanabe et al. 
86
 2601 - 9 Hospital 
Jonas et al. 
87
 4667 - 2300 Population 
Ihalainen et al. 
88
 294 1.5 30 Hospital 
 
In the case of PMD, no incidence or prevalence data exists. The general assertion is that it is 
rare, 
3, 89
 less common than KC but more common than keratoglobus or posterior KC. 
3
 
 
The effect of gender on KC remains unclear. Some authors have suggested that there is a male 
preponderance, 
90-95
 but others report higher percentages in females. 
3, 5
 
 
KC affects all ethnicities 
39, 82, 96-99
 but some authors have pointed out that individuals of Asian 
origin are more likely to be affected by the condition. 
85, 100, 101
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1.4 Clinical Characteristics 
KC and PMD present different clinical features, which largely depend on the severity of the 
condition. In the early stages, it may be difficult to make a definite diagnosis, without the aid 
of corneal topography. In KC, the subclinical type (also known as keratoconus forme fruste; 
KCFF), 
102, 103
 does not produce significant symptoms and may go unnoticed. Tobias et al. 
104
 
defined it as an abortive form of KC, where the progression of the keratectasia has stopped at a 
certain point, possibly due to some form of undefined “biomechanical strength gain” of the 
cornea. However, with progression of corneal ectasia there is significant reduction in VA and 
this should raise suspicion when VA of 6/6 or better cannot be achieved, especially with 
increasing astigmatism. 
2
 Near VA seems much better than that linked with the distance acuity 
owing to the myopia. The characteristic “scissor-reflex” on retinoscopy confirms progression 
of the condition. The so-called “Charleux oil droplet” 105 that is observed by retro-illumination 
of the cornea is a warning sign of impending KC. At this stage the keratometric readings are 
typically found to be within the normal range and the thinnest location is also usually located 
outside the visual axis. 
 
In moderate to advanced cases, the clinical signs by slit lamp biomicroscopy become obvious 
and make diagnosis much easier. Fleischer’s ring, resulting from the deposition of iron 
deposits from the tear film, is usually seen at the base of the cone. 
106, 107
 According to 
Edrington et al., 
108
 57% of individuals involved in their study had this characteristic feature. 
Another obvious sign is Vogt’s striae, seen as fine vertical lines at the apex of the cone, 
resulting from the stretching of Descemet’s membrane. These disappear when physical 
pressure is exerted on the cornea. 
2, 3
 Mocan et al. 
109
 reported 63.2% of their study population 
9 
 
exhibited Vogt’s striae. With progression of the disease, the corneal nerves become more 
apparent, and superficial and deep corneal opacities may also be present at different stages of 
the condition. 
3, 105
 Mannion et al. 
110
 observed that although the total number of 
stromal nerve fiber bundles was reduced in patients with KC versus control subjects, the 
increased tortuosity and increased nerve fiber diameter may explain why the 
corneal nerves appear more visible in patients with KC (Figure 1-4). The characteristic V-
pattern, Munson’s sign, seen in the lower eyelid from downward gaze, and Rizzuti’s sign are 
usually only observed in advanced cases. 
84
 Corneal hydrops due to ruptures in Descemet’s 
membrane has also been reported. 
111-117
 This results in acute stromal oedema, significant pain 
and usually leaves a scar upon healing. 
 
           Figure 1- 4: Comparison of corneal nerve fibres in normal and KC corneae. 
 
Corneal nerve fibres in the subepithelial plexus of the cornea of a patient with KC (A) and a normal 
subject’s cornea (B). Appearance of the stromal nerves in the KC patient (C) versus normal cornea (D).  
 
The clinical characteristics seen in PMD make it distinct from other corneal ectasias because of 
the thinning location and the absence of the inflammatory signs. The hallmark of PMD is the 
10 
 
characteristic 1-2mm of corneal thinning from the limbus, with a crescent fashion usually in 
the 4 to 8 o’clock position. 55, 58, 62, 118-121 The adjacent clear cornea protrudes markedly and 
usually results in ATR astigmatism seen on the topographic map and the consequent reduction 
in VA. Dundar et al. 
122
 and other authors 
123, 124
 report that the thinning can also occur in the 
superior portion of the cornea. This unique feature on the topographic map has been variously 
described as “lobster”, “crab-claw” or “kissing dove” pattern. 58, 125 When viewed from the 
side, some authors classically describe the inferior-central cornea in PMD to show the side-
profile contour of a “beer-belly”. 55, 107 Lee et al. 126 argue that the topographic “crab-claw” 
pattern should not be used as a diagnostic tool for PMD, as KC and other ectasias can also 
show such a characteristic pattern. 
127
 They suggested that the topographic pattern must be 
combined with slit lamp evaluations to make a firm diagnosis. Figure 1-5a&b show the 
characteristic patterns in KC and PMD. Interestingly, PMD does not appear to show 
Fleischer’s ring, scarring or vascularisation, Munson’s sign and Rizutti’s sign, which are 
commonly seen in KC. 
62
 
 
Symptoms range from gradual to progressive reduction in VA and can be attributed to the 
increased ATR astigmatism. 
3, 121
 In rare conditions, patients also experience scleral injection 
with acute pain. Corneal hydrops (which is seen only in advanced KC) have also been reported 
in PMD. 
128-132
 Surprisingly, hydrops occur in the area above the ectatic zone. 
62
 A spontaneous 
bleed following corneal hydrops has also been reported. 
133
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Figure 1-5a: Asymmetric “bow-tie” in KC.             Figure 1-5b: Characteristic “crab-claw” in PMD. 
 
Figure 1- 5 a&b: Comparison of corneal topography in KC and PMD. 
 
 
 
1.5 The Role of Corneal Topography in Differential Diagnosis 
Corneal topographers have become an indispensable tool in the diagnosis of corneal ectasia 
and are now considered the gold standard. Lee et al. 
126
 proposed that topographic maps should 
be combined with the various clinical signs to make a definite diagnosis, as some of the corneal 
ectasias share certain topographic characteristics. Corneal topographers map the entire cornea 
and identify subtle changes over time (in addition to measuring corneal thickness) and play a 
significant role in diagnosing a particular corneal ectasia. 
134
  The TMS device (Computed 
Anatomy, NY, USA) 
135
 used Placido-based rings to topographically map the cornea. More 
recent topographers have advanced to slit-scanning devices and include the Orbscan II (Bausch 
and Lomb, Rochester, NY, USA) 
136-140
 and also utilise Scheimpflug technology such as that 
used in the Oculus Pentacam HR
®
 (Wetzlar, Germany). 
141-143
 The Visante™ OCT (Carl Zeiss 
Meditec, Dublin, CA, USA) 
144-148
 uses optical coherence tomography techniques to derive 
corneal topography and thickness, in addition to anterior chamber analysis. These devices help 
in the early detection of subclinical ectasia, which is essential for pre-screening prior to various 
forms of corneal surgery. 
149, 150
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Other peripheral conditions with clinical characteristics similar to KC (and particularly PMD) 
are Mooren’s ulcer 151-157 and Terrien’s marginal degeneration. 158-164 Mooren’s ulcer is an 
idiopathic condition characterized by either unilateral or bilateral painful, inflammatory 
thinning or ectasia of the peripheral cornea. 
157
 Slit lamp assessment reveals perilimbal corneal 
infiltrates and epithelial defects within the ulcerated area. Vascularisation also occurs at the site 
of the ulceration during the healing process. 
165
 In comparison, Terrien’s marginal degeneration 
is a non-inflammatory ectasia characterised by bilateral, slow progressive, marginal cornea 
thinning which usually originates from the superior part of the cornea and spread 
circumferentially. 
55, 163
 The hallmark of this condition is the characteristic thinning in the 
peripheral part of the cornea creating the “gutter-like furrow”. Corneal topography shows 
corneal flattening over the areas of peripheral thinning produced by the disorder. When the 
thinning is restricted to the superior and/or inferior areas of the peripheral cornea only, a 
relative steepening of the inter-palpebral peripheral cornea can be found, resulting in large 
magnitudes of ATR or oblique astigmatism. 
166, 167
     
 
1.6 The Role of Corneal Pachymetry in Differential Diagnosis 
Pachymetry maps play an important role in the diagnosis of corneal ectasia. Assessment of 
both central and peripheral corneal thickness helps to locate the thinnest area of the cornea and 
subsequently help in the differential diagnosis of corneal ectasia. Reports show that there are 
significant differences in central and minimum corneal thickness in subclinical, moderate and 
advanced KC compared with the normal cornea. 
9, 168-170
 Table 1-2 compares the corneal 
thickness of normal and KC reported by various authors. 
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Table 1- 2: Corneal thickness in normal and keratoconus population. 
 
Author Instrument Normal Subclinical Keratoconus 
Ahmadi et al. 
168
 Pentacam 543.51 ± 32.14 510.60 ± 21.78 499.68± 39.59 
Prakash et al.  
171
 Orbscan IIz 542.50 ± 39.60 539.90 ± 39.20 449.30 ± 73.70 
Schlegel et al.  
172
 Orbscan IIz 559.70±  36.10 513.52±  40.76 - 
Piñero et al.  
173
 Pentacam 549.90 ± 28.48 514.29 ± 43.59 457.61 ± 38.77 
Uçakhan et al. 
174
 
Pentacam 539.52 ± 36.52 501.77 ± 38.38 488.02 ± 41.43 
 
 
 
1.7 The Role of Sagittal Depth Evaluation in Differential Diagnosis 
Numerous advancements in imaging techniques have occurred that provide information on the 
anterior part of the eye beyond the limbus. These imaging techniques include high resolution 
ultrasound (US) (Artemis-2, Arcscan Inc, Coloroda), 
175, 176
 high resolution OCT (Visante™ 
OCT, Carl Zeiss, Meditec, Dublin, California) 
177
 and a Scheimpflug camera system (Oculus 
Pentacam HR
®
, Wetzlar, Germany) 
178-181
 The Visante™ OCT and Oculus Pentacam HR® 
imaging techniques have made it possible to image and measure the corneal sagittal depth 
(CSD) at various chord diameters and this parameter continues to expand our understanding of 
how to effectively fit and assess semi-scleral contact lenses (sSCL). 
 
Evaluation of CSD and its correlation with other anterior segment parameters through the use 
of OCT has been conducted by various researchers. 
177, 182
 Sorbara et al. 
182
 evaluated CSD in 
the horizontal meridian of 40 normal eyes at a 15mm chord and found the mean CSD of 3.74 ± 
0.19 (ranges: 3.14-4.04) mm. In a related pilot study, 
183 
they found the CSD of normal eyes 
14 
 
and KC (n=14 in each group) to be 3.70 ± 0.16 (ranges: 3.39-3.94) mm and 3.93 ± 0.25 
(ranges: 3.61-4.45) mm in the steepest meridian respectively. 
 
 
1.8 Correction and Treatment Options for KC and PMD 
1.8.1 Non-Surgical Options  
1.8.1.1 Spectacle Prescription 
The use of a standard spectacle prescription can be important in the management of both KC 
and PMD. 
2, 5, 55, 119
 In mild forms of both conditions, spectacles provide good visual 
performance. However, vision begins to deteriorate following the progression of the corneal 
ectasia, often due to the development of irregular astigmatism. Over time, the spectacle 
prescription changes owing to the progressive nature of the condition and will eventually not 
provide adequate VA, at which point an alternative form of vision correction (typically in the 
form of a contact lens) will be considered. Spectacles also help in cases of contact lens 
emergencies or as back-ups to provide a temporary vision correction. 
 
1.8.1.2 Contact Lenses 
1.8.1.2.1 Corneal Contact Lenses 
Corneal contact lenses have been successfully used to manage corneal ectasias without surgical 
intervention for many years. 
62, 184-191
 Kompella et al. 
184
 and Tzelikis et al. 
119
 reported that 
almost 90% of their patients successfully used contact lenses for their visual correction. RGP 
lens designs include spherical, 
192, 193
 aspheric 
194, 195
 and bitoric designs. 
196, 197
 Fitting 
philosophies vary depending on the cone location and the design of the contact lens. 
198-204
 In 
KC, the fitting philosophies include those based on apical clearance, apical touch and three-
15 
 
point touch. 
5
 The three-point touch method (Figure 1-6b), which allows the contact lens to 
touch slightly at the cone apex, has achieved wide-spread acceptance. 
190, 205, 206
 This technique 
provides good VA and comfort. 
205, 207
  
 
The use of an RGP lens for increasing visual performance in PMD has also been documented. 
119, 184, 208, 209
 However, fitting an eye with PMD with a standard diameter spherical RGP design 
usually leads to edge “stand-off” in the inferior portion of the cornea due to the marked 
astigmatism. This typically leads to lens awareness and discomfort 
119, 121
 which may be 
prevented by fitting a larger lens diameter. 
119, 121, 209
 These large diameter lenses often provide 
satisfactory VA, stability and lens tolerance. 
5, 119
     
 
Other designs such as reverse geometry for both KC and PMD 
210, 211
 have also been reported 
to achieve satisfactory visual performance. 
212-214
 
 
            Figure 1-6a: Central touch.                                  Figure 1-6b: Three point touch. 
 
Figure 1- 6 a&b: Fluorescein patterns of two different RGP lens fittings in KC.  
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1.8.1.2.2 Soft, Hybrid and Piggy-Back Contact Lenses 
Soft contact lenses may provide adequate vision during the early stage of the condition. 
5, 55
 
Mahadevan et al. 
215
 and Sridhar et al. 
62
 suggested that soft toric lenses can be used before the 
progression to irregular astigmatism. Katsoulos et al. 
216
 reported that customized soft contact 
lenses with correction of vertical coma improved both monocular and binocular visual 
performance for eyes affected with mild or moderate KC. Marsack et al. 
217
 found that 
wavefront-guided soft lenses provided equal to or better photopic high contrast and mesopic 
low contrast VA compared to RGP lenses.  
 
Other specialised soft lenses such as Kerasoft
®
 IC (Bausch and Lomb, Inc., USA), which 
employs a unique design (“sector management control”-for lens stabilization), have been 
reported as suitable alternatives for vision correction in both KC and PMD. 
201, 218
  
Hybrid contact lenses use an RGP lens at the centre and a peripheral soft contact lens “skirt” 
and can be used in the correction of mild forms of KC. 
207, 219-225
 The use of hybrid contact 
lenses as alternative to increase visual performance and comfort has been reported. 
219, 226
  
 
So called “Piggy-back” contact lens systems combine a soft contact lens on the cornea with a 
rigid lens on top, providing a combination of both comfort and good VA. These can be 
specifically ordered, in which a customized groove is made within the soft lens to place the 
RGP, but typically standard disposable soft lenses are used as the base lens. Sengor et al. 
227
 
reported a significant increase in VA in all of his patients using such a combination, when 
compared with spectacles.  
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1.8.1.3 Semi-Scleral Contact Lenses  
Over the past few years there has been resurgence in interest in the use of sSCL for the 
management of KC and PMD. 
55, 94, 188, 207, 228-240
 These lenses are also indicated for use in the 
management of post-corneal transplant 
235
 (when residual high refractive error and irregular 
astigmatism exist), severe dry eye, 
235, 241
 neurotrophic keratitis and multiple other conditions. 
239, 241-245
 Current research on sSCL indicates that more than 50% 
188
 of patients diagnosed with 
KC, PMD and keratoglobus are fitted with sSCL and constitute the majority of patients 
wearing such lenses. Corneal transplants constitute 15.8% while the remaining percentage of 
patients ranges from persistent corneal erosions, chronic graft-versus-host disease and other 
pathological conditions of the eye.  
 
Figure 1- 7: Schematic diagram showing the fitting relationship of the sSCL.  
 
The hallmark of these lenses is that they vault the cornea to rest on the sclera. 
233
 Thus, it is 
important to choose a lens such that the sSCL haptic (Figure 1-7) approximately contours over 
the sclera and that the sagittal depth of the lens is sufficient to completely vault the cornea. 
240
 
This unique fitting characteristic of the sSCL require better understanding of CSD and the 
precise selection of an initial lens to completely vault the cornea while maximizing the effect 
on VA and comfort. 
240
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One fitting philosophy for fitting sSCL is based on the “Vault Reduction Method” (VRM).   4, 
55
 This method requires that the sSCL be fitted one dioptre steeper than the steepest radius of 
curvature. This method of selecting the initial contact lens may result in an initial lens either 
too steep or too flat, in which case multiple further lenses are placed on the eye until an 
alignment pattern (without any areas of touch) is achieved. Estimation of the tear film width 
(or corneal clearance) may be very difficult since the initial lens selected may not necessarily 
correlate with the desired corneal clearance for an “ideal” fit. To overcome these issues, some 
authors have suggested that a better option for KC and PMD fitting may be to use the 
relationship between the corneal radii of curvature, back optic zone diameter for the overall 
cones in KC and PMD and the CSD for a lens of a given diameter. 
246-248
  
 
To verify this fitting philosophy, Schornack et al. 
246
 evaluated the relationship between the 
steepest corneal radius of curvature and the final sSCL base curve dispensed to patients. They 
retrospectively evaluated 33 eyes with dry eye syndrome and 21 eyes with KC. Initial sSCL 
selection was based on the reference sphere (from the topographic elevation map) and on gross 
assessment of the corneal contour from the lateral perspective. There was a good correlation 
between the steepest corneal curvature and the final sSCL base curve dispensed; however, they 
concluded that the steepest corneal radius of curvature cannot be used to accurately predict the 
final base curve of the sSCL that provided the most appropriate fit. The procedure often lead to 
random selection of lenses until one lens provides the appropriate fit, which obviously 
increases chair time. 
177, 233, 240
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The estimation of the central corneal clearance (CCC) as observed using sodium fluorescein in 
the fitting of sSCL is currently problematic in fitting these lenses. The controversy surrounding 
the appropriate CCC stems from the fact that various authors have given different estimates of 
the “optimal fit”, which makes it difficult to precisely fit and evaluate these lenses. 249 
According to the 1997 ISO 11980 for Ophthalmic optics–Contact lenses and contact lens care 
products-guidance for clinical investigations, 
250
 it is recommended that for an “optimal fit”, 
the CCC should range from 200µm (0.2mm) to 300µm (0.3mm) and a limbal clearance of 
approximately 100µm (0.1mm).  
 
Visser et al. 
241
 characterised an “ideal” fit with CCC of  250 µm and between 50-100 µm (0.05 
to 0.1mm) of limbal clearance. Other authors have suggested between100-400 µm (0.10 to 
0.40mm) 
241, 242, 249
 of CCC. Contact lens manufacturers (Essilor Contact Lens Division, Dallas, 
TX) also suggests that to achieve an “ideal fit”, more attention should be focussed on “scleral 
alignment”, with the edge of the lens neither impinging nor excessively clearing the scleral 
conjunctiva. Schornack et al. 
246
 reported on the management of KC with sSCL and considered 
an “ideal” fit with CCC between 150-400 µm (0.15 to 0.40mm). They estimated the depth of 
the post-lens tear film by comparing it optically at the slit lamp to the thickness of the entire 
cornea. In this case, they suggested ¼ or ½ of the tear film thickness to the corneal thickness 
for an acceptable fit. Schornack et al. 
246
 hypothesized that the precise amount of clearance 
between the posterior surface of a sSCL and the anterior surface of the cornea is not critical to 
the success of the fit. They suggested that the ability to quickly and accurately align the scleral 
zone of the contact lens to the scleral contour would be of much greater value in fitting sSCL.  
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The use of sSCL results in a significant improvement in VA for patients with an irregular 
corneal surface. 
188, 225, 241
 Segal et al. 
234
 reported sSCL could improve VA in KC patients. 
They found a gain of two or more on Snellen lines in 94.5% of KC eyes fitted with these 
lenses. Similar results have been report by various authors. 
225, 235, 237, 238, 241
  
 
To date, no work has been conducted to effectively provide appropriate guidelines for the 
precise selection of an initial lens and to provide acceptable fitting characteristics for the final 
chosen lens. Current fitting procedures are still based on the steepest corneal curvature. 
177, 233, 
240, 246
 This presents significant challenges to the practitioner, as there is little guidance 
available to aid in the selection of the initial fitting lens to provide an overall improvement in 
VA. 
 
1.9 Surgical Options 
Surgical intervention is one of the management options that are employed when the corneal 
ectasia has grown to the point where contact lens fitting cannot provide the optimum vision 
required. This procedure largely depends in part on the stage of the corneal ectasia, scar 
formation and contact lens intolerance level. 
5, 55, 79, 239, 251-253
  
 
1.9.1 Penetrating Keratoplasty  
Penetrating keratoplasty (PKP) is one of the most frequently performed surgeries for KC and 
PMD and has a success rate of 80-90%. 
239, 254, 255
 This procedure typically removes a central 
8mm full thickness “button” of the cornea from the host and an 8.25mm button from the donor. 
The new cornea is typically attached using a double running suturing technique, with the 
21 
 
addition of four to eight interrupted sutures and typically provides excellent results. 
256-268
 
Irrespective of the significant improvement in vision, complications can include immune-
mediated rejection of the graft (requiring long term use of immunosuppressive drugs), 
unpredictable degrees of astigmatism and a structurally weak eye susceptible to wound 
dehiscence following trauma. 
256
 PMD patients are usually poor candidates for surgery due to 
the peripheral thinning. As a result, a large eccentric corneal graft would be needed, which is 
positioned close to the limbus. This leads to increasing chances of graft rejections, corneal 
vascularization and other complications. 
2, 62, 239
  
 
1.9.2 Other Surgical Techniques 
Other corneal surgical techniques for the treatment of moderate to advanced KC and PMD 
include deep lamellar keratoplasty (DLK), 
107, 269-273
 excimer laser-assisted anterior lamellar 
keratoplasty, 
274-276
 LASIK, 
277-279
 epikeratoplasty, 
280-282
 intra corneal ring segments, 
(INTACS
®
) 
55, 107, 283-295
 and corneal cross linking (CXL). 
5, 55, 296-303
  
 
1.10 Relationship between Contact Lens Fitting, Flexure and Vision 
Flexure refers to the bending of a rigid contact lens which is fitted steeper than 'K' to conform 
to the corneal curvature. 
304
 Fitting the contact lens relative to the contour of the cornea is 
likely to induce ATR astigmatism which may cause unwanted visual distortions. 
305
 
 
According to Rosenthal et al., 
305
 increased flexibility of the contact lenses reduces their 
capacity to resist the compression forces from the eyelids during the closing phase in each 
blink. Apart from the thickness of the contact lens, other factors that may be responsible for 
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flexure include the amount of corneal astigmatism and fitting the lens steeper than K. The 
effect of RGP lens flexure and its impact on vision have been documented by various authors. 
306, 307
 
 
Sorbara et al. 
306
 found that the steepest RGP lenses produced significant lens flexure and 
astigmatism thus reduced VA on both HCVA and LCVA. The reduced VA was attributed to 
the uncorrected residual astigmatism and combination of other factors.  
 
To date, no work has been done to effectively establish the relationship between sSCL fitting, 
flexure and vision. 
 
1.11 Contact Lens Comfort with RGP and sSCL 
Comfort plays a very important role in the successful wearing of contact lenses. 
237, 241, 308-322
 
RGP lenses have achieved success owing to the better vision provided by the contact lens 
compared to soft contact lenses and comfortable wearing them after the period of adaption. 
323-
326
 Fonn et al. 
327
 reported that in the initial adaptation period, subject acceptance of RGP 
lenses extended wear in terms of vision and comfort was superior compared to soft lenses. 
They suggested such lenses should offer high oxygen permeability to provide successful 
extended wear. Polse et al. 
328
 reported 69.6% of their subjects achieved comfort with RGP 
after 12 months of extended wear. Other studies 
329-331
 and clinical trials have shown RGP 
contact lenses to be comfortable and successful.  
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The effect of comfort level on sSCL has been reported. 
232, 237
 Visser et al. 
237
 reported that 
their subjects achieved comfort rate of 78.9 with sSCL and overall satisfaction of 87.7%. Other 
studies have also reported on the increased comfort with sSCL. 
228, 232, 308, 332
   
 
1.12 Physiological Response to Contact Lens Wear 
Contact lens wear allows the material to interact mechanically with the pre-corneal tear film, 
the cornea and other tissues of the anterior segment of the eye. This interaction is likely to 
interfere or modify the normal physiological processes of corneal tissue and likely to induce 
contact lens related complications. 
333-335
 Clinical trials with RGP lenses have shown that 
corneal staining is possible after extended wear of contact lenses especially in the 3-to-9 
o’clock direction. 327, 336 Graham et al. 337 reported the likelihood of developing keratopathy in 
overnight wearing of  RGP lenses. Other complications such as redness, contact lens induced 
papillary conjunctivitis, corneal oedema and protein deposits have been reported. 
338, 339
 
 
Scleral contact lenses have been reported to impact on the physiological activities of the 
corneal thickness 
340
. Smith et al. 
341
 reported that sSCL induced a variable amount of corneal 
swelling. They reported corneal swelling from 4.9% to 17.5%. Overnight corneal swelling also 
correlated strongly with endothelial cell density. Irrespective of these findings, they suggested 
that the degree of corneal swelling should not rule out overnight therapeutic use of sSCL in 
disease process but warn of complications for overnight wear refractive correction. The effect 
of corneal swelling and other physiological response such as limbal compression of sSCL have 
been reported by other authors. 
340, 342, 343
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1.13 Instrumentation- Corneal Topographers 
1.13.1 Medmont E300™ 
The Medmont E300™ (Medmont Pty Ltd, Australia) is a reflection based computerized 
videokeratoscope using Placido rings to map the surface of the cornea. The small cone Placido 
disc-based videokeratoscope utilizes an arc-step reconstruction algorithm. The instrument 
precisely determines the distance from the corneal apex to the instrument’s camera and 
automatically captures images only when good focus and alignment are attained for easy 
measurement and evaluation. 
344, 345
 It uses integrated Medmont studio 4, software version 
5.1.3 to analyze the scanned images.  The Medmont E-300™ emits radiation in the visual 
range of wavelength 660nm for the red LED cone illumination, 565nm (green LED fixation 
target) and 430nm (blue LED profile illumination). It has 32 Placido rings and measures 9600 
data points per scan. Each image captured is awarded a score out of 100 based on perfect 
centering, focus and minimal movement. The instrument also uses the measured data to 
construct a 3D model of the cornea. Scan scores higher than 75 are usually considered good 
according to the “Quality Specification” by the manufacturer. Figure 1-8a&b shows the 
Medmont E300™ and the corresponding interface. 
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Figure 1-8a: Medmont E300™.                                   Figure 1-8b: Medmont E300™ interface.                                     
Figure 1- 8 a&b: The Medmont E300™ and the interface showing the 4 real-time images.  
 
 
1.13.2 Oculus Pentacam HR
®
 
The Oculus Pentacam HR
®
 (Wetzlar, Germany) uses a Scheimpflug camera that rotates 
through 360 degrees and captures 25-50 Scheimpflug slit images within approximately two 
seconds. 
180, 346
 The instrument uses the custom designed cobalt blue LED with a wavelength of 
475nm, UV free, to capture images on the cornea. The images contain 25,000 data points and 
up to 138,000 data points are measured for various parameters of the cornea. The integrated 
software helps to construct a 3D model of the cornea. (Figure 1-9a&b)  The unique feature of 
Oculus Pentacam HR
®
 is that it measures height or elevation data compared to an aspheric 
surface and uses the results to calculate the anterior and posterior corneal curvatures.  By 
subtracting the front and back elevation measurements of the cornea, it determines the corneal 
pachymetry. Other parameters that can be determined are corneal wavefront aberrations, 
347, 348
 
densitometry and anterior chamber analysis  
349-355
 and intraocular (IOL) calculation. 
356-359
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Figure 1-9a: Oculus Pentacam HR
® 
unit.     Figure 1-9b: Scheimpflug image and 3D model. 
Figure 1- 9 a&b: Oculus Pentacam HR
® 
and the after image interface showing the Scheimpflug image and 
the 3D model.  
 
 
 
1.13.3 Optical Coherence Tomography (OCT) 
1.13.3.1 Visante OCT 
The Visante™ OCT (Carl Zeiss Meditec, Dublin, CA, USA) was the first commercially 
available OCT system with sufficient speed to map the anterior segment of the eye (Figure 
1.10). It is a time domain OCT (TD-OCT) that produces cross-sectional tomograms of the eye 
without contact. 
182
 The light source is a 1,310nm superluminescent diode (SLD) with axial 
resolution of 18μm and the transverse resolution of 60μm. The scan dimensions are 6mm by 
16mm wide for the anterior segment scans and 3mm by 10mm for the pachymetry scans. 
182, 
360, 361
 
The image acquisition system provides a real-time video image of the examined zone/area and 
stores the last seven images at a rate of eight frames per second and usually takes 
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approximately 0.5 seconds to scan the eye. The integrated software interprets the images and 
reconstructs the pachymetry map. The use of the Visante™ OCT to measure the thickness of 
the cornea has been previously been described by numerous researchers. 
146, 182, 362, 363
 The 
enhanced global pachymetry protocol was used for the corneal thickness measurements in this 
research. The Visante™ OCT generates a pachymetry map with concentric circles with 
diameters of 2, 5, 7, and 10 mm and each meridonial scan consists of 128 A-scans and can be 
visualized as a cross-sectional image. It also provides average, maximum, and minimum 
pachymetry at the respective areas. To achieve good centration, all scans were aligned on its 
visual axis and then adjusted to be on the geometrical axis according to the manufacturer’s 
guidelines. The images obtained were further processed using custom-built software 
(Visante™ OCT, Data Compiler, CCLR, Waterloo) into four meridians (vertical, horizontal 
and obliques). 
 
 
 
Figure 1- 10: The Visante™ OCT. 
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1.13.3.2 Custom-built Ultra-Long OCT  
The custom-built ultra-long OCT (UL-OCT) is a spectral domain (SD) OCT with scan depth 
~7.441mm and ~6µm  optical resolution. It uses high speed of 24000 A-lines per second to 
scan any part of the anterior segment of the eye with a scan width of up to 18mm. The central 
wavelenght is 840nm and bandwidth of 50nm. Images can be captured in both 2D and 3D 
mode. It uses a computer controlled fixation blue target and auto-focussing colour camera 
viewing system with low illumination. It uses the real time image x-y alignment for scanning 
position and can scan in both the vertical and horizontal plane depending on the area of interest 
of the anterior segment of the eye. The manual adjustment focal plane allows the instrument to 
be set for specific regions of the anterior segment to be captured.  Figure 1-11 show the 
custom-built SD UL-OCT. 
 
 
Figure 1- 11: The custom-built SD UL-OCT.  
 
The SD UL-OCT has proven to be a versatile instrument for imaging various parameters of the 
anterior segment of the eye ranging from the evaluation of the pre-corneal tear film, 
364-373
 
assessment and evaluation of the differential cells on the scleral  conjunctiva, 
374, 375
 and the 
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assessment of the corneal epithelium and validating the thickness of the normal cornea and 
post refractive corneae 
376-386
 and anterior chamber biometry. 
387-392
 Other researchers have 
shown that the post-lens tear film thickness can easily be measured with the instrument. 
373, 393
  
 
Shen et al. 
394
 reported that SD  UL-OCT was capable of imaging the entire soft contact lens 
both in vivo and in vitro with a lubricant drop to increase its contrast. In a related study, Wang 
et al. 
395
 evaluated the capability of using the instrument to visualize soft and RGP lenses on 
the eye using refresh liquigel. The post-lens tear film underneath the lens edge was clearly 
visualized and could easily be quantified.  
 
Over the past years since its development and clinical research testing, measurements of the 
anterior segment parameters have been shown to be repeatable. 
365-370, 396-398
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Chapter 2 
 
Repeatability and Accuracy of the Oculus Pentacam HR
®
 Corneal Topographer in 
Measuring Radius of Curvature and Shape Factor 
 
2.1 Introduction  
Measurements of the central and peripheral corneal curvatures and asphericity are useful 
parameters for making clinical diagnoses in conditions such as KC and other degenerative 
conditions of the cornea, monitoring the shape of the cornea contour following LASIK or 
refractive procedures. It is also useful for the fitting and evaluation of contact lenses and the 
effectiveness of orthokeratology procedures. 
1-3
 To effectively assess and monitor the curvature 
measurements, the instrument used must be repeatable and accurate.  
 
Measuring such parameters of the cornea has typically been with the use of reflection based 
technology such as the slit-scanning instrument used in the Orbscan II (Bausch and Lomb, 
Rochester, NY, USA). 
2, 4, 5
 However, the effects of the pre-corneal tear film volume and eyelid 
force affect the repeatability and accuracy of this technology. 
6-9
 This technology has recently 
been reported to underestimate corneal parameters such as corneal thickness measurement, and 
topographic maps of the posterior surface of the cornea show signs of corneal ectasia following 
LASIK procedures. 
10-12
 The effect of the slit-scanning technology led into culminated into the 
Scheimpflug technology. 
5
 
 
Since Scheimpflug principle was first introduced in 1904, there has been great interest among 
researchers and eye care practitioners. 
13
 This principle has been shown to be the most precise 
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and versatile method to document light scattering and biometry of the anterior eye segment 
using slit image photography. Scheimpflug cameras have advanced significantly and modern-
day instruments provide comprehensive imaging and topographic analysis of the anterior 
segment. 
13, 14
 Oculus Pentacam HR
®
 uses this technology and it is becoming popular among 
both eye care researchers and practitioners. 
5
 
 
The Oculus Pentacam HR
®
 (Oculus, Wetzlar, Germany) uses a Scheimpflug camera that 
rotates through 360 degrees and captures 25-50 Scheimpflug slit images within approximately 
two seconds. The images contain 500 data points and up to 138,000 data points are measured 
to construct three-dimensional cornea. The Oculus Pentacam HR
®
 measures height or elevation 
data compared to an aspheric surface to calculate the anterior and posterior corneal curvatures, 
1, 15-22
 corneal thickness, 
15, 23
 
14, 17, 21, 24-26
 anterior chamber depth and angle, 
16, 27, 28
 and corneal 
spherical aberration. 
29-31
 The Oculus Pentacam HR
®
 also measures other parameters such as 
the corneal volume and IOL powers. 
32-34
 Topographic indices such as corneal asphericity and 
asymmetry continue to expand our understanding on making clinical diagnoses about the 
cornea, by comparing it with the cornea in a normal eye. Clinical measurements of the anterior 
segment of the eye can easily be done with this instrument. Calculation of keratometric index 
and IOL power as well as the assessment of IOL lens implant after surgery has improved 
tremendously with the use of Scheimpflug cameras. 
35-39
 The effectiveness of orthokeratology 
treatment can also be monitored accurately with this instrument. 
40-42
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Although there are abundant papers on repeatability, reproducibility, and comparability of the 
Oculus Pentacam HR
®
 undertaken by numerous researchers, there is no single data on 
repeatability and accuracy of this instrument done on any known test surface. 
1, 15, 16, 23
 
 
Repeatability is defined as the consistency between readings obtained on the same instrument 
by the same observer or different observer under conditions that are as constant as possible. 
Repeatability improves the clinician or researcher’s ability to detect changes in curvature and 
other parameters over time for necessary intervention. Accuracy on the other hand is defined as 
the closeness of agreement between a measured quantity value and true quantity of a 
measurand. 
1, 16
 
 
2.2 Objective 
To determine the repeatability and accuracy of the Oculus Pentacam HR
®
 (Wetzlar, Germany) 
based on six polycarbonate aspheric surfaces of known radius of curvature and shape factors. 
 
2.3 Material and Method   
2.3.1 Research Design 
This experiment involved three repeated measurements on three separate days. On each day, 
the polycarbonate aspheric surfaces were examined to make sure there were no defects or 
cracks on the surfaces. A lens cloth was used to clean the surfaces to make sure the surfaces 
were free of lint particles which may affect the radius of curvature measurements. The 
polycarbonate aspheric surfaces were randomized at each day of the measurements. The radius 
of curvature measurements were repeated thrice on each day. 
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2.3.2 The Polycarbonate Aspheric Surfaces 
The six polycarbonate aspheric surfaces (Bausch and Lomb, Rochester, NY, USA) mounted on 
a transparent rectangular plastic block have predefined colour coding (red, white, blue, brown, 
green, and yellow) with corresponding radius of curvature (r) and shape factor (p). The 
rectangular block has a dimension of 263x50x18 mm (Figure 2-1). The aspheric surfaces are 
cylindrically shaped with a total diameter of approximately 13mm, which is similar to that of 
the human cornea. The shape factor is the measurement of the asphericity of the cornea. It is 
usually derived using the expression p=1-e
2
, where “e” is the eccentricity value. 
     
Figure 2- 1a: Polycarbonate block.                       Figure 2- 1b: Dark cardboard on transparent edges. 
Figure 2- 1: Polycarbonate block with the six aspheric surfaces. 
 
 
 
2.4 Instrumentation      
2.4.1 Measurement of the Radius of Curvature and Shape Factor 
The Oculus Pentacam HR
®
 (Wetzlar, Germany) has been previously described in detail in 
Chapter 1. 
 
The polycarbonate aspheric surfaces were randomly selected and their surfaces were gently 
cleaned with lens cloth before the measurements. The transparent rectangular plastic block was 
firmly attached to the Oculus Pentacam HR® unit to align with the optics and the internal 
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target of the Scheimpflug camera for easy measurement and evaluation. The room lights were 
all switched off and to reduce the reflection from the transparent rectangular surface, a piece of  
dark cardboard was used to cover the edges of the block leaving only the aspheric surfaces for 
the measurements to be taken (figure 2-1b). The investigator focussed and adjusted the joystick 
until the real-time image of the aspheric surface was shown on the computer monitor, with the 
instrument showing the centre of the surface. The mires displayed on the screen guided the 
investigator to perfectly align the horizontal and vertical (crosshairs) axes at the centre of the 
aspheric surface. To reduce the investigator dependence, the automatic release mode was used 
to take all the measurements.  
 
The rotating camera was set to capture 25 Scheimpflug slit images in 360 degrees in 
approximately two seconds. This procedure was repeated in approximately two minute 
intervals for each scan. After every measurement, the Oculus Pentacam HR
®
 was moved 
backwards and realigned for the next scan to minimize interdependence of the readings. Three 
scans were taken on each aspheric surface. Since the test objects involved in this research were 
plastic aspheric surfaces, any scan that registered as “model!”, “blinking!” and “ok” were 
considered according to the “Examination Quality Specifications” within the standard of the 
instrument. This was to ensure that the scans were not affected by poor alignment/ 
misalignment with the optics of the instrument. Any misalignment observed was readjusted 
before the measurement. This procedure was repeated on all the six aspheric surfaces. The 
measurements were repeated on three separate days, with an interval of at least 48 hours 
between sessions. 
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The radii of curvature measurements were taken from the central 3mm while the shape factor 
measurements were taken within 20 degrees as this range was found to give consistent 
readings. 
 
The true radii of curvature and shape factors were given by the manufacturer for each of the six 
aspheric surfaces. 
 
2.5 Data Analysis 
Data analysis was conducted using Statistica 11 (Statsoft. Inc., Tulsa, OK, US). The 
distributions of differences for the three days measurements were analysed to produce the 
mean, standard deviation and the 95% limits of agreement (LoA). The mean of the differences 
was compared to zero to indicate bias, i.e., to discover whether measurements in days differ 
significantly from each other. The 95% LoA is the range of values over which 95% of the 
differences lie and is calculated as the mean ± 1.96 times the SD of the differences. 
43, 44
   
 
2.6 Results 
2.6.1 Radius of curvature (r/mm)  
Table 2-1 shows the mean and the SD of the radii of curvature of the polycarbonate aspheric 
surfaces for all the 3 day sessions. The results show that almost all the mean radius of 
curvature values obtained for the colours were slightly higher than the true radius of curvature 
values except for the blue surface. The mean radii of curvature for blue were 7.78, 7.75 and 
7.73mm for day 1, 2 and 3 respectively. The mean values for days 2 and 3 were lower 
compared to the true radius of curvature values. The differences observed were 0.03 and 
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0.05mm for days 2 and 3 respectively. The overall mean of the radius of curvature for blue was 
also slightly lower compared to the true radius of curvature. There was no statistically 
significant difference (p>0.05) in the measurements among the three day sessions. 
 
Table 2- 1: Mean radii of curvature, SD and COV of all the coloured surfaces for the three day sessions. 
Colour 
Day 1 
(r/mm) 
Day 2 
(r/mm) 
Day 3 
(r/mm) 
Mean of all 
the days 
(r/mm) 
COV 
(%) 
True radius 
of  
Curvature 
(r/mm) 
Blue 7.78±0.02 7.75±0.04 7.73±0.07 7.75±0.05 0.62 7.80 
Brown 7.87±0.01 7.86±0.02 7.87±0.03 7.87±0.02 0.22 7.81 
Green 7.83±0.07 7.90±0.06 7.86±0.04 7.86±0.06 0.76 7.80 
Red 8.36±0.01 8.40±0.00 8.38±0.04 8.38±0.02 0.30 8.30 
White 7.84±0.02 7.83±0.02 7.77±0.07 7.81±0.05 0.61 7.80 
Yellow 7.38±0.01 7.35±0.02 7.37±0.01 7.36±0.02 0.26 7.30 
 
 
There was more variability relative to the mean in the distribution for the colour green with 
COV of 0.76%. Similar patterns were seen in colours blue and white with COV of 0.62% and 
0.61% respectively.  
 
Pearson correlation was performed to determine the relationship between the radii of curvature 
values obtained for the three day sessions and the true radii of curvature. There were 
significant correlations (r=≈1.00, p=0.001) between the mean radii of curvature of the 
measured values and the true radii of curvature for all the three day sessions. Concordance 
correlation coefficients for the three days sessions were also found to be 0.98, 0.97, and 0.98 
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respectively. Figures 2-2a-c show the correlation graphs for the mean radii of curvature and the 
true radius of curvature for the three days sessions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2a: Correlation of mean radii of curvature and true radii of curvature for day 1. 
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Figure 2-2b: Correlation of mean radii of curvature and true radii of curvature for day 2. 
 
 
 
 
 
 
 
Scatterplot: True radius of curvature vs. Mean radius of curvatrure
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Figure 2-2c: Correlation of mean radii of curvature and true radii of curvature for day 3. 
Figure 2- 2 a-c: Correlation of mean radii of curvature versus true radii of curvature for days 1, 2 and 3.  
The equation for the best- fit for day 1, 2 and 3 were; y = .15428+.98551*x; y = -.3255 + 1.0475*x; and y = -
.0867 + 1.0145*x respectively.   
 
 
Bland-Altman plots were created to assess the difference in the days as a function of the mean 
and the true radii of curvature (Figure 2-3a-c). For all three day sessions, good agreement 
occurred; however, the Oculus Pentacam HR
®
 slightly overestimated the radii of curvature 
measurements.      
 
Scatterplot: True radius of curvature vs. Mean radius of curvature
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Figure 2-3a: Bland-Altman plot for day 1.                                                                       
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Figure 2-3b: Bland-Altman plot for day 2 
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Figure 2-3c: Bland-Altman plot for day 3 
Figure 2- 3 a-c: Bland-Altman plot-Distribution of the means of radii of curvature and true radii of 
curvature for all the three day sessions.  
The thick line represents the average and the dotted line represents the LoA. 
 
2.6.2: Shape Factor (p) 
The table below shows the results obtained for the shape factor of the polycarbonate aspheric 
surfaces. There were no statistically significant differences among the three day sessions, with 
the exception of the brown surface (p=0.01). The mean shape factor obtained for red (0.52) on 
the third day was relatively low, however, there was no significant difference compared to the 
first and the second day sessions (p=0.15). Table 2-2 shows the mean of the shape factors for 
all the three day sessions.  
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Table 2- 2: Mean shape factor, SD and COV of all the coloured surfaces for the three day sessions. 
 
Colour Day 1 Day 2      Day 3 
Mean of all 
the days 
COV 
(%) 
True  
shape  
factor 
Blue 1.33±0.08 1.32±0.41 1.50±0.43 1.37±0.31 22.44 1.29 
Brown 0.51±0.10 0.80±0.10 0.65±0.02 0.65±0.14 22.06 0.70 
Green 0.60±0.33 0.50±0.07 0.54±0.10 0.55±0.18 33.19 0.49 
Red 0.64±.0.03 0.74±0.08 0.52±0.10 0.63±0.11 18.01 0.70 
White 1.05±0.12 0.82±0.05 1.04±0.44 0.97±0.25 26.10 0.99 
Yellow 0.75±0.09 0.80±0.11 0.72±0.01 0.76±0.08 10.43 0.70 
 
 
There was more variability relative to the mean in the distribution for the colour green with 
COV of 33.19%. Similar pattern was seen in colour white with COV of 26.10%. Yellow colour 
recorded the least variability with COV of 10.43%.  
 
There were significant linear correlations between the mean shape factors and true shape 
factors for all the three days sessions (p=0.001). Concordance correlation coefficients for the 
three days sessions were also found to be 0.93, 0.93 and 0.95 respectively. Figure 2-4a-c shows 
the correlation between the mean shape factors and true shape factor for all the day sessions.  
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Figure 2-4a: Correlation of mean shape factor and true shape factor for day 1.            
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Scatterplot: True shape factor vs. Mean shape factor
 y= .09073 + .90223 *x
Correlation: r =0.95
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Figure 2-4b: Correlation of mean shape factor and true shape factor for day 2. 
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Scatterplot: True shape factor vs. Mean shape factor
y= -.2040 + 1.2515 *x
Correlation: r = 0.97
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Figure 2-4c: Correlation of mean shape factor and true shape factor for day 3. 
Figure 2- 4 a-c: Correlation of mean shape factors versus true shape factor for days 1, 2 and 3. 
The equation for the best- fit for days 1, 2 and 3 are; y = -.0514 + 1.0539*x; y = .9073 + .90223*x and y = -
.0.2040 + 1.2515*x respectively.  
  
The results in the Figures 2-5a-c also show the Bland-Altman plots for the shape factors for all 
the three day sessions. All the three days showed good agreement, however, the mean 
difference were slightly dispersed around the zero line.  
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  Figure 2-5a: Bland-Altman plot for day 1.      
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Figure 2-5b: Bland-Altman plot for day 2. 
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Figure 2-5c: Bland-Altman plot for day 3. 
Figure 2- 5 a-c: Bland-Atman plot-Distribution of the means of shape factors and true shape factors for all 
the three day sessions.  
The thick line represents the mean difference and the dotted line represents the 95% LoA. 
 
 
2.7: Discussion 
The Oculus Pentacam HR
® 
is becoming the instrument of choice in most clinical and research 
settings. It uses a Scheimpflug rotating camera that captures Scheimpflug slit images for 
analysis of the cornea and the anterior chamber parameters. It calculates the radius of 
curvatures and other parameters that are very useful in making good clinical decisions. There 
are adequate data on precision such as comparisons, repeatability, reproducibility, 
16, 23, 24, 45
 
however, there has been no report on repeatability and accuracy using a known surface.  
 
The purpose of the study was to report on repeatability and accuracy of the Oculus Pentacam 
HR
®
 using polycarbonate aspheric surfaces of known radius of curvature and shape factor. In 
this study, we found out that the Oculus Pentacam HR
® 
was repeatable as the measurements 
obtained did not show any significant difference in terms of the mean variations on the three 
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day sessions. The measurements also show significant correlation (r=1.00, p=0.001) with both 
the true radii of curvature and shape factors.  
 
The slight variations in the means of the three day sessions observed could be explained by the 
fact that mild reflection and the internal reflection of the polycarbonate aspheric surfaces may 
have affected the instrument’s capacity to measure various parameters accurately. (Figure 2-6) 
Unlike the human cornea, the blue LED used in the Pentacam HR
® 
has to pass through a 
precise radius of curvature and thick transparent polycarbonate. Reflection from the aspheric 
surface as well as the internal reflection may be accountable for such variations although 
polycarbonate has reflectance of ˂10% 46 similar to that of human eye. Potvin et al. 46 
conducted a study on polycarbonate and steel ball surfaces and found that the reflection on a 
test surface is likely to affect the instrument’s output though polycarbonate proved to give 
good results. 
 
Figure 2- 6: Scheimpflug image of the polycarbonate aspheric surface showing the surface and the internal 
reflections. 
 
 
Surface and internal 
reflections 
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According to McCarey et al., 
47
 object centration and a target off centre by more than 0.25mm 
can result in unreliable data and again, increasing the focal distance by greater than 1mm 
beyond the focal point results in a sharp decrease in accuracy. In the case of this study, 
centration was achieved by mounting the rectangular polycarbonate rectangular block to the 
headrest with a clamp making sure that the aspheric surfaces are perpendicularly aligned with 
the optics and the internal target of the instrument. Any variation in mean may results from the 
automatic mode used in taking the measurements of which the focusing power and algorithm 
could not be determined. 
 
In conclusion, the Oculus Pentacam HR
® 
was repeatable and accurate in this experiment for the 
majority of radii of curvature and the shape factors. Based on the small test surfaces in terms of 
number and curvature variations, it was unpredictable as to whether either the range of radii of 
curvature or shape factors were over or under-estimated by the instruments, as no clear trends 
were detected. The variations found with the radius of curvature were within the International 
Organization for Standardization (ISO) of ±0.10mm.  
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Chapter 3 
Repeatability of the Visante™ OCT and Oculus Pentacam HR® Topographers in 
Measuring Topographic Corneal Thickness 
 
3.1 Introduction 
Over the years, attempts to measure and quantify the thickness of the cornea have been made 
using several imaging systems. 
1-13
 Ultrasound pachymetry (US) has been considered the gold 
standard for measuring the central corneal thickness (CCT). 
14-21
 The US pachymeter operates 
at frequencies of 20 to 50 MHz, emits short acoustic pulses, and detects reflections from the 
anterior and posterior surfaces of the cornea. Corneal thickness is then calculated from the 
measured “time-of-flight” between these reflections. 
18, 22-24
 To measure the thickness of the 
cornea, it is generally required that subjects are comfortably seated for the measurement. 
16
 The 
probe of the instrument is then carefully aligned perpendicularly to lightly applanate the cornea 
for the measurement. This imaging technique using the US pachymeter has proved to be an 
outstanding method for measuring CCT, 
22, 25-29
 however, it has been criticized for the fact that 
its measurement is limited to only single specific points on the cornea, and hence it is difficult 
to monitor progression or change since the same point on the cornea may not be measured. 
30-32
 
It also requires applanation of the cornea and the use of appropriate aseptic precautions, along 
with the use of anaesthesia. The possibility of injury to corneal epithelial cells and potential 
infection thus exists. 
33
 This procedure presents a challenge to the already compromised 
cornea, especially in KC and PMD.  
 
The Artemis US pachymeter (ArcScan Inc, Morrison, Colorado, USA) does measure global 
pachymetry but many authors have reported drawbacks with its use. 
34-36
 Current non-US 
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imaging systems are non-invasive, easy to use and also provide global pachymetry. They also 
help to monitor the progression of the cornea which makes them more efficient instruments for 
clinical and research purposes.  
 
Currently, other imaging systems using slit-scanning technology such as the Orbscan IIz, 
(Bausch and Lomb, Rochester, NY, USA) 
13
, optical coherence tomographers (OCT) such as 
the Visante™ OCT (Carl Zeiss, Meditec, Dublin, CA, USA), 37 and Scheimpflug imaging 
technology (Oculus Pentacam HR
®
, Wetzlar, Germany) 
38, 39
 are now being used in many 
clinical and research settings. Repeatability and reproducibility of these imaging techniques are 
important for making clinical diagnoses, monitoring and evaluation of treatment regimens. 
Recent reports have shown that these anterior segment imaging techniques have been effective 
in imaging the anterior segment parameters needed to measure corneal pachymetry. 
11, 20, 37, 40-
42
  
 
Visante™ OCT 43, 44 is a time domain OCT (TD-OCT), utilizing  optical coherence 
tomography to image the anterior segment of the eye. The Visante™ OCT provides detailed in 
vivo examination of the anterior segment of the eye without contact. It provides high resolution 
cross-sectional images. The axial resolution of the Visante™ OCT image is 18µm and the 
transverse resolution is 60µm. 
 
Repeatability of the Visante™ OCT has been reported. 45-48 Mencucci et al. 45 reported on the 
repeatability of the Visante OCT and compared it with the Scheimpflug imaging system with 
US techniques as the gold standard. They reported that Visante™ OCT had good repeatability 
52 
 
with the CCT and also showed good agreement compared to both the US and Scheimpflug 
technique. In another study, Mohamed et al. 
49
 assessed the repeatability and reproducibility of 
the central and peripheral cornea of normal and KC using the Visante™ OCT. Intra-observer 
and inter-observer repeatability was evaluated using intrasession and intersession 
measurements. They reported that the Visante™ OCT was repeatable and reproducible in both 
the central and peripheral corneal thickness measurements for each group. 
 
The Oculus Pentacam HR
®
 is an improvement over the earlier version of the Pentacam
®
. It has 
an improved optic design and a high resolution camera i.e. 1.45megapixels. The Oculus 
Pentacam HR
®
 is a rotating Scheimpflug camera that generates images from the anterior 
surface of cornea to the posterior surface of crystalline lens. It acquires 25-50 Scheimpflug 
images in approximately two seconds using the monochromatic cobalt blue LED light source. 
50
 The “highly sophisticated and integrated” software system extracts 25,000 true elevation 
points from each of these images, obtaining approximately 138,000 true elevation points for 
each surface, including the centre of the cornea. 
14, 51, 52
 Repeatability and reproducibility with 
the Oculus Pentacam HR
®
 have been done by numerous authors. 
40, 41, 53-59
 
 
Miranda et al. 
60
 reported on repeatability measurements of the corneal thickness at the apical 
and peripheral cornea of normal eyes. The measurements were obtained at one minute, one 
hour and one week intervals and they took three consecutive measurements of the cornea 
without re-alignment by the same observer. They reported that the Oculus Pentacam HR
® 
was 
repeatable as their results showed no significant within-subject variance for the three sessions 
and that the variability of the instrument did not increase over time. Similar results have been 
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reported by Amano et al., 
52
 Sedaghat 
61
 and Lackner 
56
 using the same instrument for 
measuring the CCT in normal eyes. 
 
Repeatability of CCT on KC eyes and comparing the results with other instruments has also 
been reported. 
62
 de Sanctis et al. 
62
 reported on the repeatability and reproducibility of the 
CCT using the Oculus Pentacam HR
®
 and the gold standard US pachymeter, Allergan-
Humphrey 850 (Allergan-Humphrey, Dublin, California, USA). They evaluated 30 eyes and 
took two measurements within a three to 10 minute interval by different examiners using these 
instruments. The Oculus Pentacam HR
®
 showed higher inter-examiner correlation and lower 
inter-examiner variability compared to the US pachymeter. They concluded that the Oculus 
Pentacam HR
®
 provided measurements of CCT that were more reproducible and repeatable 
than those obtained with the US pachymeter. They further suggested that it was imperative to 
consider such an instrument for monitoring the corneal thickness when repeated measurements 
may be done over time and by different examiners.   
 
Although there is an abundance of papers on repeatability of the CCT of normal and KC 
corneae using the Visante™ OCT and the Oculus Pentacam HR®, there are few reports on 
cases of repeatability and reproducibility of these instruments in measuring the topographic 
corneal thickness (TCT) in KC and PMD corneae. 
 
3.2 Objectives 
The main objectives of this study were to: 
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1. Measure the repeatability of the Visante™ OCT and Oculus Pentacam HR® in KC 
and PMD in measuring TCT. 
2. Compare the reproducibility of the two instruments for TCT measurements. 
 
3.3 Materials and Methods 
3.3.1 Research Design 
This study involved two study visits where corneal thickness measurements were repeated after 
at least 48hours. Measurements from one eye only were taken (right eye=12; left eye=8). 
Participants were screened to make sure the selected eye was free from any active ocular 
pathology/infection such conjunctivitis. The cornea was stained with fluorescein and carefully 
examined with slit lamp biomicroscopy using a Wratten #12 yellow filter. This was to make 
sure that the cornea was free from any form of corneal staining resulting from contact lens 
wear. After this thorough examination, the eye was rinsed with non-preserved Unisol
®
 4 saline 
solution (Alcon Laboratories, Inc., TX, USA). Participants were allowed to sit for 
approximately 5 minutes to make sure the saline had completely dissipated from the eye. 
Corneal thickness measurements were taken twice, first using the Visante™ OCT and then 
Oculus Pentacam HR
®
 at each measurement session. 
 
3.3.2 Participants and Recruitment 
Twenty participants who had been diagnosed with KC and PMD were enrolled in this study. 
These participants were recruited from the Centre for Contact Lens Research (CCLR) internal 
data/records as well as from the School of Optometry and Vision Science, University of 
Waterloo Contact Lens Clinic.  
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Approval from the university’s human research ethics panel was obtained before the study 
commenced. All the participants were treated in accordance with the tenets of the Declaration 
of Helsinki, and were provided with a written informed consent to sign. 
 
Eighteen of the participants had been diagnosed with KC and two with PMD. The majority of 
the participants had been wearing gas permeable contact lenses (RGP) (n=9), some were 
wearing spectacle prescriptions (n=7), a few wore piggy-back contact lenses (PBCL) (n=2), 
semi-scleral contact lens (sSCL) (n=1) and soft toric contact lens (n=1) for the correction of 
their condition. These participants had been using their contact lenses on a daily wear basis for 
at least 14 hours a day. On the day of the experimental visits, no contact lenses were worn. 
Measurements were repeated on two separate occasions. At each session, measurements were 
repeated twice. 
 
3.3.3 Inclusion and Exclusion Criteria 
A person was eligible for inclusion in the study if he/she:  
1. Was at least 17 years of age and has full legal capacity to volunteer. 
2. Had read and signed an information consent letter. 
3. Was willing and able to follow instructions and maintain the appointment schedule. 
4. Had been diagnosed with KC or PMD.  
 
A person was excluded from the study if he/she:  
1. Had any known active ocular disease and/or infection such as conjunctivitis.  
2. Had a systemic condition that may affect a study outcome variable. 
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3. Was using any systemic or topical medications that may affect a study outcome 
variable. 
4. Had known sensitivity to the diagnostic pharmaceuticals to be used in the study. 
5. Was aphakic. 
6. Had undergone refractive surgery. 
7. Had had any form of surgery for the correction of KC or PMD.  
 
3.3.4 Instrumentation 
3.3.4.1 Corneal Thickness Measurement with Visante™ OCT  
The Visante™ OCT has been previously described in detail in Chapter 1.  
The Visante™ OCT was used to scan the anterior segment of the eye. No direct contact on the 
eye was made with the instrument. The participants were comfortably seated and properly 
adjusted on the chin rest making sure that their forehead made contact with the forehead rest. 
The participants were asked to look at the yellow fixation target and maintain gaze on this 
target. The instrument was set to enhanced global pachymetry mode for all the measurements. 
The examiner focused and adjusted the instrument until the real-time image of the cornea was 
shown on the computer monitor. The cornea was adjusted to align within the two green 
horizontal mires displayed on the screen. The image was considered to be optimally aligned 
when the specular reflex (vertical streak line), which is reflected from the center of the front 
surface of the cornea, was observed. The participants were also instructed to keep their eyes 
wide open during scanning. Once this was achieved, the capture release button was pressed 
once to scan the cornea. The integrated software (version 2.0) automatically processed the 
OCT images and simultaneously calculated a corneal pachymetry map along eight meridians. 
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Acceptable scans were judged to be of adequate quality based on the following criteria: good 
demarcation of the anterior and posterior boundaries of the cornea, horizontal alignment and 
absence of artefacts in the scanned area. This procedure was repeated after approximately two 
minute intervals for each scan to measure its repeatability and the images were immediately 
examined and assessed to make sure that they were of acceptable quality.   
 
After every measurement, the participants were asked to pull away from the forehead rest and 
repositioned themselves for the next scan to minimize interdependence of the readings. Any 
scan that resulted from misalignment/poor alignment was immediately re-adjusted and the 
measurement was repeated. All the measurements took place in normal lighting conditions and 
these conditions were maintained for all the measurements.  The measurements were repeated 
after two days. 
 
The topographic maps generated by the Visante™ OCT were divided into zones by octants 
(superior, superotemporal, temporal, inferotemporal, inferior, inferonasal, nasal, superonasal) 
and annular rings (2, 5, 7 and 10mm chords). For analysis, the raw data unaltered binary image 
file “*.bin” were exported and processed with custom-built software. 
 
3.3.4.1.1 Visante™ OCT Image Processing and Analysis 
The Visante™ OCT software was used to export the raw unaltered binary image file “*.bin” 
for analysis. Custom-built software (Visante™ OCT Data Compiler, CCLR, Waterloo) was 
used to process the OCT images. The software locates the peak reflectance that corresponds to 
the front and back surfaces of the cornea. The custom-built software then generates all values 
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of total corneal thicknesses along multiple meridians. Once the image processing was 
completed, the software automatically generates an excel spreadsheet for recording. This 
procedure was used to process all the OCT images measured for both first and second visits.  
 
Topographic corneal thickness (TCT) (microns) was recorded in the vertical (90 degrees), 
horizontal (180 degrees) and the oblique (45 or 135 degrees) meridians at 1mm intervals across 
8mm of the central cornea (Figure 3-1a&b).  
 
In order to represent the same locations for each eye, TCT for participants whose left eyes had 
been imaged were mirrored to represent the same locations on the right eye. Figure 3-1a&b 
shows the schematic diagram of the right eye and the mirrored left eye. 
      
Figure 3- 1a: Right eye.              Figure 3- 1b: Mirrored left eye.  
Figure 3- 1a&b: Schematic diagram of the right eye and mirrored left eye.  
N represents nasal, T represents temporal, S represents superior and I represents inferior. 
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3.3.4.1.2 Measurement of Corneal Thickness with Oculus Pentacam HR
®
 
The Oculus Pentacam HR
® 
(Wetzlar, Germany) has been previously described in detail in 
chapter 1. 
 
The Oculus Pentacam HR
® 
was used to scan the anterior segment of the eye. No direct contact 
on the eye was made with the instrument. The participants were seated with their chin on the 
chin rest and their forehead against the forehead strap. The participants were asked to fixate on 
a red fixation target. The room lights were all switched off for all examinations to obtain a 
reflex-free image. The instrument was focused and adjusted using the joystick until the real-
time image of the corneal surface was shown on the computer monitor, with the instrument 
marking the centre of the pupil and the corneal apex. The mires displayed on the screen guided 
the investigator to perfectly align the horizontal and vertical crosshairs (axes) at the centre of 
the pupil. To reduce investigator variability, the automatic release mode was used to take all 
the measurements. The rotating camera was set to capture 25 Scheimpflug slit images in 360 
degrees in approximately two seconds. This procedure was repeated in approximately two 
minute intervals for each scan. After every measurement, the participants were asked to move 
away from the forehead strap and repositioned themselves for the next scan while the joystick 
was used to move the instrument backwards and realigned for the next scan to eliminate 
interdependence of the readings. Scans that registered as “ok” were considered acceptable 
according to the “Examination Quality Specifications” within the standard of the instrument. 
This was to ensure that the scans were not affected by poor alignment/misalignment with the 
optics of the instrument. Any misalignment observed was re-adjusted before the measurement 
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was taken. These measurements were performed on two separate sessions at least 48 hours 
intervals. 
 
The TCT (microns) was recorded in the 90, 180 and oblique (45 or 135) meridians at 1mm 
interval across 8mm of the central cornea.  
 
3.3.5 Conditions for Repeatability 
Repeatability of the measurements taken was based on the standard definition adopted by the 
British Standards of Institution. 
63
 The conditions were standardized by ensuring that 
independent test results were obtained with the same order of measuring the corneal thickness, 
by the same examiner and on the same sets of corneal topographers used within the shortest 
possible time lapse and between the successive sets of measurements in the same 
environmental condition. For reproducibility, the examination was carried out with the same 
method on the same participants using the two corneal topographers. Two repeated 
measurements were taken on each of the two experimental visit days. 
 
3.4 Data Management and Analysis 
Data analysis was conducted using Statistica 11 (Statsoft. Inc., Tulsa, TX, USA).  Mean and 
standard deviation (SD) are reported for both Visante™ OCT and the Oculus Pentacam HR® 
for the two visits. Coefficients of variation (COV) between visits were also performed for the 
two visits. Repeated measures analysis of variance (RM ANOVA) was performed to determine 
the statistical significance of the measurements of the two visits. P values of less than 0.05 
were considered to be statistically different. For the purpose of reproducibility, several 
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interactions within and between the visits, measurements, locations and axes were compared to 
determine whether the two instruments can be used interchangeably. 
 
3.5 Results 
There were 16 males and four females enrolled in the study. Their mean age was 33.95±7.90 
(range: 23-51) years. Two repeated measurements were taken on each of the two visits, first 
with Visante™ OCT and second with the Oculus Pentacam HR®. This order of measurement 
was maintained for all the participants.  
 
The mean CCT for the Visante OCT™ was 484.97±43.14µm and that of Oculus Pentacam 
HR
® 
was 478.86±45.31µm (P=0.67). There was no statistically significant difference in the 
TCT obtained between the two visits (p=0.54) and measurements (p=0.63) for Visante™ OCT. 
There was also no statistically significant difference in the combined visits, axes and locations 
(p= 0.86; Figure 3-2). In the case of Oculus Pentacam HR
®
, no significant difference was found 
in the visits (p=0.18) but difference exists in the measurements (p=0.001). There was also 
significant difference in the combined visits, axes and locations (p=0.001). Tukey post-hoc 
analysis shows that the differences (p˂0.05) were found in the +1 and +4 locations in the 135 
meridian. Figure 3-3 shows the plot of the visits, axes and locations of Oculus Pentacam HR
®
. 
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Figure 3- 2: Plot of visits, axes and locations of TCT for Visante™ OCT.  
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Current effect: F(24, 456)=.69, p=.86
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Figure 3- 3: Plot of visits, axes and locations of TCT for Oculus Pentacam HR
®
. 
Note: The asterisks (*) means locations of significant difference.  
 
 
 
For reproducibility, several interactions were compared. The first interaction of the results 
between the two instruments shows that there were significant differences between the 
instruments, axes and locations (p˂0.05). Tukey post-hoc analysis shows that there was no 
significant difference in the central location; however, differences were at all other locations 
for both para-central locations and the periphery. For certain axes, differences were found as 
* 
Visits*Axes*Locations; Unweighted Means
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close to 1mm out from the centre, as for example in the -1mm location in the 90 meridian 
(Figure 3-4).  
Instruments*Axes*Locations; LS Means
Current effect: F(24, 456)=18.33, p=0.001
Vertical bars denote 0.95 confidence intervals
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Figure 3- 4: Plot of instruments, axes and locations of TCT for Visante™ and Pentacam HR®. 
Note: The asterisks (*) means locations of significant difference. 
 
 
 
There were also significant differences for the interaction of instruments, visits, measurements 
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Pentacam HR
®
. Table 3-1 shows significant differences between visits and measures within the 
Oculus Pentacam HR
®
.  
 
Table 3- 1: Significant differences within Oculus Pentacam HR
®
, when comparing the repeated 
measurements and visits for each of the four visits; shown are the affected visits and measurements, and the 
corresponding p-value. 
 
 Interaction 
Instruments*Visits*Measures*Axes 
090 180 045 135 
N/A 
V1M1 vs V1M2 
p=0.017200 
V1M1 vs V2M2 
p=0.002215 
V1M1 vs V2M1 
p=0.000151 
N/A 
V1M1 vs V2M2 
p=0.000415 
N/A 
V1M1 vs V2M2 
p=0.000258 
N/A 
V2M1 vs V2M2 
p=0.045520 
N/A N/A 
 
Where: V1=visit 1, V2= visit 2, M1= measurement 1, M2= measurement 2, vs= versus 
p= significant difference, N/A= not applicable. 
 
There were also significant differences for the interaction of instruments, visits, measures, axes 
and locations across the four axes (p=0.001). Tukey post-hoc analysis shows that there was a 
difference within one pair of measurements within visit two for the Visante™ OCT (V2M1 vs 
V2M2 at 4mm; p=0.035600); however, such differences were not found for the Oculus 
Pentacam HR
®
.   
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Table 3-2 shows the COV expressed as a percentage of the total corneal thickness at the two 
visits for both Visante™ OCT and Oculus Pentacam HR®. There was slightly more variability 
relative to the mean of the corneal thickness in the -4mm location in the 90 meridian of the 
Visante™ OCT compared to the Oculus Pentacam HR®. The COV for CCT for Oculus 
Pentacam HR
® 
was 9.46% and was found to be slightly more variable compared to the 
Visante™ OCT. 
Table 3- 2: Coefficient of variation (%) of the mean corneal thickness (µm) at the centre and selected 
locations. 
 
Visits 
Locations 
(%) 
  Centre  
Instrument Axis -4 0 4 
 
 
Visante 
090 10.88 8.90 6.62 
180 9.24 8.90 8.50 
045 9.71 8.90 6.88 
135 9.33 8.90 10.26 
 
 
Pentacam 
090 9.38 9.46 6.72 
180 7.74 9.46 8.15 
045 9.43 9.46 7.53 
135 7.67 9.46 7.29 
 
 
3. 6 Discussion 
Repeatability measurements for corneal thickness are important for monitoring changes in 
various corneal conditions overtime, and as such corneal topographers must offer repeatable 
measurements. Reproducibility of the instruments is also important to determine whether they 
can be used interchangeably in clinical and research settings. Ultrasound pachymetry has been 
the gold standard for measuring corneal thickness partly because of its reliability and 
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effectiveness in detecting the anterior and posterior corneal surfaces and therefore measuring 
corneal thickness 
18, 64, 65
; however, current non-invasive imaging techniques provide another 
alternative for imaging corneal thickness. Bechmann et al. 
31
 also reported that US 
overestimates the corneal thickness by approximately 49µm.  
 
Commercially available imaging techniques such as Visante™ OCT and the Oculus Pentacam 
HR
®
 are commonly used in both clinical and research settings to measure the central and 
peripheral corneal thickness for diagnosis, 
16, 44, 50
 pre and post corneal surgical evaluation, 
3
 
screening for refractive surgery and IOL calculation. 
51
 
 
In this study, we compared the repeatability of each of the instruments for the two day visits. 
For reproducibility measurements, several interactions within and between the visits, 
measurements, locations and axes were compared to determine whether the two instruments 
can be used interchangeably. We found the mean CCT with the Visante™ OCT to be 
484.97±43.14µm. Brautaset et al. 
6
 reported 470.63±58.6µm with Visante™ OCT for KC 
corneae. Other authors have also reported similar CCT in KC patients. 
6, 45, 66-68
 The CCT for 
Oculus Pentacam HR
®
 was 478.86±45.31µm. Numerous authors have reported similar CCT in 
patients with KC. 
51, 62, 69, 70
 Uçakhan et al. 
71
 reported 488.00±41.43µm in KC patients using 
Oculus Pentacam HR
® 
while Ahmadi Hosseini et al. 
72
 reported CCT of 499.68±39.59µm with 
the same instrument. 
 
The Visante™ OCT did not show any significant difference for the interaction of visits, axes 
and locations for the repeated measures (p>0.05). Similar results were found for Pentacam 
68 
 
HR
®
 except in the +1 and +4mm locations in the 135 meridian where significant differences 
were determined. 
 
The difference in the mean CCT between the Visante™ OCT and Oculus Pentacam HR® was 
6.11µm, where the Oculus Pentacam HR
® 
measures were thinner.  
 
On the other hand, the total corneal thickness in the para-central and periphery for all 
meridians were slightly higher with the Pentacam HR
® compared with the Visante™ OCT. For 
example the mean difference of the corneal thickness in the -4mm along the 090 meridian was 
found to be 126.04±3.45µm (p=0.001) greater with Oculus Pentacam HR
®
 compared to the 
Visante™ OCT. Such a characteristic pattern, with increased peripheral corneal thickness 
(PCT) measurements variation has been observed by Prospero Ponce et al. 
70
 and Mencucci et 
al. 
45
 Prospero Ponce et al. 
70
 evaluated the CCT and PCT using the Oculus Pentacam HR
®
 
(Wetzlar, Germany), Visante™ OCT (Carl Zeiss Meditec, Dublin, CA, USA), and US 
pachymeter (Sonogage Corneo-Gage Plus, Cleveland, Ohio, USA) in normal, KC-suspect, and 
post LASIK eyes. They reported CCT with the US were consistently higher than Oculus 
Pentacam HR
®
 and Visante™ OCT. They observed mean CCT difference of 0.9±1.4 μm with 
Visante™ OCT higher than the Oculus Pentacam HR®. No significant difference was found 
between the two instruments. They further observed that the PCT with the Oculus Pentacam 
HR
® were slightly higher than Visante™ OCT measurements; however, they showed more 
agreement with each other. 
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Based on the interactions, we found that the two instruments were not reproducible and care 
must be taken when interpreting the measurements from each of the instruments. Oculus 
Pentacam HR
®
 was found to give varied measurements within and across visits and this 
suggests that to achieve more reliable measurements, it is commendable to take repeated 
measurements of the same patient during a visit and average these multiple readings in order to 
minimize the observed variability between measurements for the same eye. (Figure 3-4).  
 
The observed characteristic pattern for the CCT and PCT of our results may be based on the 
fact that Visante™ OCT obtains corneal thickness profiles in less time and corneal thickness 
measurements are not affected by stromal reflections or haze especially centrally. 
67, 73, 74
 It 
measures corneal thickness as a direct measure of reflection peaks occurring at the anterior 
cornea to the posterior surfaces, which is the distance between the two peaks. The Visante™ 
OCT has also been reported to have good intra-operator reliability when compared with US 
and Oculus Pentacam HR
®
. This makes it versatile and a promising imaging technique for 
clinical and research purposes. 
45, 75
 Mohamed et al. 
49
 reported that the COV of the Visante™ 
OCT in KC was <3% for evaluating the corneal thickness. Prospero Ponce et al. 
70
 reported 
that the OCT device gathers information about peripheral thickness within a specific area by 
averaging a number of points, while the Scheimpflug system presents the mean value along the 
line segment of a specific diameter. The differences in the softwares for evaluating corneal 
thickness are likely to result in the variation of the measurements. In this study, custom-built 
software (Visante™ OCT Data Compiler, CCLR, Waterloo) was used to process all the total 
corneal thickness at different meridians. Variations in the CCT and PCT measurements may be 
attributed to the algorithm used by the instruments in generating the topographic corneal 
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thicknesses as well as the custom-built software used in processing all the data. Moreover, in 
the periphery, there is more light scattering with the OCT and loss of lateral resolution 
contributing to the more peripheral error. 
 
The Oculus Pentacam HR
® 
has gained popularity for its repeatable and reproducible results in 
measuring corneal thickness. 
3, 14, 42, 51, 52, 70
 Its effectiveness and reliability has also been 
compared with US, Orbscan II (Bausch and Lomb, Rochester, NY, USA) and Galilei (Ziemer 
Group, Port, Switzerland). 
2, 20, 41, 49, 58, 59, 69, 70, 76
 One of the advantages of the Oculus Pentacam 
HR
®
 is that it automatically captures the image on the eye when perfect alignment is achieved. 
70, 77
 It does not depend on the reflectivity of the tear film to capture the image on the eye; 
therefore, a poor tear film does not distort the corneal imaging characteristics and 
measurements. 
77
 It measures corneal thickness by subtracting the elevation values found for 
the anterior corneal surface from the posterior elevation measurements. Irrespective of the 
advantages, repeatable and reproducible results, recent publications have criticized the Oculus 
Pentacam HR
®
.
 42
 They report that it slightly underestimates the CCT in comparison with slit a 
scanning imaging system, and in more advanced cases of KC, the difference in CCT was found 
to be statistically significant. 
56, 62
 Lam et al. 
78
 reported greater variability with the 
Scheimpflug system at the corneal periphery and therefore suggested that repeated measures 
are necessary to assess the pachymetric readings at the periphery to ensure accuracy.  
 
In this study, looking at the data for the Oculus Pentacam HR
® 
only (Figure 3-3), it was found 
to provide repeatable measurements for most of the locations except for the +1 and +4mm in 
the 135 meridian. However, it needs to be kept in mind that this finding was based on the data 
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for the Oculus Pentacam HR
® 
only, while the significant differences that were found the 
interactions of the instruments, visits, measures and axes across locations (Table 3-1) indicate 
the need for multiple, averaged measurements with this device. This variability may be 
attributed to focussing error or other unexplained factors accounting for the variations in those 
locations.  
 
The fact that the Oculus Pentacam HR
® 
is pre-calibrated by the manufacturer but does not 
provide a precise test/calibration tool raises concerns over the measurements taken in a clinical 
setting; the Visante™ OCT on the other hand has to be calibrated prior to each use by the 
operator. The effect of the light scattering and reflections from the scleral conjunctiva at the 
limbus and reflection from the iris reduces the image quality with the Oculus Pentacam HR
®
 
(Figure 3-5). These reflections may affect the pachymetry values especially at the para-central 
and peripheral cornea regions. 
79
 The effect of light scattering could explain the slightly high 
corneal thickness values observed in the corneal periphery compared to the Visante™ OCT. 
This effect may be important especially in cases of KC and PMD where significant amounts of 
corneal scarring may be found, hence, affecting the ability to measure corneal thickness 
accurately. 
72 
 
 
Figure 3- 5: Effect of light scattering and reflection from the iris and limbus. 
 
 
In conclusion, the Visante™ OCT gave repeated measurements for the two visits as there were 
no significant differences in all the respective locations in all meridians. Oculus Pentacam also 
gave repeatable measurements for the majority of the locations. The two instruments were 
found not to be reproducible and should not be used interchangeably; therefore, care must be 
taken interpreting the TCT from the two instruments. It is advisable to take at least two 
measurements and average these in order to minimize variations between measures. In 
addition, the manufacturers of Oculus Pentacam HR
®  
may consider including a calibration test 
surface so that practitioners would be able to calibrate the instrument each time it is being used. 
Again, more research may be needed to ascertain the effect of the light scattering on the 
measurement parameters, especially corneal pachymetry in the para-central and the peripheral 
areas of the cornea. 
 
Light scattering from scar formation on the cornea and 
reflection from the iris and the limbus 
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Chapter 4 
Repeatability of the Medmont E300™ and Oculus Pentacam HR® Topographers in 
Measuring Topographic Corneal Curvature 
 
4.1 Introduction 
The ability to determine corneal curvature measurements with a high degree of precision is 
important in both clinical and research purposes. The instruments are also expected to be 
repeatable and reproducible to provide a consistent reading under the same or similar 
conditions. Measurements of the central and peripheral corneal curvatures are highly important 
for clinical scientists and ophthalmic practitioners. 
1-3
 The reliability of these measurements is 
critical for providing the necessary information for calculating IOL power, 
3-6
 detecting and 
evaluating the progression of ectatic cornea conditions, 7-9 screening and managing corneal 
refractive surgeries, 
10-13
 and designing, fitting and monitoring of contact lens wear. 
14
 The 
recent introduction of overnight orthokeratology procedures to reshape the corneal curvature 
has also made corneal topographers an indispensable tool to effectively map the cornea and 
detect any significant changes following such treatment resulting from poorly fitting contact 
lenses. 
15-20
 Indices derived from the corneal topographic measurements are also useful in the 
diagnosis and classification of corneal conditions such as KC and PMD. 
1, 21
 Repeatability of 
corneal topographers is important in every clinical measurement for the effective monitoring of 
specific treatment as well as for research purposes. 
21
 
 
Due to the increased usage of corneal curvature measurements, including measurement of 
surface aberrations and tear-induced aberrations during blinking, 
22, 23
 the standards of 
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precision for modern videokeratoscopes have increased as the success of corneal topography-
based strategies to improve vision relies entirely on the accuracy and precision of such 
calculations.  
 
Instruments based on Placido-based technology have most commonly been used to measure 
corneal curvature. This technology is currently used in modern day instruments such as the 
Medmont E300™ (Medmont Pty Ltd, Australia), small cone-head type topographer. Research 
has shown that this technology is limited by tear film instability, shadows from the eyelashes, 
and the eyelids partly because of the use of reflection from the pre-corneal tear film. This effect 
has been shown to adversely interfere with the accuracy of the measurements. 
14, 24
 The 
performance of this technology is further limited by several factors including alignment and 
focusing techniques, low camera resolution, and the computer algorithms used in analyzing the 
data on the anterior corneal surface. 
21, 25, 26
 Two different mire design categories exist for 
Placido-disc topographers: large and small. 
27
 The Medmont E-300™ uses small ring 
topographer and therefore offers greater coverage and better spatial resolution from having a 
greater number of rings, but is more sensitive to focus errors. 
28
  
 
Studies on test surfaces show that the Placido-disc videokeratoscopes are generally accurate in 
the central area, as reflected mires are illuminated perpendicular to the central area, but it is 
worse toward the periphery and is less reliable on surfaces where there is a sudden change of 
curvature. 
21, 26, 29-31
 Peripheral rays of illuminated rings reflected on the cornea suffer from an 
error known as “skew ray error” when measuring rotationally symmetrical surfaces, but this 
error is believed to be small on normal corneas. 
29-32
 According to Mattioli et al., 
32
 the 
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peripheral effect is often not apparent on the topographic maps shown on videokeratoscope 
software because interpolated data are used to bridge/fill in some of the resultant gaps in the 
map. This effect has also been reported by Wilson et al. 
30
 and Tomidokoro et al. 
33
  
 
Irrespective of these limitations, available studies suggest that Placido-disc technology 
continues to provide accurate measurement of the anterior corneal curvature. 
14, 33, 34
 Tang et al. 
21
 in their study on test surfaces showed that the Medmont E300™ was the most precise 
instrument among four videokeratoscopes for detecting spherical and aspheric test surfaces. 
Other researchers have also investigated on predefined test surfaces and have proven the 
accuracy and performance with this technology. 
31, 35-37
  
 
Repeatability measurements on normal corneae have also been reported. 
14
 Cho et al. 
10
 
evaluated the performance of the Medmont E300™, Humphrey Atlas 991 (Carl Zeiss Meditec, 
Dublin, CA, USA), Orbscan II (Orbtek, Bausch and Lomb, Rochester, NY, USA) and Dicon 
CT200 (Dicon, Vismed Inc., USA) on 22 normal corneae. They reported no significant within-
examiner and between-examiner differences with Medmont E-300™. The Medmont E-300™ 
was also repeatable compared with the Humphrey Atlas 991. They reported that the number of 
repeated readings taken for a precision of 2 μm (elevation map) was 12 for the Humphrey 
Atlas 991 and 2 for the Medmont E-300™. 
 
Since its inception of Oculus Pentacam HR
®
 into the mainstream of ophthalmic corneal 
topographers, measurements on both test surfaces and normal corneae measurements have 
been reported. 
14, 24, 38-41, 42, 47
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We 
46
 have previously reported on the repeatability and accuracy of the Oculus Pentacam HR
®
 
on polycarbonate aspheric surfaces. The instrument proved to be repeatable and accurate for 
the majority of the radii of curvature and shape factors measured.    
 
Repeatability and reproducibility measurements on the anterior corneal surface have been 
undertaken by numerous researchers. 
39, 41, 48-52
 Kawamorita et al. 
48
 reported that the Oculus 
Pentacam HR
®
 proved to be repeatable and reproducible for central corneal curvature 
measurements when compared with Keratron
®
 topography systems (Optikon 2000 SpA, Italy). 
In a related study, Kawamorita et al. 
48, 53
 compared the Scheimpflug photography and slit-
scanning topography, Orbscan II (Bausch and Lomb, Rochester, NY, USA) to evaluate the 
repeatability, reproducibility and agreement with these two instruments. They reported that the 
between-instrument agreement was moderate. They concluded that the repeatability and 
reproducibility were higher in the Oculus Pentacam HR
®
 than it was in the Orbscan II.  
 
Although there is an abundance of literature on repeatability of normal cornea curvature 
measurements using the Medmont E300 and Oculus Pentacam HR
®
, 
1, 4, 9, 15, 24, 48-51, 53
 there are 
no reports on the cases of repeatability and reproducibility of these instrument in measuring the 
topographic corneal radius of curvature in KC and PMD corneae. 
 
4.2 Objective 
The main objectives of this study were to: 
1. Assess the repeatability of the Medmont E300™ and Oculus Pentacam HR® in KC 
and PMD corneae. 
77 
 
2. Compare the reproducibility of the two instruments for topographic radius of 
curvature measurements. 
 
4.3 Materials and Methods 
4.3.1 Research Design 
The research design, participants and recruitment for the study as well as the inclusion and 
exclusion criteria have been described in detail in chapter 3. 
 
4.3.2 Instrumentation 
4.3.2.1 Corneal Curvature Measurements (Corneal Topography) 
4.3.2.1.1 Corneal Curvature Measurement with Medmont E300™ 
The Medmont E300™ (Medmont Pty Ltd, Australia) has been previously described in detail in 
chapter 1. 
 
Medmont E300™ was used to measure the corneal curvature. No direct contact on the eye was 
made with the instrument, though the instrument went very close to the eye. The participants 
were seated and properly adjusted on the chin rest, making sure that the forehead made contact 
with the forehead strap. The participants were asked to look at the green fixation target and 
maintain gaze on this target. The examiner focused and adjusted the joystick until the real-time 
image of the cornea was shown on the computer monitor. The green crosshair and the red 
horizontal bar guided the researcher to properly centre and focus on the cornea. Once this was 
achieved, the software automatically captured the image on the eye. Four sets of images were 
displayed in the view pane on the computer monitor. Only one image of the four sets of images 
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was chosen. The criteria used was the image with highest percentage of image quality (>95%) 
according to the “Quality Specification” within the instrument. The selected image was saved.  
This procedure was repeated after approximately two minute intervals for each scan and the 
best image was saved. After every measurement, the participants were asked to pull away from 
the forehead strap and repositioned themselves for the next scan while the joystick was used to 
move the instrument backwards and realigned for the next scan to eliminate interdependence of 
the readings. Any misalignment observed was re-adjusted before the measurement. The 
measurement was taken in the normal lightening condition and this was maintained for the 
participants during the visits. These measurements were repeated on two separate sessions. The 
topographic tangential corneal curvatures (diopters) were recorded in the vertical (90 degrees), 
horizontal (180 degrees), and oblique (45 or 135 degrees) meridians at 1mm interval across 
8mm of the central cornea.  
 
4.3.2.1.2 Corneal Curvature Measurement with Oculus Pentacam HR
®
  
The Oculus Pentacam HR
® 
(Wetzlar, Germany) and the procedure used to measure the corneal 
curvature have been previously described in detail in chapters 1 and 3. 
 
4.3.3 Data Recording 
The corneal topography measurements were manually recorded first with the Medmont 
E300™ and then Oculus Pentacam HR®. The examiner carefully placed the cursor of the 
mouse at the respective position of 1mm on the topographic tangential map. The value 
displayed was recorded in diopters (D). The topographic corneal curvature was recorded in the 
90, 180, and the oblique (45 or 135) meridians at 1mm interval across 8mm of the central 
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cornea. This procedure was used to record all the data for the corneal topography 
measurements.  
 
4.3.4 Conditions for Repeatability 
The conditions of repeatability and reproducibility have been described in Chapter 3.  
 
4.3.5 Data Management and Analysis 
Data analysis used in this study has been described in details in Chapter 3.  
 
4.4 Results 
The mean age, SD and range have been described in Chapter 3. 
 
Two repeated measurements were taken on each of the two visits, first with Medmont E300™ 
and second with the Oculus Pentacam HR
®
. This order of measurement was maintained for all 
the participants.  
 
The mean CRC for Oculus Pentacam HR
®
 was 50.38±5.81D and Medmont E300™ was 
49.41±4.93D (p=0.26). The mean difference of the CRC between the two instruments was 
0.97±0.88 D. There was a significant difference in the visits and locations (p˂0.05) but no 
significant difference in the measures (p=0.98) for the Medmont E300™. There was also no 
significant difference in the combined visits, axes and locations (p=0.12). Figure 4-1 shows the 
plot of visits, axes and locations for the Medmont E300™. Results from the Oculus Pentacam 
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HR
® 
show that there were no significant differences in the visits (p=0.32), measures (p=0.66), 
however, significant difference was found in the axes. There was also no significant difference 
in the combined visits, axes and locations (p=0.24). Figure 4-2 shows the plot of visits, axes 
and locations for the Oculus Pentacam HR
®
. 
 
Figure 4- 1: Plot of visit, axes and locations for Medmont E300™.  
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Figure 4- 2: Plot of visits, axes and locations Oculus Pentacam HR
®
.  
 
For reproducibility, interactions of instruments, visits, measures, locations and axes were 
evaluated to determine whether the two instruments can be used interchangeably. The results 
show that there were significant differences for the interaction of instruments, axes and 
locations (p=0.001). Tukey post-hoc analysis showed that there were no significant differences 
in the centre and out to ±2mm, however, differences were found further out in the periphery 
especially for the oblique meridians. Figure 4-3 shows the locations of significant differences 
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in the respective meridians for the two instruments. No other significant interactions were 
found. 
Instruments*Axes*Locations; Unweighted Means
Current effect: F(24, 456)=3.81, p=.001
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Figure 4- 3: Plot of instruments, axes and locations of radius of curvature for Medmont E300™ and 
Pentacam HR
®
.  
Note: The asterisks (*) means locations of significant difference. 
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Table 4-1 shows the COV expressed in percentage of the mean radius of curvature of the two 
day visits for both the Medmont E300™ and the Oculus Pentacam HR®. There was more 
variability relative to the mean in the distribution of the radius of curvature for Oculus 
Pentacam HR
® compared to the Medmont E300™. The central COV for the Oculus Pentacam 
HR
® 
was 12% and it was slightly higher than the Medmont E300™. The highest variability of 
the Oculus Pentacam HR
® 
was seen in the -4mm locations in the 090 meridian with COV of 
31%. 
 
Table 4-1: Coefficient of variation (%) of the mean radius of curvature (D) at the centre and selected 
locations.  
Visits 
Locations 
(%) 
 
 Centre  
Instrument Axis -4 0 4 
 
Medmont 
 
90 15.00 10.00 21.00 
180 15.00 10.00 23.00 
45 14.00 10.00 18.00 
135 20.00 10.00 12.00 
 
Pentacam 
90 31.00 12.00 25.00 
180 15.00 12.00 27.00 
45 26.00 12.00 28.00 
135 25.00 12.00 21.00 
 
4.5 Discussion 
Interest in corneal topography in clinical and research purposes has increased in the past 
decade with the possibility of computerized corneal topography assessment. Radius of 
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curvature information derived from corneal topography have a number of applications in 
contact lens fitting and assessment, 
8, 54-59
 eye modeling and ocular surface aberration analysis, 
22, 26, 31, 54
 corneal refractive surgery, 
38, 60-64
 detection and follow-up of corneal pathological 
condition. 
65-68
 The relatively recent introduction of orthokeratology have made corneal 
topographers an indispensable tool, as this procedure relies heavily on the anterior radius of 
curvature measurements and continual monitoring of the corneal changes following such 
treatment. 
69-79
 Current clinical corneal topographers continue to use Placido-based technology, 
while other devices such as Oculus Pentacam HR
® 
employ Scheimpflug based technology to 
determine corneal curvature by means of elevation derived data. 
45, 48, 49
  
 
In this study, we assessed the repeatability and reproducibility of two devices for measurement 
of corneal topography; Medmont E300™ and Oculus Pentacam HR® when used to measure 
CRC. We also looked at the COV at the centre and ±4mm locations in all the meridians.  
 
The mean CRC with the Oculus Pentacam HR
®
 was 50.38±5.81D. This was slightly higher 
than the Medmont E300™ of 49.41±4.93D. Miháltz et al. 80 measured the radius of curvature 
of 41 eyes of KC patients using the Oculus Pentacam HR
®
 in the central region. They reported 
a mean CRC of 50.20±5.70D. De Stefano et al. 
81
 also reported 50.44±1.69D in KC patients 
with the same instrument. 
 
We found no significant difference in the combined visits, axes and locations (p=0.12) in the 
mean topographic radius of curvature with the Medmont E300™. Similar results were found 
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with the Oculus Pentacam HR
® 
(p=0.24). The Oculus Pentacam HR
® 
generally produced 
higher CRC measurements although there was no significant difference between the two 
instruments.  
 
It is interesting to note that the graphs shown in figures 4-1 and 4-2 look like a “smeared 
cone”, especially in the oblique meridians. The steepest cone area (cone apex) is located at the 
-1mm location for most of the axes and generally starts from the central portion of the cornea. 
There is flattening in the 2 to 3mm locations and further flattening towards the periphery. This 
may be explained by the fact that in KC PMD, the cone location is mostly always located in the 
temporal portion of the cornea and may also give a clue to the location of the cone apex and the 
extent of the cone diameter. 
80
 It also points to the fact that in KC and PMD, the most specific 
changes in the corneal curvature are steepening and protrusion of the cornea and usually 
temporal to the visual axis. 
82-89
    
 
The two instruments were found to be reproducible for most of the locations; however, 
significant differences were found in the periphery especially in the oblique meridians. Care 
must be taken interpreting the measurements from the two instruments in the clinical and 
research settings. 
 
The Medmont E300™ used in this study is a small cone head type topographer based on 
Placido-based technology. The principle used in calculating the radius of curvature (D) is 
based on the angle of reflection from the tear film, which is then converted to the slope of the 
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surface measured. 
31
 According to Applegate et al., 
31
 the power (D) of the corneal surface is 
obtained by differentiation of the slope.  
 
The possible explanation for the slightly lower radius of curvature values in the central and the 
steepest location may be the instrument’s inability to correctly detect the sharp contour of the 
cornea surface, especially where there is more steeping.  According to Mattioli et al., 
32
 in 
certain circumstances where there are sharp contours on a given surface, the mire reflections 
from an irregular surface may be seen to be either overlapping, doubling, or missing. In such 
situations, they reported that the Placido-ring technology may not measure accurately. In the 
case of KC, the apex of the cone is slightly displaced in the infero-temporal direction relative 
to the visual axis. 
89-97
 The shape of the cone is likely to affect the reflected mires, hence 
causing them to overlap, which may impact on the accuracy of the radius of curvature 
measurement. Another optical reason is that, light does not hit the corneal periphery at a 
normal angle of incidence hence inability to map the cornea. Figure 4-4a shows the loss of 
information in the corneal periphery.  
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Figure 4- 4a: KC shown on Medmont E300™           Figure 4- 4b: KC shown on Oculus Pentacam 
HR
® 
Figure 4- 4 a&b: Tangential corneal topography of KC of the same patient on both Medmont E300™ and 
Oculus Pentacam HR
®
.  
 
González-Méijome et al. 
98
 found that there were inherent errors when measuring corneal 
topography with the Medmont E300™. They examined axial curvature in 60 eyes and a second 
observer registered incidences with the potential to affect data acquisition. They reported 70% 
of the eyes were very easy to measure, with 27% considered to be difficult and the remaining 
3% very difficult. External factors such as fixation instability, head repositioning were the 
major causes of the difficulty in measuring the corneal topography. Other related factors were 
tear instability, the patient's upper orbital or nose interference with the keratoscope for 
centering and focusing processes. Irrespective of the challenges inherent in the use of Placido-
based technology in measuring the radius of curvature, there was no significant difference in 
the repeated visits, axes and locations for the two day visits with the Medmont E300™ and 
such difficulties were not observed in this study. 
 
The images which are produced by the Oculus Pentacam HR
® 
during the rotation process are 
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the basis for calculating height data which is used to extrapolate all other results of the anterior 
segment of the eye. To convert height data to the diopters, the formula (1.3375-1)*(1000)/R 
mm, where R is the radius of curvature (mm) is used. 
 
In this study, we found that the Oculus Pentacam HR
®
 over-estimated the radius of curvature 
compared to the Medmont E300™. Our results also show higher variability in the COV in both 
the central and the periphery of the cornea. According to Shankar et al., 
99
 the slightly higher 
variation usually seen in the peripheral cornea on the tangential map with the Oculus Pentacam 
HR
® 
probably reflects the greater rate of change in peripheral corneal curvature that occurs 
with the tangential method as a function of calculating curvature locally rather than with 
reference to the topographer axis. They argue that the greater rate of change in the periphery 
leaves the peripheral cornea vulnerable to variability. This scenario becomes even worse in the 
case of KC and PMD, as the degree of flattening becomes apparent from the corneal apex 
where the cone is usually located. This effect has also been explained by Salmon et al. 
100
 The 
effect of Scheimpflug camera’s orientation/configuration on the quality of the image is not 
fully known, however, Chen et al.
24
 reported that there is geometrical distortions of the images 
produced by the instrument. This may impact on some of the corneal parameters.   
 
In conclusion, our results show that each of the instruments per se can give repeatable 
measurements, as there were no significant differences in the two visits, axes and locations. 
However, although the two instruments were found to be produce similar results for the 
majority of locations, there were significant differences between measurements of the two 
devices particularly for the oblique meridians in the periphery. Therefore, it is crucial to always 
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identify the specific measurement device when reporting corneal curvature data.  
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Chapter 5 
 
Fitting Semi-scleral Contact Lenses  
 
5.1 Introduction  
The use of sSCL has become an indispensable option in modern contact lens practice. 
1-5
 sSCL 
are indicated for several primary corneal ectasia including KC, 
1, 3, 5-8
 PMD, 
4, 9
 post-corneal 
transplant  (when residual high refractive error and irregular astigmatism cause significant 
reduction in vision), 
2
 severe dry eye, 
2, 10
 neurotrophic keratitis, and multiple other conditions. 
7, 10-14
 
 
Recent reports claim that patients who use these lenses exhibit significantly improved VA in 
the presence of an irregular corneal surface. 
10, 15, 16
 These lenses also provide mechanical 
protection and restore function in conditions such as scarred eyelids, entropion, and ptosis. 
10
 
They can also be used to relieve symptoms in dry eye and corneal dystrophies, and to facilitate 
the healing of corneal epithelial cells following recurrent corneal erosions. 
17
  
 
The fitting of sSCL requires that they make no contact with the fragile or sutured cornea and 
completely vault over the entire cornea to rest on the scleral conjunctiva. 
3
 Thus, it is important 
to choose a lens such that the scleral haptic parallels the conjunctival sclera and that the sagittal 
height of the sSCL is sufficient to completely vault the cornea. 
4
 This unique fitting 
characteristic of the sSCL require better understanding of CSD and the precise selection of an 
initial lens to completely vault the cornea while maximizing the effect on VA and comfort. 
4
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To date no study has been undertaken to evaluate the CSD for fitting sSCL. 
  
5.2 Objectives 
The main aims of this study were: 
1. To measure the CSD using Visante™ OCT and to determine its impact on the sSCL 
selection. 
2. To assess the effect of the fitting characteristics of sSCL on the cornea, and how VA 
is impacted by the choice of fit. 
3. To measure the topographic corneal clearance (TCC) of the sSCL using UL-OCT. 
4. To assess the effect of time on the TCC over 1 hour of sSCL wear. 
5. To assess the comfort ratings of the sSCL. 
 
5.3 Materials and Methods 
5.3.1 Study Design  
This was a prospective, non-dispensing fitting study involving two visits. The first visit 
involved establishing baseline measurements while the second visit facilitated fitting three (3) 
sSCL on the eye. The CSD was measured with the Visante™ OCT at 15mm chord in the 
horizontal meridian. This measurement was conducted on the first visit and was used primarily 
to ensure that participants were eligible based on the availability of the sSCL. Hypothetical 
values of 325 (Lens 1), 375 (Lens 2) and 425 (Lens 3) µm were randomly added in sequence to 
the measured CSD. Figure 5-1 summarises the study design. Only the 15mm chord CSD in the 
horizontal meridian with the Visante™ OCT was used to select the sSCL as this has been 
evaluated in previous work.
18, 19
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High contrast visual acuity (HCVA) and low contrast visual acuity (LCVA) were measured 
with the participant’s contact lenses or the spectacle prescription presented at Visit 1. The 
anterior segment was assessed with and without NaFl with the use of slit lamp biomicroscope.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5- 1: Study design flow chart  
 
5.3.2 Participants and Recruitment 
The participants and recruitment details for the study, inclusion and exclusion criteria have 
been described in detail in chapter 3 and 4. 
 
             Semi-Scleral Contact Lens Fitting  
Baseline measurements including VA, 
biomicroscopy, e-values, corneal 
thickness, radius of curvature and CSD 
using the LogMAR VA chart, Oculus 
Pentacam HR
®
 and Visante™ OCT  
Insertion of the randomly selected sSCL with 
unpreserved saline and NaFl 
Measurement of the TCC using custom-built 
ultra-long OCT (UL-OCT) 
Over-refraction, over-keratometry and 
assessment of VA and comfort ratings using 
auto-refractor, auto-keratometer and LogMAR 
VA chart and comfort rating scale 
Repeat with 2 other lenses 
Screening 
Visit 2 Visit 1 
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5.3.3 Study Lenses 
5.3.3.1 Semi-scleral Contact Lens Design (Jupiter 15mm) 
The sSCL used in this study are designed such that they bear on the scleral conjunctiva and 
completely vault the cornea. The scleral portion is designed to allow adequate tear exchange 
but hold a relatively large volume of tears. It addresses the most irregular and asymmetric 
corneas as well as providing a tear reservoir for severe dry eye cases. They are also designed in 
such a way that the capillary force be maintained to prevent the tear layer from unwarranted 
bubbles and corneal desiccation.  
 
The Jupiter 15mm has 5 curves (Figure 5-2) that are organized into 3 main zones: 
1. The corneal zone, which comprises the central corneal curve and the second curve. 
2. The limbal zone area over the limbus. 
3. The scleral zone which comprises the landing curve and the edge lift curve. 
 
Depending upon the variations of radius of curvature and the stage of the ectatic or diseased 
condition being fit, the Jupiter 15 mm sSCL design are grouped into three fit configurations. 
Changes are made to the fit by varying the posterior design. The Jupiter “standard design” is 
designed in such a way that the second curve is 2mm (approx. 1.00D) flatter than the central 
corneal curve and is indicated for KC and post-surgical cornea. The Jupiter “advanced KC 
design” is designed in such a way that the second curve is 4.00D or 8.00D flatter than the 
central corneal curve, while the Jupiter “reverse geometry design” has the second curve 4.00D 
steeper than the central corneal curve.   
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All the contact lenses of any diameter share the same fundamental design characteristics and 
the radius of curvature of the lens may range from 4.00 to 9.00 mm. 
 
Figure 5- 2: Jupiter sSCL.  
PC=peripheral curve. 
(Photo courtesy Dennis Neifert, Essilor contact lens) 
 
 
5.3.3.2 Diagnostic Trial Lenses 
A fourteen predesigned diagnostic trial lens set (Jupiter 15mm; Essilor) was used in this study. 
These sSCL have labelled parameters including the back optic zone radius (BOZR) or base 
 curve, power and a standard diameter of 15mm. These sSCL are grouped into 3 main 
categories represented by B, K and S where B represents a lens edge with a standard periphery, 
K represents a KC contact lens design with secondary curve of 4D flatter than the base curve 
and S represents a KC contact lens design with the secondary curve 8D flatter than the base 
curve. The details of the lens parameters are listed in Table 5-1. These contact lenses are 
manufactured in Boston XO material with oxygen permeability (DK) value of 100. The 
material is a fluorosilicone acrylate with an added UV absorber. Figure 5-3a shows the Jupiter 
15mm sSCL in a case and figure 5-3b shows the lens fitted on the eye. 
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          Figure 5.3a: sSCL in a case.                                   Figure 5.3b: sSCL on the eye. 
Figure 5- 3 a&b: SCL in a case and the lens fitted on the eye. 
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Table 5-1: Parameters of the diagnostic trial set. 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B=standard periphery. 
K= KC design (secondary curve is 4D flatter than the base curve). 
S= KC design (secondary curve is 8D flatter than the base curve). 
 
   
5.3.3.3 Verification of the Parameters of the Diagnostic Trial Lenses 
The diagnostic trial lenses were clinically examined and carefully verified before using them in 
the study. This was done to ensure the sSCL were devoid of defects and the predefined 
parameters were within the tolerable range. The radii of curvature were measured with the 
radiuscope (Bausch and Lomb, Rochester, NY, USA) and the power was measured with a 
BOZR 
(D/mm) 
Power 
(D) 
Diameter 
(mm) 
40.00/8.44B 0.00 15.00 
42.00/8.04B -1.75 15.00 
44.00/7.67B -3.50 15.00 
46.00/7.34B -5.50 15.00 
48.00/7.03B -7.75 15.00 
50.00/6.75B -9.50 15.00 
52.00/6.49B -11.75 15.00 
54.00/6.25B -13.50 15.00 
57.00/5.92K -15.50 15.00 
59.00/5.72K -17.75 15.00 
61.00/5.53K -19.25 15.00 
63.00/5.53K -21.25 15.00 
66.00/5.36S -12.50 15.00 
68.00/4.96S      -13.75 15.00 
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digital auto lensmeter SLM 5000 (Ryusyo Industrial Co. Ltd., Gun, Japan). The central 
thickness of the lenses were measured using a thickness gauge (Rehder thickness gauge), while 
the diameter of the lenses were measured using a profile projector (Mitutoyo Corp., Tokyo, 
Japan). Slight variations were observed compared to the manufacturer’s given values. (Table 5-
4)  These variations were found to be within the tolerable range deemed acceptable for the 
study. The variations were seen in the power of the sSCL while the other parameters were 
found to be accurate. 
 
5.3.3.4 Measurement of Sagittal Depth/Height of Lenses 
The sagittal heights (sag) of the sSCL were measured with a radiuscope (Bausch and Lomb, 
NY, USA) using a technique described by Dr. Stephen Byrnes (Optometrist, Londonderry, NH, 
USA). 
20
 A front surface silvered mirror was placed on the stage of the radiuscope directly 
under the microscope (Figure 5-4a). With the aperture wide open, the mire image was reflected 
off this surface and brought into focus. (Figure 5-4b). The measuring gauge was set to zero. 
Next, the sSCL to be measured was placed on the mirror concave side down under the 
microscope objective lens (Figure 5-4c). The examiner, looking in the eyepiece of the 
microscope adjusted the lens position on the mirror until the faint, blurred image of the light 
bulb filament that reflected off the apex of the contact lens was clearly seen. The objective lens 
of the microscope was moved away from the stage holding the lens and front surface mirror 
until the filament image came into focus (Figure 5-4d). The objective lens was gradually 
moved away until the faint reflection of the mire image was seen. This third image was 
identified as the mire reflecting off the inner surface of the contact lens (Figure 5-4e). Very 
close to this third image was the fourth image, which reflected off the outer surface of the 
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sSCL (Figure 5-4f). The smaller aperture was rotated into place and this most distinct image 
was centred and focused. The measurement was read and recorded as the sagittal height of the 
front surface of the sSCL (measured perpendicular from the surface of the silvered mirror to 
the front surface of the sSCL). The centre thickness of the sSCL was measured with a centre 
thickness gauge (Rehder thickness gauge) and subtracted from the sagittal height of the sSCL 
to obtain the actual sagittal height of the inside of the sSCL.  
 
   
   
  Figure 5-4a                                  Figure 5-4b                                      Figure 5-4c 
            
            
  
  Figure 5-4d                              Figure 5-4e                                          Figure 5-4f 
Figure 5- 4 a-f: Stages of measurement of the sagittal height of the sSCL. 
 (All photos reproduced with permission from Dr. Stephen Byrnes-Optometrist, Londonderry, NH, USA) 
 
5.4 Study Visits 
There were two visits in the study. The first visit involved screening and establishing baseline 
measurements, while the second visit was for fitting three (3) sSCL on the eye (Table 5-2). The 
examiner was masked to the sSCL type used in the fitting on the second visit. 
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The visits consisted of the following.  
 
1. Screening visit (2 hours per visit)  
Subject eligibility for the study was determined as well as establishing baseline 
measurements.  
2. Fitting visit (6 hours per visit) 
Fitting visit involved fitting three (3) sSCL on the eye and their assessment. 
Randomization of lenses was assigned. Topographic corneal clearance (TCC), over-
refraction, over-keratometry, VA and comfort ratings measurements were obtained.  
 
 
5.5 Study Procedure 
5.5.1 Slit Lamp Biomicroscopy Screening 
A slit lamp biomicroscope was used to examine the anterior segment of the eye. The 
participants were comfortably seated and properly adjusted on the chin rest making sure that 
the forehead made contact with the forehead strap. The ocular adnexa, upper and lower eyelids 
were examined first to rule out any conditions affecting the eye lashes and also any abnormal 
skin growth. This was followed by examining and quantifying the redness of the bulbar 
conjunctiva. Participants with redness graded as 75% and above were disqualified and not 
enrolled. The corneal epithelium, the endothelium as well as the anterior chamber were 
examined in great detail to rule out any corneal erosion, infiltrates and any abnormal anterior 
chamber reaction. Classical corneal signs in KC and PMD (such as corneal scar, Vogt’s striae, 
Fleischer’s ring, corneal thinning) were recorded and not used to discontinue participants from 
the study. Participants with extremely thin corneas (< 200µm) were not enrolled. The cornea 
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was stained with NaFl and examined with cobalt blue light and a Wratten #12 yellow filter. 
This was to rule out any excessive corneal staining or marked complications from prior contact 
lens wear. A cotton swab was used to evert the upper eyelids and the palpebral conjunctiva was 
examined. Participants with redness graded as 75% and above as well as cobblestone papillae 
were not enrolled. The eye was finally rinsed with non-preserved Unisol
®
 4 saline solution and 
participants were allowed to sit for approximately 5 minutes to ensure the saline had 
completely dissipated from the eye. 
Table 5-2: Summary of the procedures conducted at the study visits. 
Visit Procedure Instrument Form (Appendix #) 
Screening & 
Baseline 
Measurement 
Sign information and consent 
letter 
Information consent letter Appendix 3 Information consent letter 
Screening Screening form Appendix 4 Screening form 
Measure VA with present CL or 
spectacle prescription 
LogMAR (HCVA & 
LCVA) chart 
Appendix 5 sSCL examination forms 
Assessment of anterior segment 
with and without NaFl 
Slit lamp biomicroscope 
Appendix 4 Biomicroscopy form 
Appendix 5 sSCL examination forms 
 
Topography measurements 
Oculus Pentacam HR® 
Recording of e-values 
Corneal thickness measurement 
Oculus Pentacam HR® and 
Visante™ OCT 
CSD measurement at 15mm 
chord 
Visante™ OCT 
Semi-scleral 
Fitting and 
assessment 
sSCL selection and fitting 
Diagnostic lens, Unisol® 4 
solution and NaFl strip 
Appendix 5 sSCL examination forms 
Photography of the sSCL lens 
on the eye 
Video slit-lamp 
biomicroscopy camera, 
wratten #12 yellow filter 
TCC assessment and 
measurement. 
UL-OCT 
Over-refraction and over-
keratometry 
Auto-refractor and auto-
keratometer 
Assessment of VA 
LogMAR (HCVA & 
LCVA) chart 
Comfort ratings Comfort rating scale 
 
101 
 
5.5.2 Baseline Measurements 
Immediately after the screening, the Oculus Pentacam HR
® 
was used to take baseline 
measurements, including corneal pachymetry, corneal topography (radius of curvature) and 
eccentricity.  The procedure has previously been described in detail in chapters 3 and 4.  
The Visante OCT was used to measure the CSD at a 15mm chord. The CSD was primarily 
used to select the three sSCL for the participants. Eligibility of the participants was determined 
after the screening and the baseline measurements. 
 
5.5.3 Measurement of Corneal Sagittal Depth using the Visante™ OCT 
A Visante™ OCT was used to measure the CSD (described in detail in chapter 3). The 
integrated software (version 2.0) automatically processed the OCT images and displayed the 
images in the view pane. Acceptable scans were judged to be of adequate quality based on the 
following criteria: good demarcation of the anterior and posterior boundaries of the cornea, and 
absence of artefacts.  
 
The built-in callipers were used to measure the CSD of the cornea at a 15mm chord. Two scans 
were taken at approximately 2 minute intervals and the average CSD of the two measurements 
was used to select the three sSCL for the participants. Figure 5-5 represents the CSD using the 
enhanced anterior segment mode. 
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Figure 5- 5: CSD measurement with Visante™ OCT. 
 
 
 
5.5.4 Semi-scleral Contact Lens Insertion/Fitting 
5.5.4.1 Semi-scleral Contact Lens Preparation and Disinfection 
The lens care system used in this study consisted of: Boston Advance Cleaner, Boston 
Advance Comfort Formula Conditioning Solution, (Bausch and Lomb Inc., Rochester, NY, 
USA), Clear Care Cleaning and Disinfectant Solution (CIBA VISION
® 
Inc., Mississauga, ON, 
CA), and Unisol
®
 4 Saline Solution (Alcon Laboratories, Inc., TX, USA). To clean the sSCL, 
Boston Advance Cleaner was used and rubbed gently on the front and back surfaces of the 
sSCL as recommended by the manufacturer. This was followed by thorough rinsing with the 
Unisol
®
 4 saline solution. After this process, the sSCL were disinfected in Clear Care cleaning 
and disinfectant solution for at least 6 hours. The sSCL were dried with KimWipes
®
 (Sigma-
Aldrich, St. Louis, MO, USA) to make sure the sSCL were free from lint and other micro 
particles. They were stored dry in their respective cases. To fit the sSCL, a drop of Boston 
Advance comfort formula conditioning solution was used on the front surface of the contact 
103 
 
lenses to provide initial comfort on insertion. Unisol
®
 4 saline solution was used to fill the 
sSCL before insertion on the eye.  
 
5.5.4.2 Semi-scleral Lens Contact Fitting and Assessment 
5.5.4.2.1 Selecting the Semi-scleral Contact Lenses from the Diagnostic Trial Lens Set 
Based on the CSD measured at a 15mm chord, hypothetical values of 325 (Lens 1), 375 (Lens 
2), 425 (Lens 3) µm were added to the measured CSD. These values were matched with the 
sagittal heights of the diagnostic contact lenses. Three sSCL that closely matched these values 
were chosen for this experiment. A typical example is shown in the tables 5-3 and 5-4 on how 
the three lenses were selected from the diagnostic trial lens set. Note that the highlighted values 
(bold) were the available lenses from the diagnostic lenses. The sSCL were randomized by an 
optometric assistant before they were inserted on the eye.  
 
Table 5- 3: Selecting sSCL from the diagnostic trial lens.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corneal Sag 
Lens 1 
(325µm) 
Lens 2 
(375µm)) 
Lens 3 
(425µm) 
4.17 4.49 (4.39) 4.54 (4.55) 4.59 (4.69) 
3.33 3.66 (3.52) 3.71 (3.72) 3.76 (3.80) 
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Table 5- 4: Diagnostic trial lenses with sagittal height and thickness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.5.4.2.2 Semi-scleral Contact Lens Fitting and Assessment with Slit Lamp 
Biomicroscopy and NaFl 
The first sSCL was mounted on a suction cup and was well adjusted in place (Figure 5-6a). 
The lens was then filled with Unisol
®
 4 saline solution and a strip of NaFl dye was dipped into 
the saline before insertion, in order to evaluate the fitting characteristics. 
 
Immediately after the lens was inserted onto the eye, (Figure 5.6c) a video-slit lamp camera 
(Canon Inc., China) was used to examine the sSCL on the eye using cobalt blue and enhancing 
Wratten #12 yellow filter. This was to ensure there were no bubbles trapped under the sSCL. 
Lens ID 
Sagittal Height 
(mm) 
Thickness 
(mm) 
1 3.45 0.45 
2 3.52 0.50 
3 3.72 0.50 
4 3.80 0.50 
5 3.97 0.51 
6 4.06 0.55 
7 4.23 0.48 
8 4.39 0.50 
9 4.55 0.54 
10 4.69 0.40 
11 4.88 0.40 
12 5.07 0.43 
13 5.20 0.50 
14       5.40 0.50 
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Bubbles that were bigger than 3-5mm and caused any discomfort were eliminated by removing 
the sSCL from the eye and the lens was then re-inserted. Micro bubbles that did not interfere 
with the visual axis and did not cause any discomfort were left in place on the eye. After 1 hour 
of wearing the sSCL, the video slit lamp was used to capture the sSCL on the eye. The video-
slit lamp camera was set at a magnification of 8x and this setting was used to capture all the 
images in the experiment. The characteristic fluorescein pattern of the central zone, mid-
periphery (over the limbus) and the periphery were assessed and recorded at the end of 1hour 
of lens wear.  
          
Figure 5.6a: sSCL mounted on the suction cup.       Figure 5.6b: Insertion of the sSCL on the eye. 
 
 
                    Figure 5-6c: sSCL with NaFl on the right eye. 
 
Figure 5- 6 a-c: Stages of fitting the sSCL on the eye. 
 
 
5.5.4.2.3 Fluorescein Fitting Characteristics Grading Scale 
An internally generated grading scale was used as a guide to assess the fit of the sSCL on the 
eye. The graded areas of the sSCL on the eye were the central, mid periphery; edge width or 
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axial edge lift (AEL). Numerical values ranging from -2 to +2 where +2 represented the 
steepest sSCL and 0 represented the “ideal” fit where the sSCL completely parallels/contour 
the corneal to land on the conjunctival sclera. Any touch on the cornea was graded as negative 
and depending on the amount of touch on the cornea it was graded as -1 or -2, where most of 
the sSCL touched the cornea. (See appendix 5) The NaFl fitting characteristics were purely 
subjective after many trials to effectively assess the fit of the sSCL. The assessment was done 
at the end of 1 hour of sSCL wear. This grading scale and assessment was used for all the 
participants.  
  
5.5.4.2.4 Slit Lamp Photography (Photo-documentation of NaFl patterns) 
The video-slit lamp camera was used to capture the images of the sSCL on the eye. The 
participants were comfortably seated and properly adjusted on the chin rest making sure that 
the forehead made contact with the forehead rest. The participants were instructed to fixate on 
a yellow target on the camera which caused them to look straight ahead and maintain gaze on 
this target. The slit lamp was gently moved forward to focus on the sSCL. The real-time image 
was seen on the flat screen monitor connected to the video slit lamp camera. The real-time 
image guided the examiner to carefully focus on the sSCL to make sure the entire lens could be 
captured. Once the sSCL was in focus, the participants were asked to blink once and the video 
slit lamp shutter was pressed once to capture the sSCL on the eye. The image was 
automatically displayed on the computer screen. The software displays two images at a time 
for each image. Acceptable images were judged to be of adequate quality based on the 
following criteria: sharp full image showing the centre, mid periphery and the periphery, no 
interruption with the eye lashes.  
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Three images were taken for each sSCL and this procedure was repeated for all the other lenses 
used in the study (Figure 5-7). 
 
Figure 5- 7: sSCL on the eye. 
 
 
5.5.4.2.4 Measurement of Tear Film Width/Topographic Corneal Clearance with UL-
OCT 
A custom-built UL-OCT was used to take corneal topographic images of the sSCL on the eye. 
These measurements were carried out at approximately 10 minute intervals over a period of 1 
hour to determine the effect of time on the tear film clearance. The amount of TCC was 
measured using the instrument’s custom-built software.  
 
5.5.4.2.5 Imaging the Semi-scleral Contact Lens on the Eye 
The UL-OCT used to capture the images of the sSCL on the eye has been described in detail in 
chapter 1. 
108 
 
No direct contact on the eye was made with the instrument. The participants were comfortably 
seated and properly adjusted on the chin rest making sure that the forehead made contact with 
the forehead strap. A scan depth of ~7.441mm, a scan width of up to 14mm and an optical 
resolution of up to ~6µm was used to image all the sSCL on the eye. The focal plane was set to 
2.8mm to capture all the images. The scan measurements were done in the vertical meridian 
using the appropriate settings. The participants were instructed to fixate on a blue target in the 
instrument in order to correctly align the eye with the optics of the instrument for easy 
measurement and evaluation. No fluorescein was used after the insertion of the lens to avoid 
unnecessary “fluorescein flooding” of the eye, which may have affected the TCC. 
 
The examiner focussed and adjusted the joystick until the real-time image of the surface of the 
sSCL was shown on the computer monitor, with the instrument showing at least 13mm 
diameter of the sSCL in both the x-and y-meridians. The real-time images displayed on the 
screen guided the investigator to perfectly align both the x and y-meridians of the sSCL. The 
image was considered to be optimally aligned when the specular reflex (vertical streak line), 
which has a high intensity, was reflected from the center of the front surface of the sSCL. The 
participants were also instructed to keep their eyes wide open during scanning. Once this was 
achieved, a manual footswitch was hit once to scan the sSCL eye. The integrated software 
automatically processed the OCT image and displayed it in the view pane. Acceptable scans 
were judged to be of adequate quality based on the following criteria: good demarcation of the 
anterior and posterior boundaries of the sSCL, good demarcation of the front and back surface 
of the cornea, vertical and horizontal alignments and absence of artefacts in the scanned area.  
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The UL-OCT processes three scan images at a time in approximately two seconds. The scan 
images were immediately assessed and evaluated to make sure they were within the established 
standards of imaging a contact lens on the cornea. Again, this was to ensure that the scans were 
not affected by poor alignment/misalignment with the optics of the instrument. If any 
misalignment was observed, the instrument was readjusted and the scan was repeated. After 
every scan, the UL-OCT was moved backwards and realigned for the next scan to ensure 
interdependence of the readings. This procedure was repeated at approximately 10 minute 
intervals for a period of 1 hour for each of the three sSCL fitted on the eye. The scans took 
place in normal lighting and the same environmental conditions were maintained for all 
measurements 
 
5.5.4.2.6 UL-OCT Image Processing and Analysis 
Using the recommended custom-built software for image analysis, the images were first 
processed into a readable (*FFT) format. Image J software (National Institutes of Health, 
Bethesda, MD, USA) 
21
 was used to resize all the images into an appropriate size (2048 x 
1088pixels) required for a 14mm image scan. The investigator manually outlined at least 25 
reference points (a, b and c) (figure 5-8) on the front and back surfaces of the sSCL and the 
front surface of the cornea image was displayed on a 22-inch flat screen monitor (LG Flatron 
W2242TQ) using the custom-built image analysis software (TD Analyzer). The software 
simultaneously calculates the thickness of the three surfaces (a and b, a and c). To obtain the 
TCC (d), the total thickness of the front surface of the sSCL and the front surface of the cornea 
were subtracted from the front and back surfaces of the sSCL. The values were recorded in 
1mm intervals at the central 8mm of the entire diameter of the sSCL, as this dimension was 
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found to give consistent values (Figure 5-8). To account for the fact that light was passing 
through the thick sSCL and through the tear film layer, a correction factor of 1.336 was used, 
which accounts for the refractive index of the tear film layer. The upper half (upper eyelid 
area) was recorded with a positive sign, while the lower half (lower eyelid) was recorded with 
a negative sign. This procedure was used to analyze all the scan images, with seven scan 
images for each of the three sSCL. 
   
 
 
Figure 5- 8: Scan of the sSCL on the eye.  
 
The reference points outlined on the surfaces of interest are indicated by the colours red, purple and green. 
The letters “a”=front surface of the sSCL, “b”= back surface of the sSCL, “c”= front surface of the cornea 
and “d”= tear film layer/topographic corneal clearance. The horizontal thick line represents the 8mm 
analysed zone area while the vertical thick dotted lines represent the range (8mm) within which the 
measurements were recorded at 1mm intervals. 
 
 
 
 
 
 
 
a 
b 
c 
d 
8mm analysed zone 
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5.5.4.2.7 Over-refraction and Visual Acuity Assessment  
At the end of 1 hour of sSCL wear, over-keratometry and over-refraction were performed to 
measure the residual astigmatism and the corresponding refractive power. The sphere and the 
cylinder powers were recorded. 
 
Spherical subjective refraction was performed over the sSCL using the phoropter. To measure 
the VA, a standard LogMAR visual acuity chart was projected on the computer screen. HCVA 
and LCVA were measured and recorded in decimal values as it is consistent with the use of 
LogMAR VA chart. This procedure was used for all participants.   
 
5.5.4.2.8 Comfort Rating  
Before removing the sSCL at the end of the 1 hour, the participants were asked to give a 
comfort rating score for the sSCL. This subjective rating was assessed using a comfort grading 
scale ranging from zero (representing very poor comfort) to 100 (representing excellent 
comfort). Figure 5-9 shows the comfort rating scale. This procedure was repeated for all three 
sSCL in this experiment.  
0                                                                                            100 
Very poor comfort                                                        Excellent comfort 
 
Figure 5- 9: Comfort rating scale. 
 
 
 
5.6 Data Management and Analysis 
Data analysis was conducted using Statistica 11 (StatSoft. Inc., Tulsa, OK, USA). The means 
and SD were used to analyse the CSD as well as the VA. Analysis of variance (ANOVA) was 
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performed to determine the statistical significance of the HCVA and LCVA as well as comfort 
ratings with the three sSCL. P values of less than 0.05 were considered statistically significant. 
Pearson correlation was also performed to determine the relationship between the HCVA and 
LCVA and comfort rating for all the three sSCL. To determine the effect of time on the TCC, 
the differences between the corneal TCC at time 0, 20, 40 and 60 minute intervals were taken. 
The mean and SD were also determined. Two point locations (±3mm) in the upper and lower 
portions of the cornea were taken for the TCC analysis for all the sSCL.  
 
5.7 Results 
The mean age, sex, and the visual correction presented by the participants at the time of study 
has been described earlier in chapters 3. 
 
The mean K-reading was 48.72±4.11D while the steepest K-reading was 56.57±7.39D. The 
mean CCT was 493.89±39.55µ while the overall cone diameter was 4.19±1.13mm. The mean 
CSD in the horizontal meridian was 3.78±0.53 (ranges: 3.33-4.17) mm at 15mm chord. The 
measurement of the CSD in horizontal meridian was used to select the three sSCL from the 
diagnostic trial lenses as this meridian has been evaluated by some researchers. 
18, 19
  
 
The table below shows the baseline measurements obtained on the first visit of the study. 
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Table 5- 5: Mean baseline measurements. 
 
 
The details of the topographic pachymetry as well as radius of curvature have been described 
in chapters 3 and 4.  
 
The mean sagittal height of the sSCL was 4.38±0.63 (range: 3.46-5.53) mm. The mean central 
thickness of the sSCL was 0.50±0.05 (range: 0.48-0.56) mm. The residual astigmatism 
(flexure) for all the three lenses was insignificant (-0.23±0.14) likely due to the thickness of the 
lenses.  
 
Slight differences (±0.25D) in the power measurement were found with the 46.00/7.34B and 
61.00/5.53K sSCL as well as the total diameter of the sSCL. However, they were all within the 
tolerable range for the study. The table below shows the measured parameters of the diagnostic 
trial lenses. 
 
 
 
 
 
 
 
K-readings (D) Pachymetry (µm) 
CSD 
(mm)  
Cone diameter 
(mm) 
Eccentricity  
 
Sim 
Flat 
Sim 
Steep 
Average  Steepest Centre Thinness 
@ 
180 
Apex Overall e 
Mean 46.90 50.75 48.72 56.57 493.89 447.85 3.78 2.00 4.19 0.83 
SD 4.45 4.02 4.11 7.39 39.55 48.76 0.53 1.14 1.13 0.26 
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Table 5- 6: Measured parameters of the diagnostic trial lenses.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It was evident that most Lens 1 options touched the cornea or were slightly decentered after 1 
hour of sSCL wear. The areas of touch were seen in the mid-periphery, the nasal or the 
temporal portions of the eye (Figure 5-10b).   
 
Figures 5-10a-b show sSCL Lens 1 fitted on different eyes with different characteristic pattern 
after 1 hour of sSCL wear. The NaFl characteristic grading concentrated on the central (C), 
mid periphery (MP) and the axial edge lift (AEL).   
Lens 
Total 
Sag(mm) 
Power (D) 
 
Diameter (mm) 
 
Central 
Thickness(mm) 
40.00/8.44B 3.46 0.00 15.00 0.48 
42.00/8.04B 3.71 -1.75 15.05 0.53 
44.00/7.67B 3.86 -3.50 15.04 0.55 
46.00/7.34B 3.82 -5.75 15.05 0.52 
48.00/7.03B 3.93 -7.75 15.05 0.55 
50.00/6.75B 4.23 -9.50 15. 05 0.56 
52.00/6.49B 4.23 -11.75 15.05 0.51 
54.00/6.25B 4.45 -13.50 15.07 0.51 
57.00/5.92K 4.42 -15.50 15.00 0.51 
59.00/5.72K 4.47 -17.75 15. 03 0.41 
61.00/5.53K 4.75 -19.00 15.00 0.41 
63.00/5.53K 5.10 -21.50 15.00 0.45 
66.00/5.36S 5.37 -12.50 15.02 0.50 
68.00/4.96S 5.53 -13.75 15.02 0.53 
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 Figure 5-10a: sSCL Lens 1                                   
 
 Figure 5-10b: sSCL Lens 1                                   
Figure 5- 10 a&b: sSCL Lens 1 fitted on two eyes with different NaFl patterns. 
Lens 1 in figure 5-10a was graded with C=0, MP=optimal, AEL=optimal. Lens 1 in figure 5-10b was graded 
with C=0, MP=-1, AEL=optimal.  
 
Visible touch on the nasal 
portion with slight central 
pooling. 
sSCL parallels on the cornea 
with visible iris. The AEL 
was optimal.   
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Most Lens 2 options exhibited adequate vault over the entire cornea to the limbal region. This 
resulted in improvement in vision (similar to Lens 1). Figures 5-10 a&b show sSCL (Lens 2) 
fitted on two eyes with characteristic patterns after 1 hour of wear.     
                       
 
 Figure 5-11a: sSCL Lens 2       
 
                                   
Adequate vault over the entire 
cornea with optimal AEL. 
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  Figure 5-11b: sSCL Lens 2  
Figure 5- 11 a&b: sSCL Lens 2 fitted on two eyes with different NaFl patterns.  
Lens 2 in figure 5-11a was graded with C=1, MP=1, AEL=0. Lens 2 in figure 5-11b was graded with C=1, 
MP=1, AEL=1.   
   
Lens 3 yielded excessive TCC especially in the central portion. The central pooling over the 
cornea extended partly to the mid-periphery. Generally, there was slight reduction in VA 
compared to Lens 1 and 2. Comfort level with Lens 3 was quite high similar to Lens 1 and 
Lens 2. Figures 5-12a-b show Lens 3 fitted on different eyes with characteristic patterns after 1 
hour of wear.     
                        
Adequate vault over the entire 
cornea with “feathery” touch in 
the upper area and visible AEL 
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  Figure 5-12a: sSCL Lens 3    
 
 
   
 
 Figure 5-12b: sSCL Lens 3      
Figure 5- 12 a&b: sSCL Lens 3 fitted on two eyes with slightly different NaFl patterns.  
Lens 3 in figure 5-12a was graded with C=+2, MP=+1, AEL=+1. Lens 3 in figure 5-12b was graded with C= 
+2, MP=+2, AEL=+2. 
Excessive CCC (pooling) with 
slightly tight AEL (dark band) 
Excessive CCC (pooling) with 
slightly tight AEL (dark band) 
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Analysis of variance for all the three sSCL show there were statistically significant differences 
in the time, lens and locations (p=0.001) after 1 hour of sSCL wear. Figure 5-13 shows mean 
TCC and the effect of time on all the three sSCL at the different locations on the cornea. It is 
evident from the graph that Lens 1 did not have enough clearance and has evidence of corneal 
touch. The corneal touch was evident with the NaFl mostly in the nasal and superior portions 
on the cornea (Figures 5-10a&b). Lens 2 exhibited a TCC within a documented acceptable 
range, 
3, 10, 22, 23
 while Lens 3 had unacceptable TCC (too high) even after 1 hour. The 
difference between Lens 1 and 2 on the graph could be considered as a critical amount, below 
which the sSCL chosen will likely vault less and increase the possibility of touching any part 
of the cornea. This could impact on the NaFl fitting characteristics as well as comfort, although 
VA may be increased.  
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Current effect: F(96, 1824)=1.11, p=0.22
Vertical bars denote 0.95 confidence intervals
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Figure 5- 13: Mean TCC of all the three sSCL after 1 hour.  
Note: Lens 3 has excessive TCC even after 1 hour of sSCL wear. Lens 1 has the least TCC. The negative 
sign on the x-axis represent inferior location and the positive sign represent superior location in the 8mm 
diameter at 1mm interval. 
 
The overall mean and SD of the CCC loss (CCCl) after 1 hour for all the three sSCL was 
0.03±0.08mm (30±80µm). Table 5-5 shows the mean and SD of ±3mm locations in the 
superior and inferior portions of the cornea. The greatest CCCl was found with Lens 3. The 
CCCl for Lens 3 was 0.04±0.05mm (40±50µm) at the end of 1 hour of the SCL wear. There 
was no significant change over time from insertion to 60 minutes (p>0.05) at the central and 
±3mm locations for each of the three lenses.    
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Table 5- 7: Mean TCC loss (µm) and SD at the end of the 1 hour and the selected points. 
 
 
 
 
 
Lens 1 Lens 2 Lens 3 
 Superior Location Inferior Superior Location Inferior Superior Location Inferior 
Time +3 Centre -3 +3 Centre -3 +3 centre -3 
20 min 0.00±10.00 10.00±10.00 10.00±20.00 20.00±40.00 10.00±20.00 20.00±60.00 0.00±30.00 10.00±20.00 20.00±30.00 
40 min 30.00±20.00 20.00±30.00 10.00±90.00 20.00±60.00 30.00±60.00 40.00±70.00 10.00±20.00 20.00±20.00 30.00±30.00 
60 min 10.00±10.00 30.00±30.00 30.00±40.00 40.00±60.00 30.00±60.00 50.00±70.00 30.00±30.00 40.00±50.00 50.00±50.00 
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Irrespective of the small amount of TCC loss, there were variations among these values after 1 
hour of lens wear. A typical example is shown for Lens 1 (Figures 5-14a&b), where there was 
CCCl of 104µm after 1 hour of sSCL wear. This was found to be significantly higher 
compared to Lens 2, where there was 50µm CCCl, while Lens 3 recorded only 6µm. The 
changes in the CCCl were evident under the slit lamp biomicroscope and UL-OCT. Figures 5-
14a-h show the three sSCL fitted on the same eye with varied CCCl after 1 hour. The details of 
the TCC loss of selected time intervals and locations for all the three SCL are shown in the 
appendices. 
 
   
Figure 5-14a: Time @ 0 minute for Lens 1.        Figure 5-14b: Time @ 60 minutes for Lens 1. 
   
  Figure 5-14c: NaFl @ 0 minute for Lens 1.        Figure 5-14d: NaFl @ 60 minutes for Lens 1.   
 
“Slight” touch Visible touch 
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Figure 5-14e: Time @ 0 minute for Lens 2.       Figure 5-14f: Time @ 60 minutes for Lens 2. 
   
Figure 5-14g: Time @ 0 minute for Lens 3.        Figure 5-14h: Time @ 60minutes for Lens 3. 
Figure 5- 14 a-h: UL-OCT images and NaFl patterns of the three sSCL fitted on the same eye for 1 hour. 
Note: Visible touch in Lens 1 after 1 hour. This was evident both in the UL-OCT scan and the NaFl 
pattern. The CCC loss for Lens 1 was 104 µm (Figure 5-14 a&d), Lens 2 was 50 µm (Figure 5-14e-f), Lens 3 
was 6 µm (Figure 5-14g-h).  
 
 
At the end of the 1 hour of sSCL wear, mean CCC was 190±100µm, 360±120µm and 
450±170µm for each lens respectively (p=0.001). Lens 1 had the least CCC while Lens 3 had 
the highest corneal clearance value. Further analyses of Lens 1, 2 and 3 show that there were 
statistically significant differences in time and location (p=0.001), except for Lens 1 (p=0.06).  
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It is evident from Figure 5-15 and 16 that there was no change in TCC after 30 minutes; 
however, in Lens 3 (figure 5-17) there was a change even at the end of the 1 hour. 
Current effect: F(48, 912)=1.35, p=0.06
Vertical bars denote 0.95 confidence intervals
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 Figure 5- 15: Mean CCC and effect of time on sSCL Lens 1. 
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Current effect: F(48, 912)=1.68, p=0.00
Vertical bars denote 0.95 confidence intervals
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 Figure 5- 16: Mean CCC and effect of time on sSCL Lens 2. 
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Current effect: F(48, 912)=1.59, p=0.01
Vertical bars denote 0.95 confidence intervals
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 Figure 5- 17: Mean CCC and effect of time on sSCL Lens 3. 
 
The mean HCVA was highest for Lens 1 (LogMAR=0.05±0.12). Lens 3 recorded the lowest 
HCVA (LogMAR=0.11±0.08). There was a significant difference between the three lenses 
(p=0.02). Tukey post hoc analysis shows that there was no significant difference between Lens 
1 and Lens 2 (p=0.32) or Lens 2 and Lens 3 (p=0.27), however, there was a significant 
difference between Lens 1 and Lens 3 (p=0.01). Similar findings were found for LCVA, with 
p=0.02.  Tukey post hoc analysis shows that only Lens 1 was significantly different from Lens 
3 (p=0.02). Table 5-6 shows the mean and SD of the HCVA and LCVA for the three sSCL.  
 
 
 
 
127 
 
Table 5- 8: Mean HCVA and LCVA. 
 
 
HCVA LCVA 
 
Lens 1 Lens 2 Lens 3 Lens 1 Lens 2 Lens 3 
Mean 0.05 0.07 0.11 0.41 0.45 0.50 
SD 0.12 0.11 0.08 0.16 0.19 0.17 
 
 
The overall comfort rating for all three sSCL was 77.7±10.6 (range: 40-100). From Table 5-7, 
Lens 2 recorded the highest comfort rating with 79.7 ±11.6 after 1 hour of wear, while Lens 1 
recorded the lowest comfort rating of 74.9±9.2. There was no statistically significant difference 
between the three lenses (p=0.24).  
 
Table 5- 9: Mean comfort ratings for all three sSCL. 
  
 
 
 
 
    
Pearson correlation was performed to assess the relationship between comfort and VA for 
Lenses 1, 2 and 3 for both HCVA and LCVA. There was no correlation between comfort and 
VA for all the sSCL, with the exception of HCVA for Lens 2, where there was a negative 
correlation. (Figure 5-20). 
 
COMFORT RATINGS 
 
 Lens 1 Lens 2 Lens 3 
Mean 74.9 79.7 78.6 
SD 9.2 11.6 10.8 
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The figures below show the correlation between HCVA and LCVA and comfort for all the 
sSCL. 
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 Figure 5- 18: Correlation between HCVA and comfort for Lens 1. 
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Figure 5- 19: Correlation between LCVA and comfort for Lens 1. 
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 Figure 5- 20: Correlation between HCVA and comfort for Lens 2. 
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 Figure 5- 21: Correlation between LCVA and comfort for Lens 2. 
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 Figure 5- 22: Correlation between HCVA and comfort for Lens 3. 
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 Y = 75.245 + 6.7764 * X
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 Figure 5- 23: Correlation between LCVA and comfort for Lens 3. 
 
 
5.8 Discussion 
Recently, there has been a marked resurgence in interest in the use of sSCL for managing 
various conditions. The major advantage is that they offer greater comfort compared to regular 
RGP lenses and can provide some therapeutic effects in some conditions affecting the cornea. 
24
 These lenses are primarily indicated for use in KC, PMD and other corneal ectasia, 
1, 10, 24-27
 
post graft management, 
21
 dry eye 
28, 29
 and limbal cell disease. 
30
 They are also indicated for 
complicated cases such as Sjogren's syndrome, ocular cicatricial pemphigoid and other related 
conditions. 
29, 31-33
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In this study, we experimentally assessed whether sSCL can be appropriately fitted using CSD 
measurements on patients diagnosed with KC (n=18) and PMD (n=2). We evaluated the CSD 
and how to effectively use this measurement to select sSCL from the diagnostic trial lenses. 
Fitting characteristics of the sSCL based on the NaFl pattern under the slit lamp biomicroscope 
in the central, mid periphery and the peripheral regions were assessed. The HCVA and LCVA 
as well as comfort ratings were also assessed at the end of 1 hour of lens wear.  
 
The mean CSD in the horizontal meridian was 3.78±0.53 (range: 3.33-4.17) mm at 15mm 
chord. Similar results have been previously reported by Sorbara et al. 
18
 
 
The majority of the sSCL vaulted completely over the cornea to rest on the conjunctival sclera. 
An interesting observation was the fact that most of the sSCL were seen to be tight, with a 
“yellowish ring/band” in the mid-periphery, followed by a slightly dark band, indicating a tight 
or inadequate AEL. A possible explanation of this pattern could be attributed to the design of 
the sSCL (from the transitional zone to the landing zone) perhaps to make the lens more stable 
in the mid periphery on the corneal with slight flattening towards the periphery to allow for 
adequate tear film exchange.  
 
The estimation of the appropriate TCC (especially CCC) remains a challenge to effectively fit 
and assess these lenses. The controversy lingers on the amount of clearance expected between 
the corneal epithelium and the back surface of the sSCL. Some authors have suggested 250µm, 
10
 or 100-400µm. 
25
 According to 1997 ISO for Ophthalmic Optics-contact lenses and contact 
lens products, 
34
 CCC was recommended to grange between 200 to 300µm for optimal fit. To 
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subjectively quantify the amount of clearance, Schornack et al. 
25
 suggested ¼ or ½ of the tear 
film thickness to the corneal thickness through the optic section of the slit lamp biomicroscope. 
In this study, we added 325 (Lens 1), 375 (Lens 2) and 425 (Lens 3) µm respectively to the 
CSD to select three sSCL to fit on the eye.   
 
At the end of the 1 hour of sSCL wear, mean CCC was 190±100, 360±120 and 450±170 µm 
for each lens respectively (p=0.001). The mean CCC loss after 1 hour for all the three sSCL 
(Table 5-5) was 0.03±0.08mm (30±80µm). Caroline et al. 
35
 reported an average of 96 (range: 
70-180) µm of apical corneal clearance (ACC) loss after 8 hours of sSCL on normal eyes. 
Mountford 
36
 reported 146 (range: 106-186) µm of ACC loss after one month of sSCL. One 
question that remains unanswered is the thickness profile of the sSCL used in their study and 
the clinical effects of the ACC loss on the VA and comfort rate. Irrespective of the small CCCl 
found in this study, there were variations at the end of the 1 hour period.  
 
The cause of the variations are unknown; however, we propose that eyelid force, dissipation of 
the saline or the tear film reservoir, design of the sSCL scleral zone radius, thickness profile, 
flexure and other unknown factors may be responsible for such variations. 
 
To assess the success of sSCL, VA plays a very important role. Schornack et al. 
25
 
hypothesized that the amount of TCC between the posterior surface of the sSCL and the 
anterior surface of the cornea is not critical to the successful  fitting of these lenses. In this 
study, we found a significant difference in the TCC (p=0.001) of the three lenses. There was 
also significant difference between Lenses 1 and 3 in both HCVA and LCVA. Tukey post hoc 
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analysis for both HCVA and LCVA for comparing Lenses 1and 3 were p=0.01 and p=0.02 
respectively. We found poor correlation in both HCVA and LCVA for the lenses. Based on our 
results, we suggest that their hypothesis is not necessarily correct. Fitting sSCL with increased 
or excessive amount of CCC may not give the best VA though comfort rate may be high. 
 
Comfort and successful wearing of sSCL have been documented by various authors. 
4, 27
 In this 
study, the overall comfort rating was 77.7±10.6. There was no significant difference (p=0.24) 
in the comfort ratings for the three lenses. Visser et al. 
27
 reported comfort rate 78.9 in their 
study with sSCL.   
 
From our results, it is evident that Lens 2 (CCC=360µm) gave the best combination of VA and 
comfort ratings. In clinical practice, it may be important to consider the mean CCCl (30µm) to 
select the initial sSCL. Therefore, the suggested mathematical expression to select the initial 
sSCL is given by: 
Initial sSCL= mCSD+mCCC+mCCCl   
Where; 
mCSD represents mean CSD, found to be 3.78mm, 
mCCC represents mean CCC, found to be 0.36mm and  
mCCCl represents mean CCC loss, found to be 0.03mm. 
 
In order to choose the initial lens from the diagnostic trial lens set, add the CSD and the 
amount of CCC and the anticipated CCCl (i.e Initial sSCL=3.78+0.36+0.03=4.17mm). Thus, 
according to our study, the initial sSCL sag value to start is 4.17mm (4170µm). Fluorescein 
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pattern must be assessed, especially the AEL, and this must be balanced with the resultant VA 
and comfort rating of the lens. 
 
In conclusion, our results show that a mCCC of “360”µm could be the “starting point” clinical 
value to add to the measured CSD and the expected CCCl to choose the initial sSCL for fitting 
and assessment on the eye. It is also evident from our study that adding more than 400µm to 
the measured CSD may affect the HCVA and LCVA (Figure 5-12a&b). Adding the range of 
less than 200µm may also cause the sSCL to touch the cornea, especially the superior part of 
the cornea or the corneal apex. This will likely reduce the comfort ratings, though there may be 
an improvement in VA. 
 
Based on our findings in this study, we propose the following: 
1. Evaluation of CSD can be used to effectively select sSCL to fit on the eye. 
2. The results suggest that lens 2 (adding 375μm with mCCC=360µm to the CSD) 
gave the best combination of VA and comfort ratings. However, evaluation of the 
fluorescein pattern must be balanced with the VA and comfort ratings for successful 
fitting in a clinical setting.  
3. There is a likelihood of TCC loss after 1 hour of sSCL wear. However, this will 
vary and depends on many factors, including eyelid force, design of the sSCL, and 
dissipation of the saline or the tear film reservoir, scleral zone radius, thickness 
profile, flexure and other unknown factors. 
4. LCVA could be used as a predictor for successful fit for sSCL when improvement 
in VA is the primary reason for fitting the lenses. 
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5. Allowing the patient to sit for approximately 1 hour is clinically important to 
determine the actual fit of the lens especially the AEL. 
6. Further research is needed to confirm the validity of the mCCC of “360” µm. 
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Chapter 6 
General Discussion 
  
This thesis has mainly focussed on using OCT and Oculus Pentacam HR
®
 as aids to fitting 
sSCL. It also focussed on how to effectively use the CSD using Visante™ OCT to select the 
appropriate sagittal depth of sSCL to fit on the eye. In addition, the evaluation of the sSCL 
fitting characteristics with NaFl was subjectively assessed. The UL-OCT was used to quantify 
the TCC and its change over time. Questions pertaining to initial sSCL selection, amount of 
CCC and CCCl were assessed and evaluated. Measurement of HCVA and LCVA as well as 
comfort ratings were also evaluated. Repeatability of the instruments in measuring the radius 
of curvature on test surfaces, radius of curvature on the corneal surfaces as well as evaluating 
the corneal thickness in KC and PMD corneae were also reported.  
 
Chapter 2 focussed on the repeatability of the Oculus Pentacam HR
® 
on predefined test 
surfaces (polycarbonate aspheric surfaces). There was no statistically significant difference in 
the measurements among the three day sessions for the radii of curvature, however, slight 
variations were found with the instrument. There was no statistically significant difference 
between the three day sessions for the shape factors, with the exception of one test target 
(brown). Significant correlations were also found with both the radii of curvature and shape 
factors for the three day sessions. Because of the small number of the test surfaces and 
variation in the radii of curvature and shape factors, the results could not predict whether the 
Oculus Pentacam HR
® 
had a specific bias, that is, to either over or under-estimate the 
predefined surfaces. 
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To the best of my knowledge, there is no available report 
1
 with the  Oculus Pentacam HR
®
 on 
predefined surfaces. The absence of a predefined test surface for the calibration before using 
the instrument leaves many clinicians and researchers with questions regarding the accuracy of 
the instrument, despite many reports of the instrument showing good repeatability. 
2-6
 This 
study calls for manufacturers of the instrument to include a test surface for calibration each 
time it is being used for both clinical and research purposes. 
 
Chapter 3 looked at the repeatability and reproducibility of the Visante™ OCT and Oculus 
Pentacam HR
®
. The Visante™ OCT gave repeated measurements for the two visits as there 
were no significant differences in all the respective locations in all meridians. Oculus Pentacam 
HR
® 
also gave repeatable measurements for the majority of the locations. The two instruments 
were found not to be reproducible and should not be used interchangeably; therefore, care must 
be taken interpreting the TCT from the two instruments. It was evident in our study that the 
Oculus Pentacam HR
® 
underestimated the CCT and overestimated the PCT measurement 
relative to the Visante™ OCT. The mean difference between the two instruments was 6.11µm. 
Ho et al. 
7
 reported that the Oculus Pentacam HR
®  
underestimated the CCT in post LASIK 
myopic patients by 4.10±10.65µm compared to the Visante™ OCT. They also reported a 
significant correlation with Visante™ OCT. Several other authors have reported that the 
Oculus Pentacam HR
®
 underestimated the CCT 
3, 8, 9
 while other authors have also reported 
that the Oculus Pentacam HR
®
 overestimated CCT. 
10, 11
 This controversy calls for more 
research with the instrument to find out whether or not the Oculus Pentacam HR
® 
under or 
over-estimates corneal thickness and the factors associated with this. 
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The literature search indicated that there are no reports on the effect of light reflection from the 
limbus and the iris on the quality of the image and its effect on pachymetric values and other 
corneal parameters. The light reflection was seen as a consistent problem with images captured 
by the Oculus Pentacam HR
®
, even though the examination took place in a completely dark 
room. Interestingly, such an effect was not evident in images captured with the Visante™ 
OCT. This may in part explain the variability in the CCT and PCT measurements using KC 
and PMD corneae. Modification may be needed to reduce the amount of corneal reflection 
from the limbus and the iris to improve the image quality. 
 
The results in chapter 4 show each of the instrument per se can give repeatable measurements, 
as there were no significant differences in the two visits, axes and locations. The two 
instruments were found to produce similar results for the majority of locations except for the 
oblique meridians in the periphery. Therefore, it is crucial to always identify the specific 
measurement device when reporting the corneal curvature measurement data.   
  
The major problem associated with Placido-based technology is the use of the reflection from 
the pre-corneal tear film. 
12-14
 This means that data output is likely to be affected when there is 
poor quality of the pre-corneal tear film. 
15-17
 Dogru et al.
18
 report significant changes in tear 
film quality in KC patients compared to normal corneae. This effect is likely to manifest itself 
in corneal topography measurements. 
17
 One of the underlying factors which may have 
accounted for the observed radius of curvature measurements in this study may be attributed to 
the quality of the pre-corneal tear film in KC and PMD corneae in the study. It was also 
observed that the steeper the cornea, the more peripheral data loss with Medmont E300™ 
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(Figure 4-3a). The possible reason is unknown, though the instrument offers greater coverage 
and better spatial resolution for mapping the entire cornea. 
19
   
 
We found slightly increased variability in the central and peripheral cornea with the Oculus 
Pentacam HR
® compared to the Medmont E300™. Shankar et al. 20 and Salmon et al. 21 
reported that there is greater change in the peripheral cornea and this is likely to result in errors 
with the measurements on a tangential maps. This result from the fact that there is no 
topographic reference axis for tangential topographic mapping hence the use of local reference 
axis in mapping the cornea results in peripheral changes in measurements. More research may 
be needed on the radius of curvature derived from height data from the corneal surface which 
in turn is used to extrapolate all the other parameters of the cornea.  
 
In chapter 5, we looked at how to effectively use the CSD to fit sSCL on the eye. We used the 
horizontal CSD (the simplest meridian to measure) measured at 15mm chord to select the 
lenses. The mean CSD was 3.78±0.53mm. Sorbara et al. 
22
 reported 3.93±0.25mm CSD in the 
steepest meridian in KC patients and this was significantly different compared to normal 
cornea. The difference in the CSD is attributed to different meridians chosen for each study 
and may partly depend on the stage of the KC.  
 
To the best of my knowledge, there is no single report on how to use the CSD to fit sSCL on 
the eye. A current fitting philosophy is still based on the radius of curvature measurement 
(VRM). 
23-25
 This philosophy has been questioned recently because sSCL vaults completely 
over the cornea and bears no relationship to the radius of curvature of the corneal surface. 
26, 27
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Schornack et al. 
26
 have also established that there is no relationship between the steepest 
radius of curvature and the sSCL that provided the “optimal” fit for their patients. The use of 
the VRM allows the CCC to be evaluated based on subjective estimation which might lead to 
many clinical errors and will present a lot of challenges to the clinician and researchers. We 
propose that the best way to use the radius of curvature from topography or keratometry is to 
use the expression below to derive the sagittal depth of the cornea in order to choose the initial 
lens. Sagittal depth expression is given by: 
 
Where: 
r= radius of curvature (mm) in the flat meridian. 
p= shape factor derived from the eccentricity (p=1-e
2
). 
chord= any diameter. 
 
It was determined from this study that “lens settling” in sSCL fitting has more clinical 
significance than physiological adaptation to the lens. We found mCCCl of 30±80µm after 1 
hour of lens wear. Caroline et al. 
28
 reported mCCCl of 96µm after 8 hours of sSCL wear. It 
may be very difficult to compare the two studies due to participants used (normal eyes) and the 
sSCL (different lens designs) used in the study. Irrespective of the difference in mCCCl found 
in each study, it is evident that there is the likelihood of corneal clearance loss after some 
period of wearing time. Variation in corneal clearance loss also exists and will depend on many 
factors. We propose that several factors such as eyelid force, dissipation of the saline or the 
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tear film reservoir, design of the sSCL scleral zone radius, thickness profile of the lens, and 
other unknown factors may be responsible for such variations. 
Based on the findings in this study, I suggest that neglecting the amount of the post-lens tear 
film and focusing on the “scleral alignment” as proposed by Schornack et al. 26 may not be 
clinically acceptable in determining the best fit of the lens. We found significant differences 
(p=0.001) in the TCC in the three sSCL used in the study. Therefore, I suggest the TCC should 
be taken into consideration when fitting these lenses. It was also evident in this study that the 
higher the TCC, the poorer the HCVA and LCVA. We found the mean CCC of 360µm to give 
the best combination of VA and comfort ratings.  
 
The results show an overall comfort rating of 77.7±10.6 after the 1 hour of sSCL wear. Similar 
findings have previously been reported by Visser et al. 
29
  
 
The mathematical expression given in chapter 5 can be used for the initial selection of the 
sSCL in a clinical setting; however, care must be taken regarding the CCCl, which may also 
depend on the thickness profile of sSCL. It was not investigated in this study as to whether 
thinner sSCL may cause more “lens settling” than the lens thickness used in this study. In any 
case, the corneal clearance loss should be compensated for to account for lens settling before 
prescribing the final lens in a clinical setting.  
Based on our study and the results obtained, we propose this fitting guide to help practitioners 
and researchers to be able to select and fit SCL in using the CSD. 
1. Measure the CSD along the horizontal meridian at 15mm chord with Visante™ 
OCT. 
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2. Add the estimated amount of corneal clearance to the CSD (360µm). 
3. Add the anticipated corneal clearance loss (30µm). 
4. Select the initial lens.  
5. Insert the lens and allow it to settle for approximately 1 hour. 
6. Assess and evaluate lens to make sure that there is compression or blanching on the 
scleral conjunctiva and the lens vault over the limbus.  
 
In summary, the evaluation of the CSD could offer another alternative where clinicians and 
researchers can effectively select the initial lens and assess the fit on the eye. Appropriate 
estimation of corneal clearance can be measured using OCT rather than the current subjective 
assessment, which compares the thickness of the post-lens tear film to the thickness of the 
cornea with the use of the slit lamp biomicroscope. 
26
  
 
In my opinion, future research should focus on validating the mCCC and understanding of the 
tear flow dynamics in sSCL wear to improve oxygen exchange beneath the lens. Research 
should also focus on accumulation of protein or other tear film components beneath the sSCL 
which is seen as one of the complications of wearing sSCL on long term basis. This will 
hopefully improve the successful wearing of these lenses.  
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APPENDICES 
Appendix 1: Results from Chapter 3 
Mean and SD of TCT in all the meridians for the two visits for Visante™ OCT and Oculus Pentacam HR®. 
Instrument Visits Axis                                            Location  
   
-4 -3 -2 -1 0 1 2 3 4 
Visante V1,2M1,2 90 557.70±60.70 504.61±65.83 468.52±60.07 467.49±46.35 484.97±43.14 511.13±42.85 545.78±43.37 589.9±42.96 643.13±42.58 
  
180 602.12±55.64 553.89±52.79 519.22±47.64 495.61±42.25 484.97±43.14 493.77±45.67 515.44±47.24 543.00±47.70 581.37±49.42 
  
45 575.49±55.93 518.79±54.41 476.70±50.51 468.87±44.77 484.97±43.14 513.05±40.76 541.71±41.41 571.71±42.91 619.43±42.64 
135 587.66±54.80 532.11±73.40 500.45±46.50 484.85±43.60 484.97±43.14 504.74±42.60 534.58±42.00 573.66±42.80 622.91±63.89 
Pentacam V1,2M1,2 90 683.74±64.15 577.10±44.89 498.24±47.67 467.73±54.77 478.86±45.31 517.05±41.64 566.69±42.16 616.71±42.58 674.71±45.33 
  
180 612.23±47.38 548.29±43.48 495.38±42.53 469.28±44.75 478.86±45.31 510.40±41.40 550.60±48.89 599.93±54.71 670.73±54.67 
  
45 654.63±61.75 554.94±50.29 479.11±39.60 456.53±51.27 478.86±45.31 521.10±42.32 565.28±42.97 610.54±45.88 673.81±50.72 
135 659.48±50.50 571.68±56.92 497.14±50.78 467.71±53.78 477.81±45.72 501.49±45.53 551.23±47.72 600.79±41.97 655.78±47.83 
 
V1, 2: Visits 1 and 2. 
M1, 2: Measurement 1 and 2 on each separate visit. 
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Appendix 2: Results from Chapter 4 
Mean and SD of topographic radius of curvature (D) for all the meridians for the two visits for Medmont E300™ and Oculus 
Pentacam HR
®
. 
 
 
V1, 2: Visits 1 and 2. 
M1, 2: Measurement 1 and 2 on each separate visit.
Instrument Visits Angle    Location 
 
 
Medmont 
 
V1,2M1,2 
 
-4 -3 -2 -1 0 1 2 3 4 
90 37.78±8.07 44.94±8.74 50.29±6.7 53.22±4.34 49.41±4.93 43.96±3.32 38.64±4.14 36.39±5.46 35.58±5.21 
180 32.18±4.94 38.99±3.37 45.97±3.35 48.62±4.20 49.41±4.93 45.25±3.23 41.56±3.36 34.01±5.67 29.50±6.47 
45 34.91±5.10 35.49±6.57 44.20±5.16 50.55±4.76 49.41±4.93 40.73±3.09 35.08±7.22 34.16±7.31 32.79±6.05 
135 30.12±5.88 34.36±7.39 41.06±5.40 49.01±4.76 49.41±4.93 44.83±3.64 37.36±4.24 35.18±4.22 32.77±3.84 
 
Pentacam 
 
V1,2M1,2 
90 32.45±9.99 44.11±7.53 51.73±6.17 54.27±5.94 50.38±5.81 42.98±3.92 37.99±8.01 38.28±5.71 36.19±9.07 
180 32.41±4.77 39.47±4.17 46.21±3.39 50.83±7.51 50.38±5.81 45.03±3.64 40.88±3.00 37.54±9.48 32.35±8.79 
45 31.21±8.21 38.72±7.82 45.90±4.59 52.32±5.82 50.38±5.81 45.23±2.78 43.35±5.12 40.61±5.59 39.07±10.81 
135 32.09±7.24 38.05±6.88 44.24±5.27 50.71±7.28 50.38±5.81 45.33±3.92 42.97±5.26 40.16±6.41 38.23±7.88 
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Appendix 3: Declaration of Informed Consent 
I have read the above description prior to deciding to participate in this study.  I have had an 
opportunity to ask questions and have received acceptable answers. I agree to adhere to the 
fitting of the semi-scleral lenses during the experimental period. If I am unable to comply due 
to difficulty wearing or tolerating with the lenses that will be fitted, I shall report this to the 
investigator as soon as possible. 
I am aware that my participation in this study does not replace the need for regular eye 
examinations, and that attending regular eye examinations (at least every two years) is essential 
to ensure that my eyes are healthy. I am aware that eye conditions such as glaucoma, diabetes, 
cataracts and macular disease can only be detected during a full eye examination, and that only 
the front portion of the eye – and, more specifically, only conditions associated with contact 
lens wear – are assessed during the initial screening visit and all subsequent visits needed for 
participation in a CCLR study.  
I am aware that I may withdraw from the study at any time without affecting my relationship 
with the CCLR or the School of Optometry.  I am aware that the investigator reserves the right 
to discontinue my participation from the study at any time, either in regards to the research or 
the health of my eyes.  
I am aware that my participation in this study does not replace or constitute a complete eye 
examination in any way.  During the study and after completion of the scheduled study visits I 
agree to continue eye care at my regular eye care practitioner. 
I am aware that my participation in this study is voluntary, but that following study procedures 
and attending scheduled sessions is important to the success of the research.  I am aware that 
the CCLR would appreciate notification if I am unable to attend a scheduled session, so that it 
can be rescheduled promptly.    
I am aware that this study has been reviewed and received ethics clearance through the Office 
of Research Ethics, and that if I have any concerns or questions about my participation in this 
study, I may contact Dr Susan Sykes, the Director of the Office of Research Ethics at 519 – 
888 - 4567 ext. 36005 or at ssykes@uwaterloo.ca. 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this study. I 
also consent to the release of information from the study, which may be relevant for my 
continued use of contact lenses, to my eye care practitioner. 
I am aware that I will receive a copy of this information and consent letter. I am aware that by 
signing this form I do not waive my legal rights or release the investigator(s), and/or involved 
institution(s) from their legal and professional responsibilities. 
___________________________________  _____________________________ 
Signature of participant                               Date 
    
___________________________________   
Printed name of participant  
 
___________________________________  _____________________________ 
Signature of person explaining consent                        Date  
   
___________________________________  _____________________________ 
Signature of witness    Date
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Appendix 4: Screening Form 
Date _____________Study _______________  Participant _______ ID _________  
ICL Checklist for Prospective Participant (PP) 
 ICL given to PP 
 PP given ample time to read ICL 
 PP given opportunity to ask questions 
 PP initialed all pages 
 PP, investigator and witness correctly signed and dated ICL 
 PP given copy of ICL 
 PP forgot copy of ICL – copy has been mailed to address listed in pre-screening database  
 PP took ICL home to discuss with family member(s) or friend(s) 
 
History: 
Date of birth ________(DD/MM/YYYY)  Age_____           Female   Male       
Occupation________________________________ 
Current Lens Wear: 
Current lens type: ________ Average wearing time: hours/day _______ days/week ____________total # years wear _______ 
Replacement frequency: _____________       Current care system: ______________      
Comfortable/tolerable wearing time: _________ hours/day    Comfortable wearing time less than average wearing time:    
Yes   No 
Presence of symptoms of dryness & discomfort:       Yes     No      Use of rewetting /lubricant drops:    Yes    No                                           
If “Yes”:   Current rewetting drops: ____________________ How often do you insert drops:  ___ / day ____ / week 
Other relevant history:   
 
General Health _______________________ Medications ____________________ Allergies _______________ 
Smoker?_________ 
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OD                                                              OS  
INCLUSION / EXCLUSION CRITERIA 
INCLUSION EXCLUSION 
Y N  Y N  
  
Is at least 17 years of age and has full legal 
capacity to volunteer 
  
Is participating in any concurrent clinical or 
research study 
  Has read and signed the informed consent letter   
Has any known active ocular disease and/or 
infection  
  
Is willing and able to follow instructions and 
maintain the appointment schedule 
  
Has a systemic condition that may affect a 
study outcome variable 
  
Has been diagnosed with keratoconus or pellucid  
Marginal degeneration 
  
Is using any systemic or topical medications 
that may affect a study outcome variable 
  
The patient is currently wearing his/her contact 
lenses or glasses to  improve his/her vision 
  
Has known sensitivity to the diagnostic 
pharmaceuticals to be used in the study 
     Is aphakic 
     
Has taken part in another (pharmaceutical) 
research study within the last 30 days 
     
Has had any form of surgery for the 
correction of the keratoconus and pellucid 
marginal degeneration. 
     Has undergone refractive surgery 
Based on the study inclusion/exclusion criteria, is the participant suitable for the 
study? 
 Yes 
   No 
Participant to continue in study?       Yes      No     
 
 
Investigator signature: ___________________________________________________ 
 
 
 
 
Date: 
______________________ 
 
Signature of lead investigator (if not completing screening): Date: 
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Biomicroscopy-Ext. Adnexa Anomalies OD OS 
 
Absent:            Present  
 
Describe:_______________________________________ 
 
_______________________________________________ 
 
_______________________________________________ 
 
   
. 
 
 
 
 
 
 
  
  
 
 
 
 
HYPEREMIA 
Bulbar    
S   
   
S   
 
  
T 
  
N 
 
N 
  
T 
  negligible  
 trace   
  mild  
  moderate  
  severe 
0___________|_____________|____________|________
____100 
 
 
 
 
I    
  
 
 
I    
 
Limbal    
S   
   
S   
 
  
T 
  
N 
 
N 
  
T 
  negligible trace/localized
   mild 
   moderate 
  severe 
 
 0___________|_____________|_________
___|____________100 
 
 
 
I    
  
 
 
I    
 
 
CORNEA & ANTERIOR EYE                                          OD                                                                  OS 
Scars or other corneal observations:  
 
Absent    Present 
 & Describe:       
 
                                         
_________ 
 
______________ 
 
______________ 
 
 
 
Absent    Present 
 & Describe:       
 
_____________ 
_________ 
 
 
Infiltrates:    
 
Size (diameter) of largest infiltrate 
 0 = none                        3 = 1 - 1.5mm 
 1 = < 0.5mm                  4 = >1.5mm 
 2 = 0.5 - 1mm 
  
Depth of largest infiltrate 
 0 = none                        3 = mid 
stromal 
 1 = epithelial                 4 = deep 
stromal 
 2 = sub-epithelial 
  
 
Absent       Present   
 
 
 
 
 
 
 
Complete only if present: 
C   
 # _____ S _____ D 
_____ 
 
MP   # 
_____ S _____ D _____ 
 
P   
 # _____ S _____ D 
_____ 
Absent       Present   
 
 
 
 
 
 
 
 
Complete only if present: 
C   
 # _____ S _____ D 
_____ 
 
MP   # 
_____ S _____ D _____ 
 
P   
 # _____ S _____ D 
_____ 
 
 
 
 
Endothelium ab ormalities:   Absent    Present  & 
Describe:       
         
Absent    Present  & 
Describe:       
 
Anterior chamber reaction:   
 
Absent    Present  & 
Describe:       
 
Absent    Present  & 
Describe:       
 
Other abnormalities:   
 
Absent    Present  & 
Describe:       
 
Absent    Present  & 
Describe:       
 
MP
C
P
MP
C
P
MP
C
P
MP
C
P
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Appendix 5: Semi-scleral Fitting Forms-Fitting and Assessment 1 
Date__________     Study: _____________                  Participant ______________ ID _____   Visit 1-1 
Current Contact Lens VA OD OS 
LogMAR chart (Mid Illumination) HCVA LCVA HCVA LCVA 
     
Remove Lens (s)/Spectacle: Image with Medmont (2X) then, Pentacam (2X), then, UL-OCT (2X) along 
both nasal and temporal and finally with the Visante OCT (both global pachymetry (2X) and two 
enhanced anterior segments i.e. at 090 and at 180 (1X each).  
 
 
Simulated K readings Flat 
D/Steep D 
OD: Pentacam OD: Medmont OS: Pentacam OS: Medmont 
_____D/_____D 
 
_____D/_____D _____D/_____D _____D/_____D 
Average K (D)     
Steepest K reading(D) @ 
apex/thinnest point 
    
Corneal cyl and axis ______X_____ _____X_____ _____X_____ _____X_____ 
Cone diameter (apex and 
overall) mm 
_____/______ _____/______ _____/______ _____/______ 
Cone type/severity 
Cen/Oval/PMD//Mi,M,S 
    
Pachymetry (central and 
thinnest pt) µm 
_____/______  _____/______ _____/______ _____/______ 
HVID (mm)     
pupil diameter (mm)     
e-value     
 Visante OCT Medmont Visante OCT Medmont 
Sag @ 15mm (mm)090     
Sag @ 15mm (mm)180     
Sag @ 10mm (mm)090     
Sag @ 10mm (mm)180     
 Visante OCT  Visante OCT  
Pachymetry-1   
Pachymetry-2   
Cent: Thinnest: Cent: Thinnest: 
Cent: Thinnest: Cent: Thinnest: 
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                                      OD 2                                       OS 2 
 
 
Simulated K readings Flat 
D/Steep D 
Pentacam Medmont Pentacam Medmont 
_____D/_____D 
 
_____D/_____D _____D/_____D _____D/_____D 
Average K (D)     
Steepest K reading(D) @ 
apex/thinnest point 
    
Corneal cyl and axis ______X_____ _____X_____ _____X_____ _____X_____ 
Cone diameter (apex and 
overall) mm 
_____/______ _____/______ _____/______ _____/______ 
Cone type/severity 
Cen/Oval/PMD//Mi,M,S 
    
Pachymetry (central and 
thinnest pt) µm 
_____/______  _____/______ _____/______ _____/______ 
HVID (mm)     
pupil diameter (mm)     
e-value     
 Visante OCT Medmont Visante OCT Medmont 
Sag @ 15mm (mm)090     
Sag @ 15mm (mm)180     
Sag @ 10mm (mm)090     
Sag @ 10mm (mm)180     
 Visante OCT  Visante OCT  
Pachymetry-1   
Pachymetry-2   
Cent: Thinnest: Cent: Thinnest: 
Cent: Thinnest: Cent: Thinnest: 
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TOPOGRAPHIC PACHYMETRY: Visante™ OCT and Pentacam (Data packs on the instruments, repeatability 2X)-OD/OS 2X 
 
  
   Inferior-1                    
 
                Superior-1 
 
Inferior-2 
 
                     Superior-2 
 
 -4 -3 -2 -1 0 +1 +2 +3 +4 -4 
 
-3 -2 -1 0 +1 +2 +3 +4 
 
Visante OCT @ 90 (µm) 
                  
 
Pentacam @ 90 (µm) 
                  
  
        Temporal-1                                                                        Nasal-1 
     
Temporal-2                                                                                  Nasal-2 
 
 -4 -3 -2 -1 0 +1 +2 +3 +4 -4 
 
-3 -2 -1 0 +1 +2 +3  
 
Visante OCT @ 180 (µm) 
                  
 
Pentacam @180 (µm) 
                  
  
   Inf-Temp-1                                                                         Sup-Nasal-1 
 
Inf-Temp-2                                                                             Sup-Nasal-2 
 -4 -3 -2 -1 0 +1 +2 +3 +4 -4 -3 -2 -1 0 +1 +2 +3 +4 
 
Visante OCT @ 045 (µm) 
                  
 
Pentacam @ 045 (µm) 
                  
  
          Inf-Temporal                                                              Sup-Temporal       
 
          Inf-Temporal                                                                        Sup-Temporal       
 -4 -3 -2 -1 0 1 2 3 4 -4 -3 -2 -1 0 1 2 3 4 
 
Visante OCT @ 135 (µm) 
                  
 
Pentacam @ 135 (µm) 
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TOPOGRAPHIC KERATOMETRY: Medmont and Pentacam (Data hand written from the instrument: repeatability 2X)-OD/OS 2X  
 
 
  
   Inferior-1                    
 
                Superior-1 
 
Inferior-2 
 
                     Superior-2 
 
 -4 -3 -2 -1 0 +1 +2 +3 +4 -4 
 
-3 -2 -1 0 +1 +2 +3 +4 
 
Visante OCT @ 90 (µm) 
                  
 
Pentacam @ 90 (µm) 
                  
  
        Temporal-1                                                                        Nasal-1 
     
Temporal-2                                                                                  Nasal-2 
 
 -4 -3 -2 -1 0 +1 +2 +3 +4 -4 
 
-3 -2 -1 0 +1 +2 +3  
 
Visante OCT @ 180 (µm) 
                  
 
Pentacam @180 (µm) 
                  
  
   Inf-Temp-1                                                                         Sup-Nasal-1 
 
Inf-Temp-2                                                                             Sup-Nasal-2 
 -4 -3 -2 -1 0 +1 +2 +3 +4 -4 -3 -2 -1 0 +1 +2 +3 +4 
 
Visante OCT @ 045 (µm) 
                  
 
Pentacam @ 045 (µm) 
                  
  
          Inf-Temporal                                                              Sup-Temporal       
 
          Inf-Temporal                                                                        Sup-Temporal       
 -4 -3 -2 -1 0 1 2 3 4 -4 -3 -2 -1 0 1 2 3 4 
 
Visante OCT @ 135 (µm) 
                  
 
Pentacam @ 135 (µm) 
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Semi-scleral Fitting Forms-Fitting and Assessment 2 
 
Date__________     Study:                       Participant ______________ ID _____   Visit 1-1 
Current Contact Lens VA OD OS 
LogMAR chart (Mid Illumination) HCVA LCVA HCVA LCVA 
     
Remove Lens (s)/Spectacle: Image with Medmont (2X) then, Pentacam (2X), then, UL-OCT (2X) along both 
nasal and temporal and finally with the Visante OCT (both global pachymetry (2X) and two enhanced 
anterior segments i.e. at 090 and at 180 (1X each).  
   
  
 
Simulated K readings Flat 
D/Steep D 
OD: Pentacam OD: Medmont OS: Pentacam OS: Medmont 
_____D/_____D 
 
_____D/_____D _____D/_____D _____D/_____D 
Average K (D)     
Steepest K reading(D) @ 
apex/thinnest point 
    
Corneal cyl and axis ______X_____ _____X_____ _____X_____ _____X_____ 
Cone diameter (apex and 
overall) mm 
_____/______ _____/______ _____/______ _____/______ 
Cone type/severity 
Cen/Oval/PMD//Mi,M,S 
    
Pachymetry (central and 
thinnest pt) µm 
_____/______  _____/______ _____/______ _____/______ 
HVID (mm)     
pupil diameter (mm)     
e-value     
 Visante OCT Medmont Visante OCT Medmont 
Sag @ 15mm (mm)090     
Sag @ 15mm (mm)180     
Sag @ 10mm (mm)090     
Sag @ 10mm (mm)180     
 Visante OCT  Visante OCT  
Pachymetry-1   
Pachymetry-2   
Cent: Thinnest: Cent: Thinnest: 
Cent: Thinnest: Cent: Thinnest: 
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                                       OD 2                                    OS 2 
 
 
Simulated K readings Flat 
D/Steep D 
Pentacam Medmont Pentacam Medmont 
_____D/_____D 
 
_____D/_____D _____D/_____D _____D/_____D 
Average K (D)     
Steepest K reading(D) @ 
apex/thinnest point 
    
Corneal cyl and axis ______X_____ _____X_____ _____X_____ _____X_____ 
Cone diameter (apex and 
overall) mm 
_____/______ _____/______ _____/______ _____/______ 
Cone type/severity 
Cen/Oval/PMD//Mi,M,S 
    
Pachymetry (central and 
thinnest pt) µm 
_____/______  _____/______ _____/______ _____/______ 
HVID (mm)     
pupil diameter (mm)     
e-value     
 Visante OCT Medmont Visante OCT Medmont 
Sag @ 15mm (mm)090     
Sag @ 15mm (mm)180     
Sag @ 10mm (mm)090     
Sag @ 10mm (mm)180     
 Visante OCT  Visante OCT  
Pachymetry-1   
Pachymetry-2   
Cent: Thinnest: Cent: Thinnest: 
Cent: Thinnest: Cent: Thinnest: 
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SEMI-SCLERAL FITTING AND ASSESSMENT 
 
 
 
OD/OS  
      
 
 
 
 
INSERTION OF THE SEMI-SCLERAL LENS Use unpreserved saline Use NaFl strip 
Randomized         Trial # 1 
 
Trial # 2 
 
Trial # 3 
Lens 
 
 
 
 
       
 
 
BC / Diam / Power / CT      /         /        /      /        /        /      /        /        / 
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FLUORESCEIN CHARACTERISTIC RATING @ 60 minutes 
  OD/OS     
Fluorescein Rating 
Central 
-2 = flat, moderate dark touch area 
-1 = slightly flat, small dark noticeable 
touch at centre 
 0 = alignment, even fluorescein across 
optic zone 
+1 = slightly steep, noticeably brighter at 
centre 
+2 = steep, clearly noticeable central 
pooling 
Lens # 1 Lens # 2 Lens # 3 
 
 
-2    -1    0   +1    +2 
 
 
-2    -1    0    +1    +2 
 
 
-2    -1    0    +1    +2 
Mid Periphery (MP) 
-2 = flat, fluorescein under MP merging 
into edge 
-1 = slightly flat, slight fluorescein under 
MP 
 0 = alignment, smooth transition into 
edge 
+1 = slightly tight, narrow or slight dark 
band before edge 
+2 = tight, moderate pressure just before 
the edge lift 
 
 
-2    -1    0    +1    +2 
 
 
-2    -1    0    +1    +2 
 
 
-2    -1    0    +1    +2 
Edge Width 
-2 = wide 
-1 = slightly wide 
 0 = optimal 
+1 = slightly narrow 
+2 = narrow 
 
 
-2    -1    0    +1    +2 
 
 
-2    -1    0    +1    +2 
 
 
-2    -1    0    +1    +2 
Edge Clearance 
-2 = excessive 
-1 = slightly excessive 
 0 = optimal 
+1 = slightly insufficient 
+2 = insufficient 
 
 
-2    -1    0    +1    +2 
 
 
-2    -1    0   +1     +2 
 
 
-2    -1    0    +1    +2 
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LENS # 1 
TOPOGRAPHIC CORNEAL CLEARANCE 
Method 2: UL-OCT 14mm (Y-scan) Images taken every 10 minutes interval. 
 
 OD/OS        
Photo white@090 white@090 white@090 white@090 white@090 white@090 white@090 
µm (0min) µm(10min) µm(20 min) µm(30 min) µm(40 min) µm(50 min) µm(60 min) 
+7 Sup        
+6 Sup        
+5 Sup        
+4 Sup        
+3 Sup        
+2 Sup        
+1 Sup        
centre        
-1 Inf        
-2 Inf        
-3 Inf        
-4 Inf        
-5 Inf        
-6 Inf        
-7 Inf        
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LENS # 2 
TOPOGRAPHIC CORNEAL CLEARANCE 
Method 2: UL-OCT 14mm (Y-scan) Images taken every 10 minutes interval. 
 
 OD/OS        
Photo white@090 white@090 white@090 white@090 white@090 white@090 white@090 
µm (0min) µm(10min) µm(20 min) µm(30 min) µm(40 min) µm(50 min) µm(60 min) 
+7 Sup        
+6 Sup        
+5 Sup        
+4 Sup        
+3 Sup        
+2 Sup        
+1 Sup        
centre        
-1 Inf        
-2 Inf        
-3 Inf        
-4 Inf        
-5 Inf        
-6 Inf        
-7 Inf        
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LENS # 3 
TOPOGRAPHIC CORNEAL CLEARANCE 
Method 2: UL-OCT 14mm (Y-scan) Images taken every 10 minutes interval. 
 
 OD/OS        
Photo white@090 white@090 white@090 white@090 white@090 white@090 white@090 
µm (0min) µm(10min) µm(20 min) µm(30 min) µm(40 min) µm(50 min) µm(60 min) 
+7 Sup        
+6 Sup        
+5 Sup        
+4 Sup        
+3 Sup        
+2 Sup        
+1 Sup        
centre        
-1 Inf        
-2 Inf        
-3 Inf        
-4 Inf        
-5 Inf        
-6 Inf        
-7 Inf        
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OVER-REFRACTION/OVER-KERATOMETRY AND VA: at 60 minutes only 
 OD/OS     
 
    Lens # 1 Lens # 2 Lens # 3 
Over-refraction 
Sph/cyl/axis           /               /          /          /             /           / 
Over-keratometry 
Cyl/axis                    /               /                   / 
Best sphere correction    
LogMAR VA  
(HCVA & LCVA)   
      
 
SUBJECTIVE COMFORT RATING 
The following questions are all of the comfort about each lens you are wearing in the study. 
This is done at 60 minutes only. 
Lens # 1. How would you rate your comfort with your study lens? 
0 100 
Very poor comfort                                                                      excellent comfort 
Lens # 2. How would you rate your comfort with your study lens? 
0 100 
Very poor comfort                                                                      excellent comfort 
Lens # 3. How would you rate your comfort with your study lens? 
0 100 
Very poor comfort                                                                      excellent comfort 
 
RE 
LE 
RE 
LE 
RE 
LE 
 
Comments  
 
Signature__________________                                     Date__________________  
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Appendix 6a: Results from Chapter 5 for Lens 1 
TCC (mm) at 1 hour for Lens 1. 
Lens 1 at 1 hour 
 
 
 
Superior 
 
 
Location 
 
Inferior 
ID +4 +3 +2 +1 Centre -1 -2 -3 -4 
01 0.058 0.100 0.130 0.135 0.150 0.194 0.264 0.339 0.386 
02 0.010 0.046 0.063 0.066 0.055 0.045 0.054 0.037 0.082 
03 0.000 -0.003 -0.002 0.001 0.001 -0.001 0.007 0.034 0.049 
04 0.200 0.268 0.307 0.314 0.289 0.265 0.238 0.203 0.146 
05 0.148 0.266 0.314 0.324 0.308 0.286 0.267 0.242 0.212 
06 0.053 0.119 0.153 0.176 0.178 0.183 0.192 0.205 0.219 
07 0.149 0.211 0.228 0.197 0.153 0.115 0.010 0.087 0.087 
08 0.166 0.247 0.304 0.312 0.334 0.354 0.374 0.386 0.361 
09 0.006 0.048 0.091 0.123 0.161 0.193 0.219 0.239 0.243 
10 0.162 0.256 0.291 0.291 0.271 0.265 0.259 0.252 0.207 
11 0.057 0.128 0.204 0.239 0.246 0.244 0.212 0.193 0.177 
12 0.134 0.191 0.220 0.213 0.204 0.192 0.162 0.121 0.068 
13 0.167 0.249 0.289 0.307 0.299 0.263 0.227 0.176 0.119 
14 0.103 0.220 0.289 0.320 0.324 0.285 0.215 0.148 0.088 
15 0.035 0.081 0.105 0.113 0.106 0.122 0.168 0.230 0.252 
16 0.188 0.293 0.325 0.313 0.266 0.212 0.155 0.107 0.067 
17 0.099 0.175 0.225 0.249 0.248 0.240 0.221 0.210 0.185 
18 0.141 0.190 0.181 0.126 0.067 0.028 0.021 0.043 0.082 
18 0.056 0.085 0.101 0.107 0.100 0.113 0.120 0.129 0.108 
20 0.000 0.000 0.000 0.008 0.033 0.056 0.107 0.139 0.171 
Mean 0.10 0.16 0.19 0.20 0.19 0.18 0.17 0.18 0.17 
SD 0.07 0.09 0.11 0.11 0.10 0.10 0.10 0.09 0.10 
 
Note: The negative sign means area of touch on the cornea. 
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Appendix 6b: Results from Chapter 5 for Lens 1 
TCC (mm) at Selected Time Interval for Lens 1. 
Lens 1 
 Superior 20 min Inferior Inferior 40 min Inferior Inferior 60 min Inferior 
ID +3 Centre -3 +3 centre -3 +3 Centre -3 
01 -0.004 0.006 0.033 0.022 0.013 0.031 0.026 0.020 0.029 
02 0.003 0.000 -0.007 0.003 0.007 0.021 0.008 0.009 0.071 
03 -0.001 -0.002 -0.037 0.000 -0.003 -0.355 0.002 -0.001 -0.027 
04 -0.013 0.021 0.048 0.048 0.064 0.103 0.034 0.075 0.112 
05 0.016 -0.006 -0.002 0.022 -0.019 -0.002 0.017 -0.003 0.003 
06 -0.005 0.005 0.021 -0.011 0.009 0.016 -0.01 0.006 0.021 
07 0.004 0.004 0.002 0.028 0.048 0.033 0.036 0.054 0.037 
08 -0.008 0.019 0.008 0.069 0.035 0.033 -0.006 0.022 0.034 
09 -0.013 -0.003 0.003 0.012 0.017 0.021 0.015 0.009 0.014 
10 0.003 -0.019 0.004 0.038 -0.001 0.015 0.009 0.013 0.020 
11 0.008 0.008 0.011 0.039 0.006 0.009 0.024 0.007 0.015 
12 0.013 0.010 -0.001 0.015 0.017 0.035 0.009 0.046 0.056 
13 0.034 0.012 -0.019 0.027 0.030 0.010 0.030 0.023 0.010 
14 -0.015 -0.003 -0.002 0.016 0.029 0.022 -0.009 0.032 0.057 
15 0.004 0.004 0.011 0.024 0.000 0.041 0.012 -0.007 -0.002 
16 0.011 0.010 0.020 0.050 -0.008 -0.008 -0.003 0.032 0.032 
17 0.015 0.017 0.020 0.020 0.010 -0.005 0.001 0.026 0.044 
18 0.001 0.023 0.046 0.026 0.082 0.106 0.030 0.104 0.121 
19 0.001 0.000 0.004 0.033 0.038 0.047 0.014 0.035 0.042 
20 -0.012 -0.002 -0.013 0.020 0.000 -0.028 0.020 0.009 -0.012 
Mean 0.00 0.01 0.01 0.03 0.02 0.01 0.01 0.03 0.03 
SD 0.01 0.01 0.02 0.02 0.03 0.09 0.01 0.03 0.04 
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Appendix 7a: Results from Chapter 5 for Lens 2 
TCC (mm) at 1 hour for Lens 2. 
Lens 2 at 1 hour 
Superior Location Inferior 
ID +4 +3 +2 +1 Centre -1 -2 -3 -4 
01 0.063 0.104 0.132 0.140 0.151 0.201 0.268 0.340 0.385 
02 0.141 0.243 0.296 0.322 0.334 0.336 0.347 0.346 0.323 
03 0.070 0.141 0.179 0.197 0.207 0.224 0.235 0.226 0.208 
04 0.311 0.434 0.493 0.528 0.512 0.500 0.465 0.403 0.336 
05 0.239 0.364 0.435 0.454 0.448 0.420 0.387 0.350 0.300 
06 0.109 0.216 0.337 0.409 0.453 0.479 0.505 0.517 0.525 
07 0.188 0.329 0.406 0.420 0.398 0.358 0.314 0.270 0.206 
08 0.202 0.327 0.405 0.446 0.476 0.497 0.505 0.519 0.476 
09 0.068 0.145 0.240 0.317 0.374 0.415 0.432 0.447 0.434 
10 0.281 0.422 0.517 0.550 0.544 0.537 0.503 0.452 0.380 
11 0.118 0.234 0.322 0.363 0.379 0.367 0.308 0.270 0.291 
12 0.195 0.294 0.363 0.406 0.406 0.399 0.371 0.332 0.269 
13 0.164 0.185 0.187 0.187 0.159 0.132 0.115 0.078 0.064 
14 0.139 0.294 0.400 0.469 0.494 0.456 0.400 0.303 0.241 
15 0.168 0.265 0.326 0.363 0.373 0.388 0.437 0.465 0.446 
16 0.196 0.349 0.433 0.460 0.411 0.392 0.328 0.263 0.194 
17 0.055 0.107 0.161 0.171 0.180 0.178 0.189 0.204 0.215 
18 0.212 0.347 0.405 0.409 0.380 0.351 0.343 0.329 0.324 
19 0.161 0.264 0.328 0.364 0.376 0.383 0.381 0.351 0.319 
20 0.068 0.099 0.116 0.136 0.151 0.174 0.187 0.215 0.230 
Mean 0.16 0.26 0.32 0.36 0.36 0.36 0.35 0.33 0.31 
SD 0.07 0.10 0.12 0.13 0.12 0.12 0.11 0.11 0.11 
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Appendix 7b:  Results from Chapter 5 for Lens 2 
TCC (mm) at Selected Time Interval for Lens 2. 
Lens 2 
 Superior 20 min Inferior Superior 40 min Inferior Superior 60 min Inferior 
ID +3 Centre -3 +3 Centre -3 +3 Centre -3 
01 -0.020 -0.010 -0.001 0.184 0.247 0.185 0.189 0.255 0.187 
02 0.016 -0.002 -0.012 -0.020 0.001 0.009 -0.023 -0.009 -0.022 
03 -0.033 -0.003 0.007 -0.039 0.002 0.017 -0.028 0.012 0.028 
04 0.005 0.006 0.009 -0.043 -0.003 0.007 -0.066 -0.004 0.044 
05 -0.004 0.010 0.006 0.007 -0.014 -0.027 0.003 -0.009 -0.021 
06 -0.031 0.003 0.010 -0.025 0.007 0.005 0.049 0.034 0.037 
07 0.035 0.017 0.014 0.022 0.052 0.041 0.071 0.050 0.039 
08 0.007 0.002 0.014 0.028 0.049 0.031 0.054 0.047 0.043 
09 -0.001 0.005 0.021 -0.006 0.003 0.023 0.055 0.033 0.029 
10 -0.006 -0.018 -0.016 0.036 -0.020 -0.020 0.016 -0.001 0.001 
11 0.029 0.015 0.012 0.015 0.021 0.032 0.015 0.019 0.074 
12 0.155 -0.048 0.264 0.147 -0.041 0.273 0.185 -0.035 0.262 
13 0.020 0.036 0.051 0.042 0.082 0.085 0.054 0.101 0.117 
14 0.043 0.025 -0.009 -0.006 0.024 0.019 0.024 0.025 0.044 
15 0.082 0.042 0.017 0.073 0.045 0.019 0.034 0.026 0.011 
16 -0.040 -0.013 -0.009 -0.016 0.010 0.012 0.023 0.008 -0.028 
17 0.066 0.024 0.043 0.052 0.025 0.014 0.033 0.024 0.032 
18 0.042 0.009 0.022 0.028 0.028 0.038 0.055 0.050 0.047 
19 0.024 0.005 0.034 0.015 0.031 0.054 0.019 0.040 0.075 
20 0.015 0.003 0.001 -0.008 -0.004 0.003 0.005 0.024 0.049 
Mean 0.02 0.01 0.02 0.02 0.03 0.04 0.04 0.03 0.05 
SD 0.04 0.02 0.06 0.06 0.06 0.07 0.06 0.06 0.07 
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Appendix 8a: Results from Chapter 5 for Lens 3 
TCC (mm) at 1 hour for Lens 3. 
Lens 3at 1 hour 
Superior Location Inferior 
ID +4 +3 +2 +1 Centre -1 -2 -3 -4 
01 0.201 0.321 0.406 0.447 0.455 0.447 0.434 0.405 0.355 
02 0.140 0.262 0.363 0.430 0.459 0.471 0.478 0.467 0.422 
03 0.147 0.237 0.322 0.349 0.368 0.389 0.400 0.390 0.351 
04 0.293 0.460 0.575 0.640 0.660 0.649 0.629 0.571 0.500 
05 0.201 0.321 0.406 0.447 0.455 0.447 0.434 0.405 0.355 
06 0.204 0.339 0.447 0.514 0.540 0.542 0.527 0.491 0.448 
07 0.176 0.270 0.308 0.289 0.251 0.204 0.182 0.150 0.104 
08 0.210 0.303 0.391 0.440 0.459 0.486 0.499 0.503 0.462 
09 0.043 0.097 0.160 0.213 0.251 0.29 0.320 0.332 0.332 
10 0.209 0.324 0.391 0.416 0.397 0.370 0.363 0.333 0.290 
11 0.249 0.441 0.560 0.635 0.661 0.649 0.601 0.542 0.458 
12 0.312 0.465 0.583 0.650 0.670 0.654 0.620 0.544 0.431 
13 0.306 0.405 0.462 0.493 0.479 0.440 0.383 0.307 0.223 
14 0.310 0.513 0.656 0.736 0.753 0.721 0.641 0.524 0.394 
15 0.068 0.137 0.186 0.210 0.214 0.219 0.250 0.297 0.306 
16 0.289 0.519 0.659 0.709 0.694 0.639 0.556 0.449 0.324 
17 0.180 0.284 0.368 0.406 0.424 0.409 0.388 0.369 0.339 
18 0.175 0.263 0.279 0.254 0.190 0.161 0.155 0.167 0.196 
19 0.179 0.255 0.300 0.317 0.332 0.347 0.374 0.391 0.353 
20 0.132 0.206 0.290 0.351 0.385 0.413 0.441 0.454 0.454 
Mean  0.20 0.32 0.41 0.45 0.45 0.45 0.43 0.40 0.35 
SD 0.08 0.12 0.14 0.16 0.17 0.16 0.14 0.12 0.10 
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Appendix 8b: Results from Chapter 5 for Lens 3 
TCC (mm) at Selected Time Interval for Lens 3. 
Lens 3 
 Superior 20 min Inferior Superior 40 min Inferior Superior 60 min Inferior 
ID +3 Centre -3 +3 Centre -3 +3 Centre -3 
01 -0.005 0.006 0.023 0.012 0.022 0.033 0.033 0.041 0.052 
02 0.059 0.009 -0.014 -0.003 -0.004 -0.005 0.033 0.023 0.029 
03 0.025 -0.002 0.028 0.040 0.020 0.051 0.053 0.032 0.065 
04 -0.023 0.003 0.033 -0.008 0.007 0.039 0.023 0.007 0.029 
05 -0.004 0.006 0.023 0.012 0.022 0.033 0.033 0.041 0.052 
06 -0.035 -0.004 0.004 -0.014 0.002 -0.023 0.048 0.003 -0.042 
07 0.010 0.023 0.012 0.019 0.065 0.051 0.026 0.061 0.049 
08 -0.050 -0.039 -0.016 -0.013 0.003 0.022 0.012 0.025 0.052 
09 0.010 0.020 0.028 0.006 0.021 0.035 0.034 0.057 0.057 
10 -0.016 0.006 0.027 0.022 0.034 0.053 0.019 0.030 0.053 
11 -0.004 0.012 0.032 0.049 0.026 0.027 0.037 0.030 0.043 
12 0.001 0.018 0.011 -0.001 0.026 0.037 -0.008 0.041 0.089 
13 0.009 0.033 0.063 0.036 0.056 0.089 0.037 0.072 0.098 
14 0.030 0.004 -0.012 -0.008 0.025 0.039 0.054 0.019 -0.008 
15 0.041 0.030 0.052 0.038 0.027 0.054 0.060 0.032 0.059 
16 -0.102 0.041 0.098 -0.018 0.041 0.056 0.004 0.025 0.065 
17 -0.003 -0.033 -0.036 0.039 -0.002 -0.018 -0.013 -0.015 0.023 
18 0.015 -0.019 0.034 0.002 0.004 0.029 0.022 0.006 0.029 
19 -0.016 0.025 0.063 -0.023 0.014 0.046 0.106 0.251 0.208 
20 -0.034 -0.014 -0.001 0.048 0.031 0.019 0.054 0.047 0.043 
Mean 0.00 0.01 0.02 0.01 0.02 0.03 0.03 0.04 0.05 
SD 0.03 0.02 0.03 0.02 0.02 0.03 0.03 0.05 0.05 
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